According to our research, the protein corona data is based on the physical and chemical properties of its formation process, and the origin of this data is reflected through the relevant research papers. Our work collected the existing data and obtained the following 652 pieces of relevant data.
| ProtID | SizeTEM (nm) | NP shape | SizeDLS (nm) | NP type | Incubation NP concentration(mg/L) | Incubation protein source | Surface modification | PDI | Centrifugation speed (g) | Zeta potential | Centrifugation repetitions | Centrifugation time （min） | NP without modification | Dispersion medium | Incubation plasma concentration (v/v%) | Modification type | Incubation time (h) | Incubation culture | Incubation temperature (℃) | Certrifugation temperature (℃) | Dispersion medium pH | Protein type | Title |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Prot0001 | 19.09 | sphere | 47.02 | metal | 0.02101 | HP | PVP | 0.126944444 | 19000.0 | -23.97 | 1 | 20.0 | Au(GNP) | plasma | 66.0 | Neutral | 1.0 | buffer | 37 | 4 | 7.4 | Serum protein | Interaction of gold and silver nanoparticles with human plasma: Analysis of protein corona reveals specific binding patterns |
| Prot0002 | 20.08 | sphere | 56.6 | metal | 0.02101 | HP | CIT | 0.126944444 | 19000.0 | -24.97 | 1 | 20.0 | Au(GNP) | plasma | 66.0 | Anionic | 1.0 | buffer | 37 | 4 | 7.4 | Serum protein | Interaction of gold and silver nanoparticles with human plasma: Analysis of protein corona reveals specific binding patterns |
| Prot0003 | 18.11 | sphere | 295.2 | metal | 0.02101 | HP | BPEI | 0.126944444 | 19000.0 | -26.9 | 1 | 20.0 | Au(GNP) | plasma | 66.0 | Cationic | 1.0 | buffer | 37 | 4 | 7.4 | Serum protein | Interaction of gold and silver nanoparticles with human plasma: Analysis of protein corona reveals specific binding patterns |
| Prot0004 | 59.3 | sphere | 52 | metal | 474.087541 | HS | MSA | 0.287666667 | 15000.0 | -14.23833333 | 1 | 45.0 | Au(GNP) | PBS | 100.0 | Anionic | 1.0 | buffer | 37 | 4 | 7.4 | Serum protein | Protein corona fingerprinting predicts the cellular interaction of gold and silver nanoparticles |
| Prot0005 | 59.3 | sphere | 97.68 | metal | 1888.699399 | HS | amino acid | 0.095888889 | 1500.0 | -12.15 | 1 | 45.0 | Au(GNP) | PBS | 100.0 | Anionic | 1.0 | buffer | 37 | 4 | 7.4 | Serum protein | Protein corona fingerprinting predicts the cellular interaction of gold and silver nanoparticles |
| Prot0006 | 59.3 | sphere | 41.78 | metal | 474.087541 | HS | ODA | 0.42125 | 15000.0 | -11.75166667 | 1 | 45.0 | Au(GNP) | PBS | 100.0 | Cationic | 1.0 | buffer | 37 | 4 | 7.4 | Serum protein | Protein corona fingerprinting predicts the cellular interaction of gold and silver nanoparticles |
| Prot0007 | 59.3 | sphere | 60.9 | metal | 1007.212946 | HS | amino acid | 0.143777778 | 4500.0 | -11.645 | 1 | 45.0 | Au(GNP) | PBS | 100.0 | Anionic | 1.0 | buffer | 37 | 4 | 7.4 | Serum protein | Protein corona fingerprinting predicts the cellular interaction of gold and silver nanoparticles |
| Prot0008 | 59.3 | sphere | 103.94 | metal | 1888.699399 | HS | CVVIT | 0.0575 | 1500.0 | -11.57666667 | 1 | 45.0 | Au(GNP) | PBS | 100.0 | Anionic | 1.0 | buffer | 37 | 4 | 7.4 | Serum protein | Protein corona fingerprinting predicts the cellular interaction of gold and silver nanoparticles |
| Prot0009 | 59.3 | sphere | 108.27 | metal | 1888.699399 | HS | AuT | 0.086111111 | 1500.0 | -11.46666667 | 1 | 45.0 | Au(GNP) | PBS | 100.0 | Cationic | 1.0 | buffer | 37 | 4 | 7.4 | Serum protein | Protein corona fingerprinting predicts the cellular interaction of gold and silver nanoparticles |
| Prot0010 | 59.3 | sphere | 65.4 | metal | 1007.212946 | HS | CALNN | 0.08625 | 4500.0 | -11.405 | 1 | 45.0 | Au(GNP) | PBS | 100.0 | Anionic | 1.0 | buffer | 37 | 4 | 7.4 | Serum protein | Protein corona fingerprinting predicts the cellular interaction of gold and silver nanoparticles |
| Prot0011 | 31.6 | sphere | 64.29 | metal | 1007.212946 | HS | AC | 0.248 | 4500.0 | -11.355 | 1 | 45.0 | Au(GNP) | PBS | 100.0 | Anionic | 1.0 | buffer | 37 | 4 | 7.4 | Serum protein | Protein corona fingerprinting predicts the cellular interaction of gold and silver nanoparticles |
| Prot0012 | 59.3 | sphere | 61.91 | metal | 1007.212946 | HS | MAA | 0.214444444 | 4500.0 | -11.13833333 | 1 | 45.0 | Au(GNP) | PBS | 100.0 | Anionic | 1.0 | buffer | 37 | 4 | 7.4 | Serum protein | Protein corona fingerprinting predicts the cellular interaction of gold and silver nanoparticles |
| Prot0013 | 59.3 | sphere | 55.65 | metal | 474.087541 | HS | MPA | 0.289111111 | 15000.0 | -10.96166667 | 1 | 45.0 | Au(GNP) | PBS | 100.0 | Anionic | 1.0 | buffer | 37 | 4 | 7.4 | Serum protein | Protein corona fingerprinting predicts the cellular interaction of gold and silver nanoparticles |
| Prot0014 | 59.3 | sphere | 62.97 | metal | 1007.212946 | HS | LA | 0.158 | 4500.0 | -10.8975 | 1 | 45.0 | Au(GNP) | PBS | 100.0 | Anionic | 1.0 | buffer | 37 | 4 | 7.4 | Serum protein | Protein corona fingerprinting predicts the cellular interaction of gold and silver nanoparticles |
| Prot0015 | 59.3 | sphere | 94.45 | metal | 1888.699399 | HS | HDA | 0.106333333 | 1500.0 | -10.795 | 1 | 45.0 | Au(GNP) | PBS | 100.0 | Cationic | 1.0 | buffer | 37 | 4 | 7.4 | Serum protein | Protein corona fingerprinting predicts the cellular interaction of gold and silver nanoparticles |
| Prot0016 | 59.3 | sphere | 60.99 | metal | 474.087541 | HS | MAA | 0.238444444 | 15000.0 | -10.705 | 1 | 45.0 | Au(GNP) | PBS | 100.0 | Anionic | 1.0 | buffer | 37 | 4 | 7.4 | Serum protein | Protein corona fingerprinting predicts the cellular interaction of gold and silver nanoparticles |
| Prot0017 | 59.3 | sphere | 105.18 | metal | 1888.699399 | HS | DTNB | 0.056777778 | 1500.0 | -10.66 | 1 | 45.0 | Au(GNP) | PBS | 100.0 | Anionic | 1.0 | buffer | 37 | 4 | 7.4 | Serum protein | Protein corona fingerprinting predicts the cellular interaction of gold and silver nanoparticles |
| Prot0018 | 59.3 | sphere | 61.31 | metal | 1007.212946 | HS | amino acid | 0.201333333 | 4500.0 | -10.59833333 | 1 | 45.0 | Au(GNP) | PBS | 100.0 | Anionic | 1.0 | buffer | 37 | 4 | 7.4 | Serum protein | Protein corona fingerprinting predicts the cellular interaction of gold and silver nanoparticles |
| Prot0019 | 59.3 | sphere | 41.93 | metal | 474.087541 | HS | amino acid | 0.140388889 | 15000.0 | -10.42333333 | 1 | 45.0 | Au(GNP) | PBS | 100.0 | Anionic | 1.0 | buffer | 37 | 4 | 7.4 | Serum protein | Protein corona fingerprinting predicts the cellular interaction of gold and silver nanoparticles |
| Prot0020 | 59.3 | sphere | 60.27 | metal | 474.087541 | HS | DTNB | 0.247555556 | 15000.0 | -10.41666667 | 1 | 45.0 | Au(GNP) | PBS | 100.0 | Anionic | 1.0 | buffer | 37 | 4 | 7.4 | Serum protein | Protein corona fingerprinting predicts the cellular interaction of gold and silver nanoparticles |
| Prot0021 | 59.3 | sphere | 94.89 | metal | 1888.699399 | HS | amino acid | 0.103777778 | 1500.0 | -10.26333333 | 1 | 45.0 | Au(GNP) | PBS | 100.0 | Anionic | 1.0 | buffer | 37 | 4 | 7.4 | Serum protein | Protein corona fingerprinting predicts the cellular interaction of gold and silver nanoparticles |
| Prot0022 | 59.3 | sphere | 61.86 | metal | 474.087541 | HS | MES | 0.286 | 15000.0 | -10.21333333 | 1 | 45.0 | Au(GNP) | PBS | 100.0 | Anionic | 1.0 | buffer | 37 | 4 | 7.4 | Serum protein | Protein corona fingerprinting predicts the cellular interaction of gold and silver nanoparticles |
| Prot0023 | 59.3 | sphere | 57.28 | metal | 474.087541 | HS | TP | 0.27 | 15000.0 | -10.09 | 1 | 45.0 | Au(GNP) | PBS | 100.0 | Anionic | 1.0 | buffer | 37 | 4 | 7.4 | Serum protein | Protein corona fingerprinting predicts the cellular interaction of gold and silver nanoparticles |
| Prot0024 | 59.3 | sphere | 77.26 | metal | 1007.212946 | HS | Au(GNP)T | 0.167 | 4500.0 | -10.03333333 | 1 | 45.0 | Au(GNP) | PBS | 100.0 | Cationic | 1.0 | buffer | 37 | 4 | 7.4 | Serum protein | Protein corona fingerprinting predicts the cellular interaction of gold and silver nanoparticles |
| Prot0025 | 59.3 | sphere | 68.42 | metal | 1007.212946 | HS | PAH-SH | 0.278 | 4500.0 | -9.8175 | 1 | 45.0 | Au(GNP) | PBS | 100.0 | Cationic | 1.0 | buffer | 37 | 4 | 7.4 | Serum protein | Protein corona fingerprinting predicts the cellular interaction of gold and silver nanoparticles |
| Prot0026 | 59.3 | sphere | 107.61 | metal | 1888.699399 | HS | CTAB | 0.094833333 | 1500.0 | -9.765 | 1 | 45.0 | Au(GNP) | PBS | 100.0 | Cationic | 1.0 | buffer | 37 | 4 | 7.4 | Serum protein | Protein corona fingerprinting predicts the cellular interaction of gold and silver nanoparticles |
| Prot0027 | 59.3 | sphere | 68.38 | metal | 1007.212946 | HS | CFGAILS | 0.0975 | 4500.0 | -9.72 | 1 | 45.0 | Au(GNP) | PBS | 100.0 | Anionic | 1.0 | buffer | 37 | 4 | 7.4 | Serum protein | Protein corona fingerprinting predicts the cellular interaction of gold and silver nanoparticles |
| Prot0028 | 59.3 | sphere | 47.03 | metal | 474.087541 | HS | DDT | 0.336444444 | 15000.0 | -9.7 | 1 | 45.0 | Au(GNP) | PBS | 100.0 | Cationic | 1.0 | buffer | 37 | 4 | 7.4 | Serum protein | Protein corona fingerprinting predicts the cellular interaction of gold and silver nanoparticles |
| Prot0029 | 59.3 | sphere | 114.53 | metal | 1888.699399 | HS | DDT | 0.138111111 | 1500.0 | -9.696666667 | 1 | 45.0 | Au(GNP) | PBS | 100.0 | Cationic | 1.0 | buffer | 37 | 4 | 7.4 | Serum protein | Protein corona fingerprinting predicts the cellular interaction of gold and silver nanoparticles |
| Prot0030 | 59.3 | sphere | 105.01 | metal | 1888.699399 | HS | SPP | 0.073333333 | 1500.0 | -9.683333333 | 1 | 45.0 | Au(GNP) | PBS | 100.0 | Anionic | 1.0 | buffer | 37 | 4 | 7.4 | Serum protein | Protein corona fingerprinting predicts the cellular interaction of gold and silver nanoparticles |
| Prot0031 | 59.3 | sphere | 100.73 | metal | 1888.699399 | HS | amino acid | 0.1 | 1500.0 | -9.628333333 | 1 | 45.0 | Au(GNP) | PBS | 100.0 | Anionic | 1.0 | buffer | 37 | 4 | 7.4 | Serum protein | Protein corona fingerprinting predicts the cellular interaction of gold and silver nanoparticles |
| Prot0032 | 59.3 | sphere | 88.32 | metal | 1888.699399 | HS | PEG | 0.050333333 | 1500.0 | -9.618166667 | 1 | 45.0 | Au(GNP) | PBS | 100.0 | Neutral | 1.0 | buffer | 37 | 4 | 7.4 | Serum protein | Protein corona fingerprinting predicts the cellular interaction of gold and silver nanoparticles |
| Prot0033 | 59.3 | sphere | 53.24 | metal | 1007.212946 | HS | DDT | 0.260666667 | 4500.0 | -9.611666667 | 1 | 45.0 | Au(GNP) | PBS | 100.0 | Cationic | 1.0 | buffer | 37 | 4 | 7.4 | Serum protein | Protein corona fingerprinting predicts the cellular interaction of gold and silver nanoparticles |
| Prot0034 | 59.3 | sphere | 100.75 | metal | 1888.699399 | HS | MPA | 0.087111111 | 1500.0 | -9.600833333 | 1 | 45.0 | Au(GNP) | PBS | 100.0 | Anionic | 1.0 | buffer | 37 | 4 | 7.4 | Serum protein | Protein corona fingerprinting predicts the cellular interaction of gold and silver nanoparticles |
| Prot0035 | 59.3 | sphere | 66.32 | metal | 1007.212946 | HS | MUA | 0.161222222 | 4500.0 | -9.411666667 | 1 | 45.0 | Au(GNP) | PBS | 100.0 | Anionic | 1.0 | buffer | 37 | 4 | 7.4 | Serum protein | Protein corona fingerprinting predicts the cellular interaction of gold and silver nanoparticles |
| Prot0036 | 59.3 | sphere | 95.18 | metal | 1888.699399 | HS | ODA | 0.099916667 | 1500.0 | -9.311666667 | 1 | 45.0 | Au(GNP) | PBS | 100.0 | Cationic | 1.0 | buffer | 37 | 4 | 7.4 | Serum protein | Protein corona fingerprinting predicts the cellular interaction of gold and silver nanoparticles |
| Prot0037 | 59.3 | sphere | 59.7 | metal | 474.087541 | HS | CTAB | 0.371 | 15000.0 | -9.25875 | 1 | 45.0 | Au(GNP) | PBS | 100.0 | Cationic | 1.0 | buffer | 37 | 4 | 7.4 | Serum protein | Protein corona fingerprinting predicts the cellular interaction of gold and silver nanoparticles |
| Prot0038 | 14.9 | sphere | 57.53 | metal | 474.087541 | HS | AC | 0.270222222 | 15000.0 | -9.111666667 | 1 | 45.0 | Au(GNP) | PBS | 100.0 | Anionic | 1.0 | buffer | 37 | 4 | 7.4 | Serum protein | Protein corona fingerprinting predicts the cellular interaction of gold and silver nanoparticles |
| Prot0039 | 59.3 | sphere | 39.99 | metal | 474.087541 | HS | PEG | 0.146333333 | 15000.0 | -8.9875 | 1 | 45.0 | Au(GNP) | PBS | 100.0 | Neutral | 1.0 | buffer | 37 | 4 | 7.4 | Serum protein | Protein corona fingerprinting predicts the cellular interaction of gold and silver nanoparticles |
| Prot0040 | 59.3 | sphere | 109.94 | metal | 1888.699399 | HS | CIT | 0.080888889 | 1500.0 | -8.966666667 | 1 | 45.0 | Au(GNP) | PBS | 100.0 | Anionic | 1.0 | buffer | 37 | 4 | 7.4 | Serum protein | Protein corona fingerprinting predicts the cellular interaction of gold and silver nanoparticles |
| Prot0041 | 59.3 | sphere | 48.09 | metal | 474.087541 | HS | LA | 0.201166667 | 15000.0 | -8.9525 | 1 | 45.0 | Au(GNP) | PBS | 100.0 | Anionic | 1.0 | buffer | 37 | 4 | 7.4 | Serum protein | Protein corona fingerprinting predicts the cellular interaction of gold and silver nanoparticles |
| Prot0042 | 59.3 | sphere | 58.99 | metal | 474.087541 | HS | MHA | 0.244333333 | 15000.0 | -8.918333333 | 1 | 45.0 | Au(GNP) | PBS | 100.0 | Anionic | 1.0 | buffer | 37 | 4 | 7.4 | Serum protein | Protein corona fingerprinting predicts the cellular interaction of gold and silver nanoparticles |
| Prot0043 | 59.3 | sphere | 67.37 | metal | 1007.212946 | HS | MHDA | 0.120777778 | 4500.0 | -8.81 | 1 | 45.0 | Au(GNP) | PBS | 100.0 | Anionic | 1.0 | buffer | 37 | 4 | 7.4 | Serum protein | Protein corona fingerprinting predicts the cellular interaction of gold and silver nanoparticles |
| Prot0044 | 14.9 | sphere | 90.06 | metal | 474.087541 | HS | AHT | 0.215222222 | 15000.0 | -8.788333333 | 1 | 45.0 | Au(GNP) | PBS | 100.0 | Cationic | 1.0 | buffer | 37 | 4 | 7.4 | Serum protein | Protein corona fingerprinting predicts the cellular interaction of gold and silver nanoparticles |
| Prot0045 | 59.3 | sphere | 67.7 | metal | 474.087541 | HS | MBA | 0.272888889 | 15000.0 | -8.738333333 | 1 | 45.0 | Au(GNP) | PBS | 100.0 | Anionic | 1.0 | buffer | 37 | 4 | 7.4 | Serum protein | Protein corona fingerprinting predicts the cellular interaction of gold and silver nanoparticles |
| Prot0046 | 59.3 | sphere | 57.25 | metal | 474.087541 | HS | amino acid | 0.265888889 | 15000.0 | -8.731666667 | 1 | 45.0 | Au(GNP) | PBS | 100.0 | Anionic | 1.0 | buffer | 37 | 4 | 7.4 | Serum protein | Protein corona fingerprinting predicts the cellular interaction of gold and silver nanoparticles |
| Prot0047 | 59.3 | sphere | 65.58 | metal | 1007.212946 | HS | PEG | 0.046444444 | 4500.0 | -8.713333333 | 1 | 45.0 | Au(GNP) | PBS | 100.0 | Neutral | 1.0 | buffer | 37 | 4 | 7.4 | Serum protein | Protein corona fingerprinting predicts the cellular interaction of gold and silver nanoparticles |
| Prot0048 | 59.3 | sphere | 102.9 | metal | 1888.699399 | HS | MBA | 0.082833333 | 1500.0 | -8.661666667 | 1 | 45.0 | Au(GNP) | PBS | 100.0 | Anionic | 1.0 | buffer | 37 | 4 | 7.4 | Serum protein | Protein corona fingerprinting predicts the cellular interaction of gold and silver nanoparticles |
| Prot0049 | 59.3 | sphere | 43.62 | metal | 474.087541 | HS | MHDA | 0.154555556 | 15000.0 | -8.646666667 | 1 | 45.0 | Au(GNP) | PBS | 100.0 | Anionic | 1.0 | buffer | 37 | 4 | 7.4 | Serum protein | Protein corona fingerprinting predicts the cellular interaction of gold and silver nanoparticles |
| Prot0050 | 59.3 | sphere | 41.94 | metal | 474.087541 | HS | NT | 0.131888889 | 15000.0 | -8.595 | 1 | 45.0 | Au(GNP) | PBS | 100.0 | Anionic | 1.0 | buffer | 37 | 4 | 7.4 | Serum protein | Protein corona fingerprinting predicts the cellular interaction of gold and silver nanoparticles |
| Prot0051 | 59.3 | sphere | 54.03 | metal | 474.087541 | HS | CIT | 0.217148148 | 15000.0 | -8.501666667 | 1 | 45.0 | Au(GNP) | PBS | 100.0 | Anionic | 1.0 | buffer | 37 | 4 | 7.4 | Serum protein | Protein corona fingerprinting predicts the cellular interaction of gold and silver nanoparticles |
| Prot0052 | 59.3 | sphere | 51.52 | metal | 474.087541 | HS | T20 | 0.209083333 | 15000.0 | -8.451666667 | 1 | 45.0 | Au(GNP) | PBS | 100.0 | Anionic | 1.0 | buffer | 37 | 4 | 7.4 | Serum protein | Protein corona fingerprinting predicts the cellular interaction of gold and silver nanoparticles |
| Prot0053 | 59.3 | sphere | 106.63 | metal | 1888.699399 | HS | MUTA | 0.196666667 | 1500.0 | -8.354444444 | 1 | 45.0 | Au(GNP) | PBS | 100.0 | Cationic | 1.0 | buffer | 37 | 4 | 7.4 | Serum protein | Protein corona fingerprinting predicts the cellular interaction of gold and silver nanoparticles |
| Prot0054 | 59.3 | sphere | 45.52 | metal | 474.087541 | HS | MUA | 0.165518519 | 15000.0 | -8.349722222 | 1 | 45.0 | Au(GNP) | PBS | 100.0 | Anionic | 1.0 | buffer | 37 | 4 | 7.4 | Serum protein | Protein corona fingerprinting predicts the cellular interaction of gold and silver nanoparticles |
| Prot0055 | 14.9 | sphere | 37.75 | metal | 474.087541 | HS | amino acid | 0.206666667 | 15000.0 | -8.291666667 | 1 | 45.0 | Au(GNP) | PBS | 100.0 | Anionic | 1.0 | buffer | 37 | 4 | 7.4 | Serum protein | Protein corona fingerprinting predicts the cellular interaction of gold and silver nanoparticles |
| Prot0056 | 59.3 | sphere | 50.05 | metal | 1007.212946 | HS | TP | 0.282444444 | 4500.0 | -8.138333333 | 1 | 45.0 | Au(GNP) | PBS | 100.0 | Anionic | 1.0 | buffer | 37 | 4 | 7.4 | Serum protein | Protein corona fingerprinting predicts the cellular interaction of gold and silver nanoparticles |
| Prot0057 | 59.3 | sphere | 106.12 | metal | 1888.699399 | HS | PVA | 0.070166667 | 1500.0 | -8.073333333 | 1 | 45.0 | Au(GNP) | PBS | 100.0 | Anionic | 1.0 | buffer | 37 | 4 | 7.4 | Serum protein | Protein corona fingerprinting predicts the cellular interaction of gold and silver nanoparticles |
| Prot0058 | 59.3 | sphere | 127.34 | metal | 474.087541 | HS | MUTA | 0.173240741 | 15000.0 | -8.065833333 | 1 | 45.0 | Au(GNP) | PBS | 100.0 | Cationic | 1.0 | buffer | 37 | 4 | 7.4 | Serum protein | Protein corona fingerprinting predicts the cellular interaction of gold and silver nanoparticles |
| Prot0059 | 59.3 | sphere | 48.66 | metal | 474.087541 | HS | SPP | 0.115222222 | 15000.0 | -8.028333333 | 1 | 45.0 | Au(GNP) | PBS | 100.0 | Anionic | 1.0 | buffer | 37 | 4 | 7.4 | Serum protein | Protein corona fingerprinting predicts the cellular interaction of gold and silver nanoparticles |
| Prot0060 | 59.3 | sphere | 43.77 | metal | 474.087541 | HS | NT | 0.3395 | 15000.0 | -7.945833333 | 1 | 45.0 | Au(GNP) | PBS | 100.0 | Anionic | 1.0 | buffer | 37 | 4 | 7.4 | Serum protein | Protein corona fingerprinting predicts the cellular interaction of gold and silver nanoparticles |
| Prot0061 | 59.3 | sphere | 55.98 | metal | 474.087541 | HS | AuT | 0.272555556 | 15000.0 | -7.945 | 1 | 45.0 | Au(GNP) | PBS | 100.0 | Cationic | 1.0 | buffer | 37 | 4 | 7.4 | Serum protein | Protein corona fingerprinting predicts the cellular interaction of gold and silver nanoparticles |
| Prot0062 | 59.3 | sphere | 122.28 | metal | 1007.212946 | HS | MUTA | 0.203333333 | 4500.0 | -7.943333333 | 1 | 45.0 | Au(GNP) | PBS | 100.0 | Cationic | 1.0 | buffer | 37 | 4 | 7.4 | Serum protein | Protein corona fingerprinting predicts the cellular interaction of gold and silver nanoparticles |
| Prot0063 | 59.3 | sphere | 58.53 | metal | 474.087541 | HS | amino acid | 0.267333333 | 15000.0 | -7.907666667 | 1 | 45.0 | Au(GNP) | PBS | 100.0 | Anionic | 1.0 | buffer | 37 | 4 | 7.4 | Serum protein | Protein corona fingerprinting predicts the cellular interaction of gold and silver nanoparticles |
| Prot0064 | 59.3 | sphere | 41.64 | metal | 474.087541 | HS | NT | 0.129333333 | 15000.0 | -7.806666667 | 1 | 45.0 | Au(GNP) | PBS | 100.0 | Anionic | 1.0 | buffer | 37 | 4 | 7.4 | Serum protein | Protein corona fingerprinting predicts the cellular interaction of gold and silver nanoparticles |
| Prot0065 | 59.3 | sphere | 54.89 | metal | 474.087541 | HS | HDA | 0.234777778 | 15000.0 | -7.726666667 | 1 | 45.0 | Au(GNP) | PBS | 100.0 | Cationic | 1.0 | buffer | 37 | 4 | 7.4 | Serum protein | Protein corona fingerprinting predicts the cellular interaction of gold and silver nanoparticles |
| Prot0066 | 59.3 | sphere | 61.79 | metal | 474.087541 | HS | NT | 0.183888889 | 15000.0 | -7.573333333 | 1 | 45.0 | Au(GNP) | PBS | 100.0 | Anionic | 1.0 | buffer | 37 | 4 | 7.4 | Serum protein | Protein corona fingerprinting predicts the cellular interaction of gold and silver nanoparticles |
| Prot0067 | 59.3 | sphere | 44.6 | metal | 474.087541 | HS | PEG | 0.092888889 | 15000.0 | -7.48 | 1 | 45.0 | Au(GNP) | PBS | 100.0 | Neutral | 1.0 | buffer | 37 | 4 | 7.4 | Serum protein | Protein corona fingerprinting predicts the cellular interaction of gold and silver nanoparticles |
| Prot0068 | 59.3 | sphere | 43.48 | metal | 474.087541 | HS | amino acid | 0.145333333 | 15000.0 | -7.368333333 | 1 | 45.0 | Au(GNP) | PBS | 100.0 | Anionic | 1.0 | buffer | 37 | 4 | 7.4 | Serum protein | Protein corona fingerprinting predicts the cellular interaction of gold and silver nanoparticles |
| Prot0069 | 59.3 | sphere | 52.42 | metal | 474.087541 | HS | amino acid | 0.215333333 | 15000.0 | -7.198333333 | 1 | 45.0 | Au(GNP) | PBS | 100.0 | Anionic | 1.0 | buffer | 37 | 4 | 7.4 | Serum protein | Protein corona fingerprinting predicts the cellular interaction of gold and silver nanoparticles |
| Prot0070 | 59.3 | sphere | 71.85 | metal | 1007.212946 | HS | DDT | 0.155555556 | 4500.0 | -7.196666667 | 1 | 45.0 | Au(GNP) | PBS | 100.0 | Cationic | 1.0 | buffer | 37 | 4 | 7.4 | Serum protein | Protein corona fingerprinting predicts the cellular interaction of gold and silver nanoparticles |
| Prot0071 | 59.3 | sphere | 52.46 | metal | 474.087541 | HS | PEI-SH | 0.176333333 | 15000.0 | -7.043333333 | 1 | 45.0 | Au(GNP) | PBS | 100.0 | Cationic | 1.0 | buffer | 37 | 4 | 7.4 | Serum protein | Protein corona fingerprinting predicts the cellular interaction of gold and silver nanoparticles |
| Prot0072 | 59.3 | sphere | 42.05 | metal | 474.087541 | HS | amino acid | 0.193222222 | 15000.0 | -6.778333333 | 1 | 45.0 | Au(GNP) | PBS | 100.0 | Anionic | 1.0 | buffer | 37 | 4 | 7.4 | Serum protein | Protein corona fingerprinting predicts the cellular interaction of gold and silver nanoparticles |
| Prot0073 | 14.9 | sphere | 44.43 | metal | 474.087541 | HS | amino acid | 0.183888889 | 15000.0 | -6.728333333 | 1 | 45.0 | Au(GNP) | PBS | 100.0 | Anionic | 1.0 | buffer | 37 | 4 | 7.4 | Serum protein | Protein corona fingerprinting predicts the cellular interaction of gold and silver nanoparticles |
| Prot0074 | 59.3 | sphere | 46.63 | metal | 474.087541 | HS | F127 | 0.1965 | 15000.0 | -6.633333333 | 1 | 45.0 | Au(GNP) | PBS | 100.0 | Anionic | 1.0 | buffer | 37 | 4 | 7.4 | Serum protein | Protein corona fingerprinting predicts the cellular interaction of gold and silver nanoparticles |
| Prot0075 | 59.3 | sphere | 29.68 | metal | 474.087541 | HS | PEG | 0.151777778 | 15000.0 | -6.628333333 | 1 | 45.0 | Au(GNP) | PBS | 100.0 | Neutral | 1.0 | buffer | 37 | 4 | 7.4 | Serum protein | Protein corona fingerprinting predicts the cellular interaction of gold and silver nanoparticles |
| Prot0076 | 59.3 | sphere | 38.8 | metal | 474.087541 | HS | CALNN | 0.154083333 | 15000.0 | -6.536666667 | 1 | 45.0 | Au(GNP) | PBS | 100.0 | Anionic | 1.0 | buffer | 37 | 4 | 7.4 | Serum protein | Protein corona fingerprinting predicts the cellular interaction of gold and silver nanoparticles |
| Prot0077 | 59.3 | sphere | 48.4 | metal | 474.087541 | HS | DDT | 0.308 | 15000.0 | -6.523333333 | 1 | 45.0 | Au(GNP) | PBS | 100.0 | Cationic | 1.0 | buffer | 37 | 4 | 7.4 | Serum protein | Protein corona fingerprinting predicts the cellular interaction of gold and silver nanoparticles |
| Prot0078 | 59.3 | sphere | 93.52 | metal | 1888.699399 | HS | NT | 0.0545 | 1500.0 | -6.52 | 1 | 45.0 | Au(GNP) | PBS | 100.0 | Anionic | 1.0 | buffer | 37 | 4 | 7.4 | Serum protein | Protein corona fingerprinting predicts the cellular interaction of gold and silver nanoparticles |
| Prot0079 | 59.3 | sphere | 68.07 | metal | 474.087541 | HS | PAH-SH | 0.310111111 | 15000.0 | -6.483333333 | 1 | 45.0 | Au(GNP) | PBS | 100.0 | Cationic | 1.0 | buffer | 37 | 4 | 7.4 | Serum protein | Protein corona fingerprinting predicts the cellular interaction of gold and silver nanoparticles |
| Prot0080 | 59.3 | sphere | 47.34 | metal | 474.087541 | HS | DDT | 0.237111111 | 15000.0 | -6.373333333 | 1 | 45.0 | Au(GNP) | PBS | 100.0 | Cationic | 1.0 | buffer | 37 | 4 | 7.4 | Serum protein | Protein corona fingerprinting predicts the cellular interaction of gold and silver nanoparticles |
| Prot0081 | 59.3 | sphere | 59.93 | metal | 474.087541 | HS | DDT | 0.366916667 | 15000.0 | -6.096666667 | 1 | 45.0 | Au(GNP) | PBS | 100.0 | Cationic | 1.0 | buffer | 37 | 4 | 7.4 | Serum protein | Protein corona fingerprinting predicts the cellular interaction of gold and silver nanoparticles |
| Prot0082 | 59.3 | sphere | 46.53 | metal | 474.087541 | HS | SA | 0.214166667 | 15000.0 | -6.091666667 | 1 | 45.0 | Au(GNP) | PBS | 100.0 | Anionic | 1.0 | buffer | 37 | 4 | 7.4 | Serum protein | Protein corona fingerprinting predicts the cellular interaction of gold and silver nanoparticles |
| Prot0083 | 59.3 | sphere | 53.12 | metal | 474.087541 | HS | PVA | 0.178083333 | 15000.0 | -6.063333333 | 1 | 45.0 | Au(GNP) | PBS | 100.0 | Anionic | 1.0 | buffer | 37 | 4 | 7.4 | Serum protein | Protein corona fingerprinting predicts the cellular interaction of gold and silver nanoparticles |
| Prot0084 | 59.3 | sphere | 52.02 | metal | 474.087541 | HS | PEG | 0.193666667 | 15000.0 | -5.993333333 | 1 | 45.0 | Au(GNP) | PBS | 100.0 | Neutral | 1.0 | buffer | 37 | 4 | 7.4 | Serum protein | Protein corona fingerprinting predicts the cellular interaction of gold and silver nanoparticles |
| Prot0085 | 59.3 | sphere | 38.69 | metal | 474.087541 | HS | PEG | 0.153555556 | 15000.0 | -5.913333333 | 1 | 45.0 | Au(GNP) | PBS | 100.0 | Neutral | 1.0 | buffer | 37 | 4 | 7.4 | Serum protein | Protein corona fingerprinting predicts the cellular interaction of gold and silver nanoparticles |
| Prot0086 | 59.3 | sphere | 100.13 | metal | 474.087541 | HS | DDT | 0.370166667 | 15000.0 | -5.705 | 1 | 45.0 | Au(GNP) | PBS | 100.0 | Cationic | 1.0 | buffer | 37 | 4 | 7.4 | Serum protein | Protein corona fingerprinting predicts the cellular interaction of gold and silver nanoparticles |
| Prot0087 | 59.3 | sphere | 55.39 | metal | 474.087541 | HS | amino acid | 0.236222222 | 15000.0 | -5.676666667 | 1 | 45.0 | Au(GNP) | PBS | 100.0 | Anionic | 1.0 | buffer | 37 | 4 | 7.4 | Serum protein | Protein corona fingerprinting predicts the cellular interaction of gold and silver nanoparticles |
| Prot0088 | 59.3 | sphere | 72.3 | metal | 474.087541 | HS | amino acid | 0.201277778 | 15000.0 | -5.643333333 | 1 | 45.0 | Au(GNP) | PBS | 100.0 | Anionic | 1.0 | buffer | 37 | 4 | 7.4 | Serum protein | Protein corona fingerprinting predicts the cellular interaction of gold and silver nanoparticles |
| Prot0089 | 59.3 | sphere | 61.43 | metal | 1007.212946 | HS | DDT | 0.225666667 | 4500.0 | -5.518333333 | 1 | 45.0 | Au(GNP) | PBS | 100.0 | Cationic | 1.0 | buffer | 37 | 4 | 7.4 | Serum protein | Protein corona fingerprinting predicts the cellular interaction of gold and silver nanoparticles |
| Prot0090 | 59.3 | sphere | 58.95 | metal | 474.087541 | HS | DDT | 0.345916667 | 15000.0 | -5.455 | 1 | 45.0 | Au(GNP) | PBS | 100.0 | Cationic | 1.0 | buffer | 37 | 4 | 7.4 | Serum protein | Protein corona fingerprinting predicts the cellular interaction of gold and silver nanoparticles |
| Prot0091 | 59.3 | sphere | 53.41 | metal | 1888.699399 | HS | DDT | 0.085666667 | 1500.0 | -5.43 | 1 | 45.0 | Au(GNP) | PBS | 100.0 | Cationic | 1.0 | buffer | 37 | 4 | 7.4 | Serum protein | Protein corona fingerprinting predicts the cellular interaction of gold and silver nanoparticles |
| Prot0092 | 59.3 | sphere | 44.75 | metal | 474.087541 | HS | NT | 0.298666667 | 15000.0 | -5.351666667 | 1 | 45.0 | Au(GNP) | PBS | 100.0 | Anionic | 1.0 | buffer | 37 | 4 | 7.4 | Serum protein | Protein corona fingerprinting predicts the cellular interaction of gold and silver nanoparticles |
| Prot0093 | 59.3 | sphere | 41.88 | metal | 474.087541 | HS | NT | 0.118444444 | 15000.0 | -5.258333333 | 1 | 45.0 | Au(GNP) | PBS | 100.0 | Anionic | 1.0 | buffer | 37 | 4 | 7.4 | Serum protein | Protein corona fingerprinting predicts the cellular interaction of gold and silver nanoparticles |
| Prot0094 | 59.3 | sphere | 52.96 | metal | 474.087541 | HS | PVP | 0.216875 | 15000.0 | -5.238333333 | 1 | 45.0 | Au(GNP) | PBS | 100.0 | Anionic | 1.0 | buffer | 37 | 4 | 7.4 | Serum protein | Protein corona fingerprinting predicts the cellular interaction of gold and silver nanoparticles |
| Prot0095 | 59.3 | sphere | 55.07 | metal | 1007.212946 | HS | DDT | 0.251833333 | 4500.0 | -5.140833333 | 1 | 45.0 | Au(GNP) | PBS | 100.0 | Cationic | 1.0 | buffer | 37 | 4 | 7.4 | Serum protein | Protein corona fingerprinting predicts the cellular interaction of gold and silver nanoparticles |
| Prot0096 | 59.3 | sphere | 51.18 | metal | 474.087541 | HS | PEG | 0.162888889 | 15000.0 | -5.0435 | 1 | 45.0 | Au(GNP) | PBS | 100.0 | Neutral | 1.0 | buffer | 37 | 4 | 7.4 | Serum protein | Protein corona fingerprinting predicts the cellular interaction of gold and silver nanoparticles |
| Prot0097 | 59.3 | sphere | 226.51 | metal | 474.087541 | HS | MUEG4 | 0.438527778 | 15000.0 | -5.007083333 | 1 | 45.0 | Au(GNP) | PBS | 100.0 | Neutral | 1.0 | buffer | 37 | 4 | 7.4 | Serum protein | Protein corona fingerprinting predicts the cellular interaction of gold and silver nanoparticles |
| Prot0098 | 59.3 | sphere | 84.87 | metal | 1007.212946 | HS | PEG | 0.037888889 | 4500.0 | -4.4106 | 1 | 45.0 | Au(GNP) | PBS | 100.0 | Neutral | 1.0 | buffer | 37 | 4 | 7.4 | Serum protein | Protein corona fingerprinting predicts the cellular interaction of gold and silver nanoparticles |
| Prot0099 | 59.3 | sphere | 47 | metal | 1007.212946 | HS | NT | 0.178333333 | 4500.0 | -3.916833333 | 1 | 45.0 | Au(GNP) | PBS | 100.0 | Anionic | 1.0 | buffer | 37 | 4 | 7.4 | Serum protein | Protein corona fingerprinting predicts the cellular interaction of gold and silver nanoparticles |
| Prot0100 | 59.3 | sphere | 64.65 | metal | 474.087541 | HS | NT | 0.252333333 | 15000.0 | -3.891333333 | 1 | 45.0 | Au(GNP) | PBS | 100.0 | Anionic | 1.0 | buffer | 37 | 4 | 7.4 | Serum protein | Protein corona fingerprinting predicts the cellular interaction of gold and silver nanoparticles |
| Prot0101 | 59.3 | sphere | 47.07 | metal | 474.087541 | HS | PEG | 0.124555556 | 15000.0 | -3.772566667 | 1 | 45.0 | Au(GNP) | PBS | 100.0 | Neutral | 1.0 | buffer | 37 | 4 | 7.4 | Serum protein | Protein corona fingerprinting predicts the cellular interaction of gold and silver nanoparticles |
| Prot0102 | 59.3 | sphere | 100.88 | metal | 1888.699399 | HS | NT | 0.083916667 | 1500.0 | -3.580333333 | 1 | 45.0 | Au(GNP) | PBS | 100.0 | Anionic | 1.0 | buffer | 37 | 4 | 7.4 | Serum protein | Protein corona fingerprinting predicts the cellular interaction of gold and silver nanoparticles |
| Prot0103 | 59.3 | sphere | 48.76 | metal | 474.087541 | HS | PEG | 0.133888889 | 15000.0 | -2.935 | 1 | 45.0 | Au(GNP) | PBS | 100.0 | Neutral | 1.0 | buffer | 37 | 4 | 7.4 | Serum protein | Protein corona fingerprinting predicts the cellular interaction of gold and silver nanoparticles |
| Prot0104 | 59.3 | sphere | 33.05 | metal | 474.087541 | HS | PEG | 0.158222222 | 15000.0 | -2.753333333 | 1 | 45.0 | Au(GNP) | PBS | 100.0 | Neutral | 1.0 | buffer | 37 | 4 | 7.4 | Serum protein | Protein corona fingerprinting predicts the cellular interaction of gold and silver nanoparticles |
| Prot0105 | 59.3 | sphere | 110.75 | metal | 1888.699399 | HS | PEG | 0.077777778 | 1500.0 | -2.232166667 | 1 | 45.0 | Au(GNP) | PBS | 100.0 | Neutral | 1.0 | buffer | 37 | 4 | 7.4 | Serum protein | Protein corona fingerprinting predicts the cellular interaction of gold and silver nanoparticles |
| Prot0106 | 59.3 | sphere | 98.21 | metal | 1888.699399 | HS | PEG | 0.044222222 | 1500.0 | -2.015 | 1 | 45.0 | Au(GNP) | PBS | 100.0 | Neutral | 1.0 | buffer | 37 | 4 | 7.4 | Serum protein | Protein corona fingerprinting predicts the cellular interaction of gold and silver nanoparticles |
| Prot0107 | 59.3 | sphere | 34.77 | metal | 474.087541 | HS | PEG | 0.134666667 | 15000.0 | -1.730833333 | 1 | 45.0 | Au(GNP) | PBS | 100.0 | Neutral | 1.0 | buffer | 37 | 4 | 7.4 | Serum protein | Protein corona fingerprinting predicts the cellular interaction of gold and silver nanoparticles |
| Prot0108 | 59.3 | sphere | 127.22 | metal | 1888.699399 | HS | PEG | 0.027666667 | 1500.0 | -0.61 | 1 | 45.0 | Au(GNP) | PBS | 100.0 | Neutral | 1.0 | buffer | 37 | 4 | 7.4 | Serum protein | Protein corona fingerprinting predicts the cellular interaction of gold and silver nanoparticles |
| Prot0109 | 15 | sphere | 38.88 | metal | 816.85 | FBS | CIT | 0.25 | 15000.0 | -13.5 | 1 | 20.0 | Au(GNP) | plasma | 10.0 | Anionic | 0.0 | DMEM | 37 | 25 | 7.4 | Serum protein | Secreted biomolecules alter the biological identity and cellular interactions of nanoparticles |
| Prot0110 | 15 | sphere | 38.88 | metal | 816.85 | FBS | CIT | 0.25 | 15000.0 | -13.5 | 1 | 20.0 | Au(GNP) | plasma | 10.0 | Anionic | 1.0 | DMEM | 37 | 25 | 7.4 | Serum protein | Secreted biomolecules alter the biological identity and cellular interactions of nanoparticles |
| Prot0111 | 15 | sphere | 38.88 | metal | 816.85 | FBS | CIT | 0.25 | 15000.0 | -13.5 | 1 | 20.0 | Au(GNP) | plasma | 10.0 | Anionic | 4.0 | DMEM | 37 | 25 | 7.4 | Serum protein | Secreted biomolecules alter the biological identity and cellular interactions of nanoparticles |
| Prot0112 | 15 | sphere | 38.88 | metal | 816.85 | FBS | CIT | 0.25 | 15000.0 | -13.5 | 1 | 20.0 | Au(GNP) | plasma | 10.0 | Anionic | 8.0 | DMEM | 37 | 25 | 7.4 | Serum protein | Secreted biomolecules alter the biological identity and cellular interactions of nanoparticles |
| Prot0113 | 15 | sphere | 38.88 | metal | 816.85 | FBS | CIT | 0.25 | 15000.0 | -13.5 | 1 | 20.0 | Au(GNP) | plasma | 10.0 | Anionic | 12.0 | DMEM | 37 | 25 | 7.4 | Serum protein | Secreted biomolecules alter the biological identity and cellular interactions of nanoparticles |
| Prot0114 | 15 | sphere | 38.88 | metal | 816.85 | FBS | CIT | 0.25 | 15000.0 | -13.5 | 1 | 20.0 | Au(GNP) | plasma | 10.0 | Anionic | 24.0 | DMEM | 37 | 25 | 7.4 | Serum protein | Secreted biomolecules alter the biological identity and cellular interactions of nanoparticles |
| Prot0115 | 81.7 | sphere | 112.2 | metal | 250.0 | HP | PEG | 0.212 | 20000.0 | 12.8 | 1 | 30.0 | Au(GNP) | water | 55.0 | Neutral | 1.0 | buffer | 37 | 20 | 7.0 | Plasma protein | Surface chemistry of gold nanoparticles determines the biocorona composition impacting cellular uptake, toxicity and gene expression profiles in human endothelial cells |
| Prot0116 | 39.7 | sphere | 52.64 | metal | 250.0 | HP | BPEI | 0.207 | 20000.0 | 63.1 | 1 | 30.0 | Au(GNP) | water | 55.0 | Cationic | 1.0 | buffer | 37 | 20 | 7.0 | Plasma protein | Surface chemistry of gold nanoparticles determines the biocorona composition impacting cellular uptake, toxicity and gene expression profiles in human endothelial cells |
| Prot0117 | 82.3 | sphere | 106.7 | metal | 250.0 | HP | BPEI | 0.132 | 20000.0 | 69.3 | 1 | 30.0 | Au(GNP) | water | 55.0 | Cationic | 1.0 | buffer | 37 | 20 | 7.0 | Plasma protein | Surface chemistry of gold nanoparticles determines the biocorona composition impacting cellular uptake, toxicity and gene expression profiles in human endothelial cells |
| Prot0118 | 81.7 | sphere | 133 | metal | 250.0 | HP | PEG | 0.035 | 20000.0 | -1.98 | 1 | 30.0 | Au(GNP) | cell culture | 55.0 | Neutral | 1.0 | buffer | 37 | 20 | 7.4 | Plasma protein | Surface chemistry of gold nanoparticles determines the biocorona composition impacting cellular uptake, toxicity and gene expression profiles in human endothelial cells |
| Prot0119 | 41.5 | sphere | 68.87 | metal | 250.0 | HP | PEG | 0.143 | 20000.0 | -10.8 | 1 | 30.0 | Au(GNP) | water | 55.0 | Neutral | 1.0 | buffer | 37 | 20 | 7.0 | Plasma protein | Surface chemistry of gold nanoparticles determines the biocorona composition impacting cellular uptake, toxicity and gene expression profiles in human endothelial cells |
| Prot0120 | 41.5 | sphere | 69.7 | metal | 250.0 | HP | PEG | 0.074 | 20000.0 | -3.58 | 1 | 30.0 | Au(GNP) | cell culture | 55.0 | Neutral | 1.0 | buffer | 37 | 20 | 7.4 | Plasma protein | Surface chemistry of gold nanoparticles determines the biocorona composition impacting cellular uptake, toxicity and gene expression profiles in human endothelial cells |
| Prot0121 | 81.8 | sphere | 92.19 | metal | 250.0 | HP | LA | 0.083 | 20000.0 | -43.9 | 1 | 30.0 | Au(GNP) | water | 55.0 | Anionic | 1.0 | buffer | 37 | 20 | 7.0 | Plasma protein | Surface chemistry of gold nanoparticles determines the biocorona composition impacting cellular uptake, toxicity and gene expression profiles in human endothelial cells |
| Prot0122 | 82.3 | sphere | 317.82 | metal | 250.0 | HP | BPEI | 0.181 | 20000.0 | -5.32 | 1 | 30.0 | Au(GNP) | cell culture | 55.0 | Cationic | 1.0 | buffer | 37 | 20 | 7.4 | Plasma protein | Surface chemistry of gold nanoparticles determines the biocorona composition impacting cellular uptake, toxicity and gene expression profiles in human endothelial cells |
| Prot0123 | 39.7 | sphere | 331.3 | metal | 250.0 | HP | BPEI | 0.205 | 20000.0 | -7.43 | 1 | 30.0 | Au(GNP) | cell culture | 55.0 | Cationic | 1.0 | buffer | 37 | 20 | 7.4 | Plasma protein | Surface chemistry of gold nanoparticles determines the biocorona composition impacting cellular uptake, toxicity and gene expression profiles in human endothelial cells |
| Prot0124 | 40.2 | sphere | 50.15 | metal | 250.0 | HP | LA | 0.161 | 20000.0 | -73.3 | 1 | 30.0 | Au(GNP) | water | 55.0 | Anionic | 1.0 | buffer | 37 | 20 | 7.0 | Plasma protein | Surface chemistry of gold nanoparticles determines the biocorona composition impacting cellular uptake, toxicity and gene expression profiles in human endothelial cells |
| Prot0125 | 40.2 | sphere | 69.32 | metal | 250.0 | HP | LA | 0.27 | 20000.0 | -8.29 | 1 | 30.0 | Au(GNP) | cell culture | 55.0 | Anionic | 1.0 | buffer | 37 | 20 | 7.4 | Plasma protein | Surface chemistry of gold nanoparticles determines the biocorona composition impacting cellular uptake, toxicity and gene expression profiles in human endothelial cells |
| Prot0126 | 81.8 | sphere | 159.5 | metal | 250.0 | HP | LA | 0.215 | 20000.0 | -8.99 | 1 | 30.0 | Au(GNP) | cell culture | 55.0 | Anionic | 1.0 | buffer | 37 | 20 | 7.4 | Plasma protein | Surface chemistry of gold nanoparticles determines the biocorona composition impacting cellular uptake, toxicity and gene expression profiles in human endothelial cells |
| Prot0127 | 14 | rod | 16 | metal | 913.8369 | FBS | nan | 0.126944444 | 20000.0 | -13.5 | 1 | 30.0 | Au(GNP) | plasma | 10.0 | Neutral | 1.0 | buffer | 45 | 10 | 7.4 | nan | Variation of protein corona composition of gold nanoparticles following plasmonic heating |
| Prot0128 | 14 | rod | 16 | metal | 913.8369 | FBS | nan | 0.126944444 | 20000.0 | -13.5 | 1 | 30.0 | Au(GNP) | plasma | 10.0 | Neutral | 1.0 | buffer | 55 | 10 | 7.4 | nan | Variation of protein corona composition of gold nanoparticles following plasmonic heating |
| Prot0129 | 14 | rod | 16 | metal | 913.8369 | FBS | nan | 0.126944444 | 20000.0 | -13.5 | 1 | 30.0 | Au(GNP) | plasma | 100.0 | Neutral | 1.0 | buffer | 45 | 10 | 7.4 | nan | Variation of protein corona composition of gold nanoparticles following plasmonic heating |
| Prot0130 | 14 | rod | 16 | metal | 913.8369 | FBS | nan | 0.126944444 | 20000.0 | -13.5 | 1 | 30.0 | Au(GNP) | plasma | 100.0 | Neutral | 1.0 | buffer | 55 | 10 | 7.4 | nan | Variation of protein corona composition of gold nanoparticles following plasmonic heating |
| Prot0131 | 14 | rod | 16 | metal | 913.8369 | FBS | nan | 0.126944444 | 20000.0 | -13.5 | 1 | 30.0 | Au(GNP) | plasma | 10.0 | Neutral | 1.0 | buffer | 45 | 10 | 7.4 | nan | Variation of protein corona composition of gold nanoparticles following plasmonic heating |
| Prot0132 | 14 | rod | 16 | metal | 913.8369 | FBS | nan | 0.126944444 | 20000.0 | -13.5 | 1 | 30.0 | Au(GNP) | plasma | 10.0 | Neutral | 1.0 | buffer | 55 | 10 | 7.4 | nan | Variation of protein corona composition of gold nanoparticles following plasmonic heating |
| Prot0133 | 14 | rod | 16 | metal | 913.8369 | FBS | nan | 0.126944444 | 20000.0 | -13.5 | 1 | 30.0 | Au(GNP) | plasma | 100.0 | Neutral | 1.0 | buffer | 45 | 10 | 7.4 | nan | Variation of protein corona composition of gold nanoparticles following plasmonic heating |
| Prot0134 | 14 | rod | 16 | metal | 913.8369 | FBS | nan | 0.126944444 | 20000.0 | -13.5 | 1 | 30.0 | Au(GNP) | plasma | 100.0 | Neutral | 1.0 | buffer | 55 | 10 | 7.4 | nan | Variation of protein corona composition of gold nanoparticles following plasmonic heating |
| Prot0135 | 14 | rod | 16 | metal | 913.8369 | FBS | nan | 0.126944444 | 20000.0 | -18.9 | 1 | 30.0 | Au(GNP) | plasma | 10.0 | Neutral | 1.0 | buffer | 37 | 10 | 7.4 | nan | Variation of protein corona composition of gold nanoparticles following plasmonic heating |
| Prot0136 | 14 | rod | 16 | metal | 913.8369 | FBS | nan | 0.126944444 | 20000.0 | -18.9 | 1 | 30.0 | Au(GNP) | plasma | 10.0 | Neutral | 1.0 | buffer | 55 | 10 | 7.4 | nan | Variation of protein corona composition of gold nanoparticles following plasmonic heating |
| Prot0137 | 14 | rod | 16 | metal | 913.8369 | FBS | nan | 0.126944444 | 20000.0 | -18.9 | 1 | 30.0 | Au(GNP) | plasma | 100.0 | Neutral | 1.0 | buffer | 37 | 10 | 7.4 | nan | Variation of protein corona composition of gold nanoparticles following plasmonic heating |
| Prot0138 | 14 | rod | 16 | metal | 913.8369 | FBS | nan | 0.126944444 | 20000.0 | -18.9 | 1 | 30.0 | Au(GNP) | plasma | 100.0 | Neutral | 1.0 | buffer | 55 | 10 | 7.4 | nan | Variation of protein corona composition of gold nanoparticles following plasmonic heating |
| Prot0139 | 14 | rod | 16 | metal | 913.8369 | FBS | nan | 0.126944444 | 20000.0 | -18.9 | 1 | 30.0 | Au(GNP) | plasma | 10.0 | Neutral | 1.0 | buffer | 37 | 10 | 7.4 | nan | Variation of protein corona composition of gold nanoparticles following plasmonic heating |
| Prot0140 | 14 | rod | 16 | metal | 913.8369 | FBS | nan | 0.126944444 | 20000.0 | -18.9 | 1 | 30.0 | Au(GNP) | plasma | 10.0 | Neutral | 1.0 | buffer | 55 | 10 | 7.4 | nan | Variation of protein corona composition of gold nanoparticles following plasmonic heating |
| Prot0141 | 14 | rod | 16 | metal | 913.8369 | FBS | nan | 0.126944444 | 20000.0 | -18.9 | 1 | 30.0 | Au(GNP) | plasma | 100.0 | Neutral | 1.0 | buffer | 37 | 10 | 7.4 | nan | Variation of protein corona composition of gold nanoparticles following plasmonic heating |
| Prot0142 | 14 | rod | 16 | metal | 913.8369 | FBS | nan | 0.126944444 | 20000.0 | -18.9 | 1 | 30.0 | Au(GNP) | plasma | 100.0 | Neutral | 1.0 | buffer | 55 | 10 | 7.4 | nan | Variation of protein corona composition of gold nanoparticles following plasmonic heating |
| Prot0143 | 71.4 | star | 93.36 | metal | 500.0 | RP | nan | 0.388 | 3000.0 | -18.88 | 2 | 20.0 | Au(GNP) | plasma | 100.0 | Neutral | 0.166666667 | water | 37 | 4 | 7.4 | Plasma protein | In Vivo Formation of Protein Corona on Gold Nanoparticles. The effect of Size and Shape |
| Prot0144 | 14.5 | rod | 75.67 | metal | 500.0 | RP | nan | 0.388 | 3000.0 | -20.32 | 2 | 20.0 | Au(GNP) | plasma | 100.0 | Neutral | 0.166666667 | water | 37 | 4 | 7.4 | Plasma protein | In Vivo Formation of Protein Corona on Gold Nanoparticles. The effect of Size and Shape |
| Prot0145 | 11.2 | rod | 21.25 | metal | 500.0 | RP | nan | 0.786 | 3000.0 | -28.57 | 2 | 20.0 | Au(GNP) | water | 100.0 | Neutral | 0.166666667 | water | 37 | 4 | 7.0 | Plasma protein | In Vivo Formation of Protein Corona on Gold Nanoparticles. The effect of Size and Shape |
| Prot0146 | 14.5 | rod | 24.91 | metal | 500.0 | RP | nan | 0.378 | 3000.0 | -28.77 | 2 | 20.0 | Au(GNP) | water | 100.0 | Neutral | 0.166666667 | water | 37 | 4 | 7.0 | Plasma protein | In Vivo Formation of Protein Corona on Gold Nanoparticles. The effect of Size and Shape |
| Prot0147 | 42.3 | star | 82.09 | metal | 500.0 | RP | nan | 0.245 | 3000.0 | -29.33 | 2 | 20.0 | Au(GNP) | water | 100.0 | Neutral | 0.166666667 | water | 37 | 4 | 7.0 | Plasma protein | In Vivo Formation of Protein Corona on Gold Nanoparticles. The effect of Size and Shape |
| Prot0148 | 42.3 | star | 79.98 | metal | 500.0 | RP | nan | 0.232 | 3000.0 | -31.78 | 2 | 20.0 | Au(GNP) | plasma | 100.0 | Neutral | 0.166666667 | water | 37 | 4 | 7.4 | Plasma protein | In Vivo Formation of Protein Corona on Gold Nanoparticles. The effect of Size and Shape |
| Prot0149 | 71.4 | star | 122 | metal | 500.0 | RP | nan | 0.101 | 3000.0 | -33.63 | 2 | 20.0 | Au(GNP) | water | 100.0 | Neutral | 0.166666667 | water | 37 | 4 | 7.0 | Plasma protein | In Vivo Formation of Protein Corona on Gold Nanoparticles. The effect of Size and Shape |
| Prot0150 | 11.2 | rod | 83.28 | metal | 500.0 | RP | nan | 0.315 | 3000.0 | -36.76 | 2 | 20.0 | Au(GNP) | plasma | 100.0 | Neutral | 0.166666667 | water | 37 | 4 | 7.4 | Plasma protein | In Vivo Formation of Protein Corona on Gold Nanoparticles. The effect of Size and Shape |
| Prot0151 | 10 | sphere | nan | metal | 8.0 | HS | nan | nan | 100.0 | nan | 1 | 30.0 | Au(GNP) | PBS | nan | nan | 1.0 | water | 37 | 4 | 7.4 | Plasma protein | The viral protein corona directs viral pathogenesis and amyloid aggregation |
| Prot0152 | 10 | sphere | nan | metal | 5.0 | HS | nan | nan | 3000.0 | nan | 2 | 30.0 | Au(GNP) | PBS | nan | nan | nan | water | 37 | 4 | 7.8 | Plasma protein | Identifying cell receptors for the nanoparticle protein corona using genome screens |
| Prot0153 | 10 | sphere | nan | metal | 2.0 | PEG | nan | nan | 1000.0 | -26 | 2 | 30.0 | Au(GNP) | PBS | nan | nan | nan | water | 37 | 4 | 7.2 | Plasma protein | Dynamic intracellular exchange of nanomaterials’ protein corona perturbs proteostasis and remodels cell metabolism |
| Prot0154 | 30 | sphere | nan | metal | 0.5 | HS | nan | nan | 1000.0 | -20 | 2 | 30.0 | Au(GNP) | FBS | 0.1 | nan | nan | water | 37 | 4 | 7.2 | Plasma protein | Dynamic intracellular exchange of nanomaterials’ protein corona perturbs proteostasis and remodels cell metabolism |
| Prot0155 | 13.0±1.0 | sphere | nan | metal | nan | HS | nan | nan | 1000.0 | -16 | 2 | 30.0 | Au(GNP) | FBS | 10.0 | nan | nan | water | 37 | 4 | 7.2 | Plasma protein | Dynamic intracellular exchange of nanomaterials’ protein corona perturbs proteostasis and remodels cell metabolism |
| Prot0156 | 21.6 | sphere | 53.3 | metal | 1000.0 | HP | PVP | 0.126944444 | 19000.0 | -21.2 | 1 | 20.0 | Ag | plasma | 100.0 | Neutral | 3.0 | buffer | 25 | 4 | 7.4 | Plasma protein | An Evaluation of Blood Compatibility of Silver Nanoparticles |
| Prot0157 | 21.6 | sphere | 53.3 | metal | 1000.0 | HP | PVP | 0.126944444 | 19000.0 | -21.2 | 1 | 20.0 | Ag | plasma | 100.0 | Neutral | 3.0 | buffer | 25 | 4 | 7.4 | Plasma protein | An Evaluation of Blood Compatibility of Silver Nanoparticles |
| Prot0158 | 24.3 | sphere | 58.1 | metal | 1000.0 | HP | CIT | 0.126944444 | 19000.0 | -26.1 | 1 | 20.0 | Ag | plasma | 100.0 | Anionic | 3.0 | buffer | 25 | 4 | 7.4 | Plasma protein | An Evaluation of Blood Compatibility of Silver Nanoparticles |
| Prot0159 | 24.3 | sphere | 58.1 | metal | 1000.0 | HP | CIT | 0.126944444 | 19000.0 | -26.1 | 1 | 20.0 | Ag | plasma | 100.0 | Anionic | 3.0 | buffer | 25 | 4 | 7.4 | Plasma protein | An Evaluation of Blood Compatibility of Silver Nanoparticles |
| Prot0160 | 21.6 | sphere | 93.5 | metal | 1000.0 | HP | PVP | 0.126944444 | 19000.0 | -6.6 | 1 | 20.0 | Ag | cell culture | 100.0 | Neutral | 3.0 | buffer | 25 | 4 | 7.4 | Plasma protein | An Evaluation of Blood Compatibility of Silver Nanoparticles |
| Prot0161 | 21.6 | sphere | 93.5 | metal | 1000.0 | HP | PVP | 0.126944444 | 19000.0 | -6.6 | 1 | 20.0 | Ag | cell culture | 100.0 | Neutral | 3.0 | buffer | 25 | 4 | 7.4 | Plasma protein | An Evaluation of Blood Compatibility of Silver Nanoparticles |
| Prot0162 | 24.3 | sphere | 115.3 | metal | 1000.0 | HP | CIT | 0.126944444 | 19000.0 | -9.9 | 1 | 20.0 | Ag | cell culture | 100.0 | Anionic | 3.0 | buffer | 25 | 4 | 7.4 | Plasma protein | An Evaluation of Blood Compatibility of Silver Nanoparticles |
| Prot0163 | 24.3 | sphere | 115.3 | metal | 1000.0 | HP | CIT | 0.126944444 | 19000.0 | -9.9 | 1 | 20.0 | Ag | cell culture | 100.0 | Anionic | 3.0 | buffer | 25 | 4 | 7.4 | Plasma protein | An Evaluation of Blood Compatibility of Silver Nanoparticles |
| Prot0164 | 19.09 | sphere | 75.36 | metal | 0.01141 | HP | PVP | 0.126944444 | 19000.0 | -21.2 | 1 | 20.0 | Ag | plasma | 66.0 | Neutral | 1.0 | buffer | 37 | 4 | 7.4 | Serum protein | Interaction of gold and silver nanoparticles with human plasma: Analysis of protein corona reveals specific binding patterns |
| Prot0165 | 18.11 | sphere | 301.67 | metal | 0.01141 | HP | BPEI | 0.126944444 | 19000.0 | -25.7 | 1 | 20.0 | Ag | plasma | 66.0 | Cationic | 1.0 | buffer | 37 | 4 | 7.4 | Serum protein | Interaction of gold and silver nanoparticles with human plasma: Analysis of protein corona reveals specific binding patterns |
| Prot0166 | 20.08 | sphere | 58.1 | metal | 0.01141 | HP | CIT | 0.126944444 | 19000.0 | -26.13 | 1 | 20.0 | Ag | plasma | 66.0 | Anionic | 1.0 | buffer | 37 | 4 | 7.4 | Serum protein | Interaction of gold and silver nanoparticles with human plasma: Analysis of protein corona reveals specific binding patterns |
| Prot0167 | 38.4 | sphere | 38.4 | metal | 671.2825 | HS | Au(GNP)T | 0.126944444 | 5000.0 | -13.5 | 1 | 45.0 | Ag | PBS | 100.0 | Cationic | 1.0 | buffer | 37 | 4 | 7.4 | Serum protein | Protein corona fingerprinting predicts the cellular interaction of gold and silver nanoparticles |
| Prot0168 | 38.4 | sphere | 38.4 | metal | 154800.795 | HS | CIT | 0.126944444 | 5000.0 | -13.5 | 1 | 45.0 | Ag | PBS | 100.0 | Anionic | 1.0 | buffer | 37 | 4 | 7.4 | Serum protein | Protein corona fingerprinting predicts the cellular interaction of gold and silver nanoparticles |
| Prot0169 | 38.4 | sphere | 38.4 | metal | 671.2825 | HS | PEG | 0.126944444 | 5000.0 | -13.5 | 1 | 45.0 | Ag | PBS | 100.0 | Neutral | 1.0 | buffer | 37 | 4 | 7.4 | Serum protein | Protein corona fingerprinting predicts the cellular interaction of gold and silver nanoparticles |
| Prot0170 | 38.4 | sphere | 38.4 | metal | 671.2825 | HS | DDT | 0.126944444 | 5000.0 | -13.5 | 1 | 45.0 | Ag | PBS | 100.0 | Cationic | 1.0 | buffer | 37 | 4 | 7.4 | Serum protein | Protein corona fingerprinting predicts the cellular interaction of gold and silver nanoparticles |
| Prot0171 | 38.4 | sphere | 38.4 | metal | 671.2825 | HS | HDA | 0.126944444 | 5000.0 | -13.5 | 1 | 45.0 | Ag | PBS | 100.0 | Cationic | 1.0 | buffer | 37 | 4 | 7.4 | Serum protein | Protein corona fingerprinting predicts the cellular interaction of gold and silver nanoparticles |
| Prot0172 | 38.4 | sphere | 38.4 | metal | 671.2825 | HS | LA | 0.126944444 | 5000.0 | -13.5 | 1 | 45.0 | Ag | PBS | 100.0 | Anionic | 1.0 | buffer | 37 | 4 | 7.4 | Serum protein | Protein corona fingerprinting predicts the cellular interaction of gold and silver nanoparticles |
| Prot0173 | 38.4 | sphere | 38.4 | metal | 671.2825 | HS | MAA | 0.126944444 | 5000.0 | -13.5 | 1 | 45.0 | Ag | PBS | 100.0 | Anionic | 1.0 | buffer | 37 | 4 | 7.4 | Serum protein | Protein corona fingerprinting predicts the cellular interaction of gold and silver nanoparticles |
| Prot0174 | 38.4 | sphere | 38.4 | metal | 671.2825 | HS | MBA | 0.126944444 | 5000.0 | -13.5 | 1 | 45.0 | Ag | PBS | 100.0 | Anionic | 1.0 | buffer | 37 | 4 | 7.4 | Serum protein | Protein corona fingerprinting predicts the cellular interaction of gold and silver nanoparticles |
| Prot0175 | 38.4 | sphere | 38.4 | metal | 671.2825 | HS | MES | 0.126944444 | 5000.0 | -13.5 | 1 | 45.0 | Ag | PBS | 100.0 | Anionic | 1.0 | buffer | 37 | 4 | 7.4 | Serum protein | Protein corona fingerprinting predicts the cellular interaction of gold and silver nanoparticles |
| Prot0176 | 38.4 | sphere | 38.4 | metal | 671.2825 | HS | MHDA | 0.126944444 | 5000.0 | -13.5 | 1 | 45.0 | Ag | PBS | 100.0 | Anionic | 1.0 | buffer | 37 | 4 | 7.4 | Serum protein | Protein corona fingerprinting predicts the cellular interaction of gold and silver nanoparticles |
| Prot0177 | 38.4 | sphere | 38.4 | metal | 671.2825 | HS | PEG | 0.126944444 | 5000.0 | -13.5 | 1 | 45.0 | Ag | PBS | 100.0 | Neutral | 1.0 | buffer | 37 | 4 | 7.4 | Serum protein | Protein corona fingerprinting predicts the cellular interaction of gold and silver nanoparticles |
| Prot0178 | 38.4 | sphere | 38.4 | metal | 671.2825 | HS | MUTA | 0.126944444 | 5000.0 | -13.5 | 1 | 45.0 | Ag | PBS | 100.0 | Cationic | 1.0 | buffer | 37 | 4 | 7.4 | Serum protein | Protein corona fingerprinting predicts the cellular interaction of gold and silver nanoparticles |
| Prot0179 | 38.4 | sphere | 38.4 | metal | 671.2825 | HS | PEG | 0.126944444 | 5000.0 | -13.5 | 1 | 45.0 | Ag | PBS | 100.0 | Neutral | 1.0 | buffer | 37 | 4 | 7.4 | Serum protein | Protein corona fingerprinting predicts the cellular interaction of gold and silver nanoparticles |
| Prot0180 | 38.4 | sphere | 38.4 | metal | 671.2825 | HS | amino acid | 0.126944444 | 5000.0 | -13.5 | 1 | 45.0 | Ag | PBS | 100.0 | Anionic | 1.0 | buffer | 37 | 4 | 7.4 | Serum protein | Protein corona fingerprinting predicts the cellular interaction of gold and silver nanoparticles |
| Prot0181 | 38.4 | sphere | 38.4 | metal | 671.2825 | HS | PVA | 0.126944444 | 5000.0 | -13.5 | 1 | 45.0 | Ag | PBS | 100.0 | Anionic | 1.0 | buffer | 37 | 4 | 7.4 | Serum protein | Protein corona fingerprinting predicts the cellular interaction of gold and silver nanoparticles |
| Prot0182 | 38.4 | sphere | 38.4 | metal | 671.2825 | HS | SA | 0.126944444 | 5000.0 | -13.5 | 1 | 45.0 | Ag | PBS | 100.0 | Anionic | 1.0 | buffer | 37 | 4 | 7.4 | Serum protein | Protein corona fingerprinting predicts the cellular interaction of gold and silver nanoparticles |
| Prot0183 | 112 | sphere | 120.9 | metal | 100.0 | FBS | CIT | 0.126944444 | 3000.0 | -25.1 | 1 | 15.0 | Ag | cell culture | 10.0 | Anionic | 1.0 | DMEM | 37 | 22 | 7.4 | albumin, apolipoproteins, keratins, and other serum proteins | Silver Nanoparticle Protein Corona Composition in Cell Culture Media |
| Prot0184 | 20.5 | sphere | 23.4 | metal | 100.0 | FBS | CIT | 0.126944444 | 3000.0 | -25.3 | 1 | 15.0 | Ag | cell culture | 10.0 | Anionic | 1.0 | DMEM | 37 | 22 | 7.4 | albumin, apolipoproteins, keratins, and other serum proteins | Silver Nanoparticle Protein Corona Composition in Cell Culture Media |
| Prot0185 | 112 | sphere | 113.2 | metal | 100.0 | FBS | PVP | 0.126944444 | 3000.0 | -25.5 | 1 | 15.0 | Ag | water | 10.0 | Anionic | 1.0 | DMEM | 37 | 22 | 7.0 | albumin, apolipoproteins, keratins, and other serum proteins | Silver Nanoparticle Protein Corona Composition in Cell Culture Media |
| Prot0186 | 21 | sphere | 22.9 | metal | 100.0 | FBS | PVP | 0.126944444 | 3000.0 | -27.9 | 1 | 15.0 | Ag | cell culture | 10.0 | Anionic | 1.0 | DMEM | 37 | 22 | 7.4 | albumin, apolipoproteins, keratins, and other serum proteins | Silver Nanoparticle Protein Corona Composition in Cell Culture Media |
| Prot0187 | 112 | sphere | 121.5 | metal | 100.0 | FBS | PVP | 0.126944444 | 3000.0 | -30 | 1 | 15.0 | Ag | cell culture | 10.0 | Anionic | 1.0 | DMEM | 37 | 22 | 7.4 | albumin, apolipoproteins, keratins, and other serum proteins | Silver Nanoparticle Protein Corona Composition in Cell Culture Media |
| Prot0188 | 21 | sphere | 26.6 | metal | 100.0 | FBS | PVP | 0.126944444 | 3000.0 | -35.9 | 1 | 15.0 | Ag | water | 10.0 | Anionic | 1.0 | DMEM | 37 | 22 | 7.0 | albumin, apolipoproteins, keratins, and other serum proteins | Silver Nanoparticle Protein Corona Composition in Cell Culture Media |
| Prot0189 | 112 | sphere | 104.5 | metal | 100.0 | FBS | CIT | 0.126944444 | 3000.0 | -43.6 | 1 | 15.0 | Ag | water | 10.0 | Anionic | 1.0 | DMEM | 37 | 22 | 7.0 | albumin, apolipoproteins, keratins, and other serum proteins | Silver Nanoparticle Protein Corona Composition in Cell Culture Media |
| Prot0190 | 20.5 | sphere | 24.4 | metal | 100.0 | FBS | CIT | 0.126944444 | 3000.0 | -46.6 | 1 | 15.0 | Ag | water | 10.0 | Anionic | 1.0 | DMEM | 37 | 22 | 7.0 | albumin, apolipoproteins, keratins, and other serum proteins | Silver Nanoparticle Protein Corona Composition in Cell Culture Media |
| Prot0191 | 117 | sphere | 117 | other | 836.3325 | HP | PEG | 2.5 | 20000.0 | 14 | 1 | 60.0 | PS | water | 80.0 | Neutral | 1.0 | water | 37 | 25 | 7.0 | Plasma protein | Protein adsorption is required for stealth effect of poly(ethylene glycol)- and poly(phosphoester)-coated nanocarriers |
| Prot0192 | 106 | sphere | 106 | other | 923.114 | HP | NH2 | 2.5 | 20000.0 | 46 | 1 | 60.0 | PS | water | 80.0 | Anionic | 1.0 | water | 37 | 25 | 7.0 | Plasma protein | Protein adsorption is required for stealth effect of poly(ethylene glycol)- and poly(phosphoester)-coated nanocarriers |
| Prot0193 | 122 | sphere | 122 | other | 802.0499 | HP | PEEP | 2.5 | 20000.0 | -10 | 1 | 60.0 | PS | water | 80.0 | Neutral | 1.0 | water | 37 | 25 | 7.0 | Plasma protein | Protein adsorption is required for stealth effect of poly(ethylene glycol)- and poly(phosphoester)-coated nanocarriers |
| Prot0194 | 117 | sphere | 117 | other | 836.3255 | HP | PEEP | 2.5 | 20000.0 | -9 | 1 | 60.0 | PS | water | 80.0 | Neutral | 1.0 | water | 37 | 25 | 7.0 | Plasma protein | Protein adsorption is required for stealth effect of poly(ethylene glycol)- and poly(phosphoester)-coated nanocarriers |
| Prot0195 | 40 | sphere | 73.7 | other | 40.0 | HP | COOH | 0.06 | 250.0 | -43.5 | 1 | 3.0 | PS | PBS | 10.0 | Anionic | 1.0 | buffer | 25 | 25 | 7.4 | Plasma protein | Characterization of the bionano interface and mapping extrinsic interactions of the corona of nanomaterials |
| Prot0196 | 40 | sphere | 73.7 | other | 40.0 | HP | COOH | 0.06 | 250.0 | -43.5 | 1 | 3.0 | PS | PBS | 25.0 | Anionic | 1.0 | buffer | 25 | 25 | 7.4 | Plasma protein | Characterization of the bionano interface and mapping extrinsic interactions of the corona of nanomaterials |
| Prot0197 | 40 | sphere | 73.7 | other | 40.0 | HP | COOH | 0.06 | 250.0 | -43.5 | 1 | 3.0 | PS | PBS | 55.0 | Anionic | 1.0 | buffer | 25 | 25 | 7.4 | Plasma protein | Characterization of the bionano interface and mapping extrinsic interactions of the corona of nanomaterials |
| Prot0198 | 40 | sphere | 73.7 | other | 40.0 | HP | COOH | 0.06 | 250.0 | -43.5 | 1 | 3.0 | PS | PBS | 75.0 | Anionic | 1.0 | buffer | 25 | 25 | 7.4 | Plasma protein | Characterization of the bionano interface and mapping extrinsic interactions of the corona of nanomaterials |
| Prot0199 | 100 | sphere | 116.3 | other | 5.0 | HP | COOH | 0.05 | 250.0 | -53.2 | 1 | 3.0 | PS | PBS | 10.0 | Anionic | 1.0 | buffer | 25 | 25 | 7.4 | Plasma protein | Characterization of the bionano interface and mapping extrinsic interactions of the corona of nanomaterials |
| Prot0200 | 100 | sphere | 130 | other | 1.0 | HP | OSO3 | 0.09 | 250.0 | -61.2 | 1 | 3.0 | PS | PBS | 10.0 | Anionic | 1.0 | buffer | 25 | 25 | 7.4 | Plasma protein | Characterization of the bionano interface and mapping extrinsic interactions of the corona of nanomaterials |
| Prot0201 | 204 | sphere | 240 | other | 1000.0 | FBS | nan | 0.02 | 20000.0 | -13.5 | 3 | 20.0 | PS | PBS | 80.0 | Neutral | 1.0 | buffer | 37 | 25 | 7.4 | Transferrin | In situ characterization of nanoparticle biomolecular interactions in complex biological media by flow cytometry |
| Prot0202 | 200 | sphere | 220 | other | 1000.0 | HP | COOH | 0.126944444 | 20000.0 | -13.5 | 1 | 10.0 | PS | plasma | 80.0 | Anionic | 1.0 | buffer | 25 | 25 | 7.4 | Transferrin | Mapping protein binding sites on the biomolecular corona of nanoparticles |
| Prot0203 | 116 | sphere | 116 | other | 100.0 | HP | NH2 | 0.126944444 | 20000.0 | 42.8 | 1 | 60.0 | PS | water | 76.92 | Anionic | 1.0 | water | 37 | 25 | 7.0 | Serum protein and Plasma protein | Protein source and choice of anticoagulant decisively affect nanoparticle protein corona and cellular uptake |
| Prot0204 | 116 | sphere | 116 | other | 100.0 | HP | NH2 | 0.126944444 | 20000.0 | 42.8 | 1 | 60.0 | PS | water | 76.92 | Anionic | 1.0 | water | 37 | 25 | 7.0 | Serum protein and Plasma protein | Protein source and choice of anticoagulant decisively affect nanoparticle protein corona and cellular uptake |
| Prot0205 | 116 | sphere | 116 | other | 100.0 | HP | NH2 | 0.126944444 | 20000.0 | 42.8 | 1 | 60.0 | PS | water | 76.92 | Anionic | 1.0 | water | 37 | 25 | 7.0 | Serum protein and Plasma protein | Protein source and choice of anticoagulant decisively affect nanoparticle protein corona and cellular uptake |
| Prot0206 | 116 | sphere | 116 | other | 100.0 | HP | NH2 | 0.126944444 | 20000.0 | 42.8 | 1 | 60.0 | PS | water | 76.92 | Anionic | 1.0 | water | 37 | 25 | 7.0 | Serum protein and Plasma protein | Protein source and choice of anticoagulant decisively affect nanoparticle protein corona and cellular uptake |
| Prot0207 | 116 | sphere | 116 | other | 100.0 | HP | NH2 | 0.126944444 | 20000.0 | 42.8 | 1 | 60.0 | PS | water | 76.92 | Anionic | 1.0 | water | 37 | 25 | 7.0 | Serum protein and Plasma protein | Protein source and choice of anticoagulant decisively affect nanoparticle protein corona and cellular uptake |
| Prot0208 | 116 | sphere | 116 | other | 100.0 | HP | NH2 | 0.126944444 | 20000.0 | 42.8 | 1 | 60.0 | PS | water | 76.92 | Anionic | 1.0 | water | 37 | 25 | 7.0 | Serum protein and Plasma protein | Protein source and choice of anticoagulant decisively affect nanoparticle protein corona and cellular uptake |
| Prot0209 | 115 | sphere | 117 | other | 600.0 | HP | nan | 0.011 | 15300.0 | 51 | 1 | 20.0 | PS | buffer | 90.0 | Neutral | 0.5 | buffer | 37 | 4 | 7.4 | Plasma protein | Rapid formation of plasma protein corona critically affects nanoparticle pathophysiology |
| Prot0210 | 115 | sphere | 117 | other | 600.0 | HP | nan | 0.011 | 15300.0 | 51 | 1 | 20.0 | PS | buffer | 90.0 | Neutral | 2.0 | buffer | 37 | 4 | 7.4 | Plasma protein | Rapid formation of plasma protein corona critically affects nanoparticle pathophysiology |
| Prot0211 | 115 | sphere | 117 | other | 600.0 | HP | nan | 0.011 | 15300.0 | 51 | 1 | 20.0 | PS | buffer | 90.0 | Neutral | 5.0 | buffer | 37 | 4 | 7.4 | Plasma protein | Rapid formation of plasma protein corona critically affects nanoparticle pathophysiology |
| Prot0212 | 115 | sphere | 117 | other | 600.0 | HP | nan | 0.011 | 15300.0 | 51 | 1 | 20.0 | PS | buffer | 90.0 | Neutral | 15.0 | buffer | 37 | 4 | 7.4 | Plasma protein | Rapid formation of plasma protein corona critically affects nanoparticle pathophysiology |
| Prot0213 | 115 | sphere | 117 | other | 600.0 | HP | nan | 0.011 | 15300.0 | 51 | 1 | 20.0 | PS | buffer | 90.0 | Neutral | 30.0 | buffer | 37 | 4 | 7.4 | Plasma protein | Rapid formation of plasma protein corona critically affects nanoparticle pathophysiology |
| Prot0214 | 115 | sphere | 117 | other | 600.0 | HP | nan | 0.011 | 15300.0 | 51 | 1 | 20.0 | PS | buffer | 90.0 | Neutral | 60.0 | buffer | 37 | 4 | 7.4 | Plasma protein | Rapid formation of plasma protein corona critically affects nanoparticle pathophysiology |
| Prot0215 | 115 | sphere | 117 | other | 600.0 | HP | nan | 0.011 | 15300.0 | 51 | 1 | 20.0 | PS | buffer | 90.0 | Neutral | 120.0 | buffer | 37 | 4 | 7.4 | Plasma protein | Rapid formation of plasma protein corona critically affects nanoparticle pathophysiology |
| Prot0216 | 115 | sphere | 156 | other | 600.0 | HP | nan | 0.011 | 15300.0 | -18 | 1 | 20.0 | PS | plasma | 90.0 | Neutral | 0.5 | buffer | 37 | 4 | 7.4 | Plasma protein | Rapid formation of plasma protein corona critically affects nanoparticle pathophysiology |
| Prot0217 | 115 | sphere | 156 | other | 600.0 | HP | nan | 0.011 | 15300.0 | -18 | 1 | 20.0 | PS | plasma | 90.0 | Neutral | 2.0 | buffer | 37 | 4 | 7.4 | Plasma protein | Rapid formation of plasma protein corona critically affects nanoparticle pathophysiology |
| Prot0218 | 115 | sphere | 156 | other | 600.0 | HP | nan | 0.011 | 15300.0 | -18 | 1 | 20.0 | PS | plasma | 90.0 | Neutral | 5.0 | buffer | 37 | 4 | 7.4 | Plasma protein | Rapid formation of plasma protein corona critically affects nanoparticle pathophysiology |
| Prot0219 | 115 | sphere | 156 | other | 600.0 | HP | nan | 0.011 | 15300.0 | -18 | 1 | 20.0 | PS | plasma | 90.0 | Neutral | 15.0 | buffer | 37 | 4 | 7.4 | Plasma protein | Rapid formation of plasma protein corona critically affects nanoparticle pathophysiology |
| Prot0220 | 115 | sphere | 156 | other | 600.0 | HP | nan | 0.011 | 15300.0 | -18 | 1 | 20.0 | PS | plasma | 90.0 | Neutral | 30.0 | buffer | 37 | 4 | 7.4 | Plasma protein | Rapid formation of plasma protein corona critically affects nanoparticle pathophysiology |
| Prot0221 | 115 | sphere | 156 | other | 600.0 | HP | nan | 0.011 | 15300.0 | -18 | 1 | 20.0 | PS | plasma | 90.0 | Neutral | 60.0 | buffer | 37 | 4 | 7.4 | Plasma protein | Rapid formation of plasma protein corona critically affects nanoparticle pathophysiology |
| Prot0222 | 115 | sphere | 156 | other | 600.0 | HP | nan | 0.011 | 15300.0 | -18 | 1 | 20.0 | PS | plasma | 90.0 | Neutral | 120.0 | buffer | 37 | 4 | 7.4 | Plasma protein | Rapid formation of plasma protein corona critically affects nanoparticle pathophysiology |
| Prot0223 | 112 | sphere | 126 | other | 600.0 | HP | nan | 0.011 | 15300.0 | -24 | 1 | 20.0 | PS | plasma | 90.0 | Neutral | 0.5 | buffer | 37 | 4 | 7.4 | Plasma protein | Rapid formation of plasma protein corona critically affects nanoparticle pathophysiology |
| Prot0224 | 112 | sphere | 126 | other | 600.0 | HP | nan | 0.011 | 15300.0 | -24 | 1 | 20.0 | PS | plasma | 90.0 | Neutral | 2.0 | buffer | 37 | 4 | 7.4 | Plasma protein | Rapid formation of plasma protein corona critically affects nanoparticle pathophysiology |
| Prot0225 | 112 | sphere | 126 | other | 600.0 | HP | nan | 0.011 | 15300.0 | -24 | 1 | 20.0 | PS | plasma | 90.0 | Neutral | 5.0 | buffer | 37 | 4 | 7.4 | Plasma protein | Rapid formation of plasma protein corona critically affects nanoparticle pathophysiology |
| Prot0226 | 112 | sphere | 126 | other | 600.0 | HP | nan | 0.011 | 15300.0 | -24 | 1 | 20.0 | PS | plasma | 90.0 | Neutral | 15.0 | buffer | 37 | 4 | 7.4 | Plasma protein | Rapid formation of plasma protein corona critically affects nanoparticle pathophysiology |
| Prot0227 | 112 | sphere | 126 | other | 600.0 | HP | nan | 0.011 | 15300.0 | -24 | 1 | 20.0 | PS | plasma | 90.0 | Neutral | 30.0 | buffer | 37 | 4 | 7.4 | Plasma protein | Rapid formation of plasma protein corona critically affects nanoparticle pathophysiology |
| Prot0228 | 112 | sphere | 126 | other | 600.0 | HP | nan | 0.011 | 15300.0 | -24 | 1 | 20.0 | PS | plasma | 90.0 | Neutral | 60.0 | buffer | 37 | 4 | 7.4 | Plasma protein | Rapid formation of plasma protein corona critically affects nanoparticle pathophysiology |
| Prot0229 | 112 | sphere | 126 | other | 600.0 | HP | nan | 0.011 | 15300.0 | -24 | 1 | 20.0 | PS | plasma | 90.0 | Neutral | 120.0 | buffer | 37 | 4 | 7.4 | Plasma protein | Rapid formation of plasma protein corona critically affects nanoparticle pathophysiology |
| Prot0230 | 112 | sphere | 134 | other | 600.0 | HP | nan | 0.009 | 15300.0 | -55 | 1 | 20.0 | PS | buffer | 90.0 | Neutral | 0.5 | buffer | 37 | 4 | 7.4 | Plasma protein | Rapid formation of plasma protein corona critically affects nanoparticle pathophysiology |
| Prot0231 | 112 | sphere | 134 | other | 600.0 | HP | nan | 0.009 | 15300.0 | -55 | 1 | 20.0 | PS | buffer | 90.0 | Neutral | 2.0 | buffer | 37 | 4 | 7.4 | Plasma protein | Rapid formation of plasma protein corona critically affects nanoparticle pathophysiology |
| Prot0232 | 112 | sphere | 134 | other | 600.0 | HP | nan | 0.009 | 15300.0 | -55 | 1 | 20.0 | PS | buffer | 90.0 | Neutral | 5.0 | buffer | 37 | 4 | 7.4 | Plasma protein | Rapid formation of plasma protein corona critically affects nanoparticle pathophysiology |
| Prot0233 | 112 | sphere | 134 | other | 600.0 | HP | nan | 0.009 | 15300.0 | -55 | 1 | 20.0 | PS | buffer | 90.0 | Neutral | 15.0 | buffer | 37 | 4 | 7.4 | Plasma protein | Rapid formation of plasma protein corona critically affects nanoparticle pathophysiology |
| Prot0234 | 112 | sphere | 134 | other | 600.0 | HP | nan | 0.009 | 15300.0 | -55 | 1 | 20.0 | PS | buffer | 90.0 | Neutral | 30.0 | buffer | 37 | 4 | 7.4 | Plasma protein | Rapid formation of plasma protein corona critically affects nanoparticle pathophysiology |
| Prot0235 | 112 | sphere | 134 | other | 600.0 | HP | nan | 0.009 | 15300.0 | -55 | 1 | 20.0 | PS | buffer | 90.0 | Neutral | 60.0 | buffer | 37 | 4 | 7.4 | Plasma protein | Rapid formation of plasma protein corona critically affects nanoparticle pathophysiology |
| Prot0236 | 112 | sphere | 134 | other | 600.0 | HP | nan | 0.009 | 15300.0 | -55 | 1 | 20.0 | PS | buffer | 90.0 | Neutral | 120.0 | buffer | 37 | 4 | 7.4 | Plasma protein | Rapid formation of plasma protein corona critically affects nanoparticle pathophysiology |
| Prot0237 | 73 | sphere | 73 | other | 10000.0 | HS | nan | 0.126944444 | 20000.0 | -13.5 | 1 | 60.0 | PS | water | 77.0 | Neutral | 1.0 | buffer | 37 | 4 | 7.0 | Serum protein | Visualization of the protein corona: Towards a biomolecular understanding of nanoparticle-cell-interactions |
| Prot0238 | 73 | sphere | 73 | other | 10000.0 | HS | nan | 0.126944444 | 20000.0 | -13.5 | 1 | 60.0 | PS | water | 77.0 | Neutral | 1.0 | buffer | 37 | 4 | 7.0 | Serum protein | Visualization of the protein corona: Towards a biomolecular understanding of nanoparticle-cell-interactions |
| Prot0239 | 73 | sphere | 73 | other | 10000.0 | HS | nan | 0.126944444 | 20000.0 | -13.5 | 1 | 60.0 | PS | water | 77.0 | Neutral | 1.0 | buffer | 37 | 4 | 7.0 | Serum protein | Visualization of the protein corona: Towards a biomolecular understanding of nanoparticle-cell-interactions |
| Prot0240 | 73 | sphere | 73 | other | 10000.0 | HS | nan | 0.126944444 | 20000.0 | -13.5 | 1 | 60.0 | PS | water | 77.0 | Neutral | 1.0 | buffer | 37 | 4 | 7.0 | Serum protein | Visualization of the protein corona: Towards a biomolecular understanding of nanoparticle-cell-interactions |
| Prot0241 | 70 | sphere | 70 | other | 10000.0 | HS | COOH | 0.126944444 | 20000.0 | -13.5 | 1 | 60.0 | PS | water | 77.0 | Anionic | 1.0 | buffer | 37 | 4 | 7.0 | Serum protein | Visualization of the protein corona: Towards a biomolecular understanding of nanoparticle-cell-interactions |
| Prot0242 | 70 | sphere | 70 | other | 10000.0 | HS | COOH | 0.126944444 | 20000.0 | -13.5 | 1 | 60.0 | PS | water | 77.0 | Anionic | 1.0 | buffer | 37 | 4 | 7.0 | Serum protein | Visualization of the protein corona: Towards a biomolecular understanding of nanoparticle-cell-interactions |
| Prot0243 | 74 | sphere | 74 | other | 10000.0 | HS | NH2 | 0.126944444 | 20000.0 | -13.5 | 1 | 60.0 | PS | water | 77.0 | Anionic | 1.0 | buffer | 37 | 4 | 7.0 | Serum protein | Visualization of the protein corona: Towards a biomolecular understanding of nanoparticle-cell-interactions |
| Prot0244 | 74 | sphere | 74 | other | 10000.0 | HS | NH2 | 0.126944444 | 20000.0 | -13.5 | 1 | 60.0 | PS | water | 77.0 | Anionic | 1.0 | buffer | 37 | 4 | 7.0 | Serum protein | Visualization of the protein corona: Towards a biomolecular understanding of nanoparticle-cell-interactions |
| Prot0245 | 73 | sphere | 73 | other | 10000.0 | HS | nan | 0.126944444 | 20000.0 | -13.5 | 1 | 60.0 | PS | water | 77.0 | Neutral | 1.0 | buffer | 37 | 4 | 7.0 | Serum protein | Visualization of the protein corona: Towards a biomolecular understanding of nanoparticle-cell-interactions |
| Prot0246 | 73 | sphere | 73 | other | 10000.0 | HS | nan | 0.126944444 | 20000.0 | -13.5 | 1 | 60.0 | PS | water | 77.0 | Neutral | 1.0 | buffer | 37 | 4 | 7.0 | Serum protein | Visualization of the protein corona: Towards a biomolecular understanding of nanoparticle-cell-interactions |
| Prot0247 | 73 | sphere | 73 | other | 10000.0 | HS | nan | 0.126944444 | 20000.0 | -13.5 | 1 | 60.0 | PS | water | 77.0 | Neutral | 1.0 | buffer | 37 | 4 | 7.0 | Serum protein | Visualization of the protein corona: Towards a biomolecular understanding of nanoparticle-cell-interactions |
| Prot0248 | 73 | sphere | 73 | other | 10000.0 | HS | nan | 0.126944444 | 20000.0 | -13.5 | 1 | 60.0 | PS | water | 77.0 | Neutral | 1.0 | buffer | 37 | 4 | 7.0 | Serum protein | Visualization of the protein corona: Towards a biomolecular understanding of nanoparticle-cell-interactions |
| Prot0249 | 70 | sphere | 70 | other | 10000.0 | HS | COOH | 0.126944444 | 20000.0 | -13.5 | 1 | 60.0 | PS | water | 77.0 | Anionic | 1.0 | buffer | 37 | 4 | 7.0 | Serum protein | Visualization of the protein corona: Towards a biomolecular understanding of nanoparticle-cell-interactions |
| Prot0250 | 70 | sphere | 70 | other | 10000.0 | HS | COOH | 0.126944444 | 20000.0 | -13.5 | 1 | 60.0 | PS | water | 77.0 | Anionic | 1.0 | buffer | 37 | 4 | 7.0 | Serum protein | Visualization of the protein corona: Towards a biomolecular understanding of nanoparticle-cell-interactions |
| Prot0251 | 74 | sphere | 74 | other | 10000.0 | HS | NH2 | 0.126944444 | 20000.0 | -13.5 | 1 | 60.0 | PS | water | 77.0 | Anionic | 1.0 | buffer | 37 | 4 | 7.0 | Serum protein | Visualization of the protein corona: Towards a biomolecular understanding of nanoparticle-cell-interactions |
| Prot0252 | 74 | sphere | 74 | other | 10000.0 | HS | NH2 | 0.126944444 | 20000.0 | -13.5 | 1 | 60.0 | PS | water | 77.0 | Anionic | 1.0 | buffer | 37 | 4 | 7.0 | Serum protein | Visualization of the protein corona: Towards a biomolecular understanding of nanoparticle-cell-interactions |
| Prot0253 | nan | sphere | 79 | other | 1000.0 | FBS | nan | 0.03 ± 0.02 | 18000.0 | -45.4 | 1 | nan | SiO2 | PBS | 1.98 | nan | 0.08933 | water | 37 | 4 | 7.4 | Serum protein | Nanoparticle Biomolecular Corona-Based Enrichment of Plasma Glycoproteinsfor N‑GlycanProfiling and Applicationin Biomarker Discovery |
| Prot0254 | 103 | sphere | 235 | other | 500.0 | FBS | nan | 0.126944444 | 15000.0 | -11.6 | 1 | 20.0 | SiO2 | plasma | 50.0 | Neutral | 0.008333333 | buffer | 37 | 25 | 7.4 | Serum protein | The timeline of corona formation around silica nanocarriers highlights the role of the protein interactome |
| Prot0255 | 103 | sphere | 235 | other | 500.0 | FBS | nan | 0.126944444 | 15000.0 | -11.6 | 1 | 20.0 | SiO2 | plasma | 50.0 | Neutral | 0.083333333 | buffer | 37 | 25 | 7.4 | Serum protein | The timeline of corona formation around silica nanocarriers highlights the role of the protein interactome |
| Prot0256 | 103 | sphere | 235 | other | 500.0 | FBS | nan | 0.126944444 | 15000.0 | -11.6 | 1 | 20.0 | SiO2 | plasma | 50.0 | Neutral | 0.25 | buffer | 37 | 25 | 7.4 | Serum protein | The timeline of corona formation around silica nanocarriers highlights the role of the protein interactome |
| Prot0257 | 103 | sphere | 235 | other | 500.0 | FBS | nan | 0.126944444 | 15000.0 | -11.6 | 1 | 20.0 | SiO2 | plasma | 50.0 | Neutral | 0.5 | buffer | 37 | 25 | 7.4 | Serum protein | The timeline of corona formation around silica nanocarriers highlights the role of the protein interactome |
| Prot0258 | 103 | sphere | 235 | other | 500.0 | FBS | nan | 0.126944444 | 15000.0 | -11.6 | 1 | 20.0 | SiO2 | plasma | 50.0 | Neutral | 1.0 | buffer | 37 | 25 | 7.4 | Serum protein | The timeline of corona formation around silica nanocarriers highlights the role of the protein interactome |
| Prot0259 | 103 | sphere | 235 | other | 500.0 | FBS | nan | 0.126944444 | 15000.0 | -11.6 | 1 | 20.0 | SiO2 | plasma | 50.0 | Neutral | 2.0 | buffer | 37 | 25 | 7.4 | Serum protein | The timeline of corona formation around silica nanocarriers highlights the role of the protein interactome |
| Prot0260 | 103 | sphere | 235 | other | 500.0 | FBS | nan | 0.126944444 | 15000.0 | -11.6 | 1 | 20.0 | SiO2 | plasma | 50.0 | Neutral | 8.0 | buffer | 37 | 25 | 7.4 | Serum protein | The timeline of corona formation around silica nanocarriers highlights the role of the protein interactome |
| Prot0261 | 103 | sphere | 235 | other | 500.0 | FBS | nan | 0.126944444 | 15000.0 | -11.6 | 1 | 20.0 | SiO2 | plasma | 50.0 | Neutral | 24.0 | buffer | 37 | 25 | 7.4 | Serum protein | The timeline of corona formation around silica nanocarriers highlights the role of the protein interactome |
| Prot0262 | 103 | sphere | 235 | other | 500.0 | FBS | nan | 0.126944444 | 15000.0 | -11.6 | 1 | 20.0 | SiO2 | plasma | 50.0 | Neutral | 48.0 | buffer | 37 | 25 | 7.4 | Serum protein | The timeline of corona formation around silica nanocarriers highlights the role of the protein interactome |
| Prot0263 | 103 | sphere | 235 | other | 500.0 | FBS | nan | 0.126944444 | 15000.0 | -11.6 | 1 | 20.0 | SiO2 | plasma | 50.0 | Neutral | 168.0 | buffer | 37 | 25 | 7.4 | Serum protein | The timeline of corona formation around silica nanocarriers highlights the role of the protein interactome |
| Prot0264 | 103 | sphere | 190 | other | 500.0 | HS | nan | 0.126944444 | 15000.0 | -15.1 | 1 | 20.0 | SiO2 | plasma | 50.0 | Neutral | 0.008333333 | buffer | 37 | 25 | 7.4 | Serum protein | The timeline of corona formation around silica nanocarriers highlights the role of the protein interactome |
| Prot0265 | 103 | sphere | 190 | other | 500.0 | HS | nan | 0.126944444 | 15000.0 | -15.1 | 1 | 20.0 | SiO2 | plasma | 50.0 | Neutral | 0.083333333 | buffer | 37 | 25 | 7.4 | Serum protein | The timeline of corona formation around silica nanocarriers highlights the role of the protein interactome |
| Prot0266 | 103 | sphere | 190 | other | 500.0 | HS | nan | 0.126944444 | 15000.0 | -15.1 | 1 | 20.0 | SiO2 | plasma | 50.0 | Neutral | 0.25 | buffer | 37 | 25 | 7.4 | Serum protein | The timeline of corona formation around silica nanocarriers highlights the role of the protein interactome |
| Prot0267 | 103 | sphere | 190 | other | 500.0 | HS | nan | 0.126944444 | 15000.0 | -15.1 | 1 | 20.0 | SiO2 | plasma | 50.0 | Neutral | 0.5 | buffer | 37 | 25 | 7.4 | Serum protein | The timeline of corona formation around silica nanocarriers highlights the role of the protein interactome |
| Prot0268 | 103 | sphere | 190 | other | 500.0 | HS | nan | 0.126944444 | 15000.0 | -15.1 | 1 | 20.0 | SiO2 | plasma | 50.0 | Neutral | 1.0 | buffer | 37 | 25 | 7.4 | Serum protein | The timeline of corona formation around silica nanocarriers highlights the role of the protein interactome |
| Prot0269 | 103 | sphere | 190 | other | 500.0 | HS | nan | 0.126944444 | 15000.0 | -15.1 | 1 | 20.0 | SiO2 | plasma | 50.0 | Neutral | 2.0 | buffer | 37 | 25 | 7.4 | Serum protein | The timeline of corona formation around silica nanocarriers highlights the role of the protein interactome |
| Prot0270 | 103 | sphere | 190 | other | 500.0 | HS | nan | 0.126944444 | 15000.0 | -15.1 | 1 | 20.0 | SiO2 | plasma | 50.0 | Neutral | 8.0 | buffer | 37 | 25 | 7.4 | Serum protein | The timeline of corona formation around silica nanocarriers highlights the role of the protein interactome |
| Prot0271 | 103 | sphere | 190 | other | 500.0 | HS | nan | 0.126944444 | 15000.0 | -15.1 | 1 | 20.0 | SiO2 | plasma | 50.0 | Neutral | 24.0 | buffer | 37 | 25 | 7.4 | Serum protein | The timeline of corona formation around silica nanocarriers highlights the role of the protein interactome |
| Prot0272 | 103 | sphere | 190 | other | 500.0 | HS | nan | 0.126944444 | 15000.0 | -15.1 | 1 | 20.0 | SiO2 | plasma | 50.0 | Neutral | 48.0 | buffer | 37 | 25 | 7.4 | Serum protein | The timeline of corona formation around silica nanocarriers highlights the role of the protein interactome |
| Prot0273 | 103 | sphere | 190 | other | 500.0 | HS | nan | 0.126944444 | 15000.0 | -15.1 | 1 | 20.0 | SiO2 | plasma | 50.0 | Neutral | 168.0 | buffer | 37 | 25 | 7.4 | Serum protein | The timeline of corona formation around silica nanocarriers highlights the role of the protein interactome |
| Prot0274 | 103 | sphere | 159 | other | 500.0 | HS | nan | 0.126944444 | 15000.0 | -38.7 | 1 | 20.0 | SiO2 | PBS | 50.0 | Neutral | 0.008333333 | buffer | 37 | 25 | 7.4 | Serum protein | The timeline of corona formation around silica nanocarriers highlights the role of the protein interactome |
| Prot0275 | 103 | sphere | 159 | other | 500.0 | HS | nan | 0.126944444 | 15000.0 | -38.7 | 1 | 20.0 | SiO2 | PBS | 50.0 | Neutral | 0.083333333 | buffer | 37 | 25 | 7.4 | Serum protein | The timeline of corona formation around silica nanocarriers highlights the role of the protein interactome |
| Prot0276 | 103 | sphere | 159 | other | 500.0 | HS | nan | 0.126944444 | 15000.0 | -38.7 | 1 | 20.0 | SiO2 | PBS | 50.0 | Neutral | 0.25 | buffer | 37 | 25 | 7.4 | Serum protein | The timeline of corona formation around silica nanocarriers highlights the role of the protein interactome |
| Prot0277 | 103 | sphere | 159 | other | 500.0 | HS | nan | 0.126944444 | 15000.0 | -38.7 | 1 | 20.0 | SiO2 | PBS | 50.0 | Neutral | 0.5 | buffer | 37 | 25 | 7.4 | Serum protein | The timeline of corona formation around silica nanocarriers highlights the role of the protein interactome |
| Prot0278 | 103 | sphere | 159 | other | 500.0 | HS | nan | 0.126944444 | 15000.0 | -38.7 | 1 | 20.0 | SiO2 | PBS | 50.0 | Neutral | 1.0 | buffer | 37 | 25 | 7.4 | Serum protein | The timeline of corona formation around silica nanocarriers highlights the role of the protein interactome |
| Prot0279 | 103 | sphere | 159 | other | 500.0 | HS | nan | 0.126944444 | 15000.0 | -38.7 | 1 | 20.0 | SiO2 | PBS | 50.0 | Neutral | 2.0 | buffer | 37 | 25 | 7.4 | Serum protein | The timeline of corona formation around silica nanocarriers highlights the role of the protein interactome |
| Prot0280 | 103 | sphere | 159 | other | 500.0 | HS | nan | 0.126944444 | 15000.0 | -38.7 | 1 | 20.0 | SiO2 | PBS | 50.0 | Neutral | 8.0 | buffer | 37 | 25 | 7.4 | Serum protein | The timeline of corona formation around silica nanocarriers highlights the role of the protein interactome |
| Prot0281 | 103 | sphere | 159 | other | 500.0 | HS | nan | 0.126944444 | 15000.0 | -38.7 | 1 | 20.0 | SiO2 | PBS | 50.0 | Neutral | 24.0 | buffer | 37 | 25 | 7.4 | Serum protein | The timeline of corona formation around silica nanocarriers highlights the role of the protein interactome |
| Prot0282 | 103 | sphere | 159 | other | 500.0 | HS | nan | 0.126944444 | 15000.0 | -38.7 | 1 | 20.0 | SiO2 | PBS | 50.0 | Neutral | 48.0 | buffer | 37 | 25 | 7.4 | Serum protein | The timeline of corona formation around silica nanocarriers highlights the role of the protein interactome |
| Prot0283 | 103 | sphere | 159 | other | 500.0 | HS | nan | 0.126944444 | 15000.0 | -38.7 | 1 | 20.0 | SiO2 | PBS | 50.0 | Neutral | 168.0 | buffer | 37 | 25 | 7.4 | Serum protein | The timeline of corona formation around silica nanocarriers highlights the role of the protein interactome |
| Prot0284 | 103 | sphere | 159 | other | 500.0 | FBS | nan | 0.126944444 | 15000.0 | -38.7 | 1 | 20.0 | SiO2 | PBS | 50.0 | Neutral | 0.008333333 | buffer | 37 | 25 | 7.4 | Serum protein | The timeline of corona formation around silica nanocarriers highlights the role of the protein interactome |
| Prot0285 | 103 | sphere | 159 | other | 500.0 | FBS | nan | 0.126944444 | 15000.0 | -38.7 | 1 | 20.0 | SiO2 | PBS | 50.0 | Neutral | 0.083333333 | buffer | 37 | 25 | 7.4 | Serum protein | The timeline of corona formation around silica nanocarriers highlights the role of the protein interactome |
| Prot0286 | 103 | sphere | 159 | other | 500.0 | FBS | nan | 0.126944444 | 15000.0 | -38.7 | 1 | 20.0 | SiO2 | PBS | 50.0 | Neutral | 0.25 | buffer | 37 | 25 | 7.4 | Serum protein | The timeline of corona formation around silica nanocarriers highlights the role of the protein interactome |
| Prot0287 | 103 | sphere | 159 | other | 500.0 | FBS | nan | 0.126944444 | 15000.0 | -38.7 | 1 | 20.0 | SiO2 | PBS | 50.0 | Neutral | 0.5 | buffer | 37 | 25 | 7.4 | Serum protein | The timeline of corona formation around silica nanocarriers highlights the role of the protein interactome |
| Prot0288 | 103 | sphere | 159 | other | 500.0 | FBS | nan | 0.126944444 | 15000.0 | -38.7 | 1 | 20.0 | SiO2 | PBS | 50.0 | Neutral | 1.0 | buffer | 37 | 25 | 7.4 | Serum protein | The timeline of corona formation around silica nanocarriers highlights the role of the protein interactome |
| Prot0289 | 103 | sphere | 159 | other | 500.0 | FBS | nan | 0.126944444 | 15000.0 | -38.7 | 1 | 20.0 | SiO2 | PBS | 50.0 | Neutral | 2.0 | buffer | 37 | 25 | 7.4 | Serum protein | The timeline of corona formation around silica nanocarriers highlights the role of the protein interactome |
| Prot0290 | 103 | sphere | 159 | other | 500.0 | FBS | nan | 0.126944444 | 15000.0 | -38.7 | 1 | 20.0 | SiO2 | PBS | 50.0 | Neutral | 8.0 | buffer | 37 | 25 | 7.4 | Serum protein | The timeline of corona formation around silica nanocarriers highlights the role of the protein interactome |
| Prot0291 | 103 | sphere | 159 | other | 500.0 | FBS | nan | 0.126944444 | 15000.0 | -38.7 | 1 | 20.0 | SiO2 | PBS | 50.0 | Neutral | 24.0 | buffer | 37 | 25 | 7.4 | Serum protein | The timeline of corona formation around silica nanocarriers highlights the role of the protein interactome |
| Prot0292 | 103 | sphere | 159 | other | 500.0 | FBS | nan | 0.126944444 | 15000.0 | -38.7 | 1 | 20.0 | SiO2 | PBS | 50.0 | Neutral | 48.0 | buffer | 37 | 25 | 7.4 | Serum protein | The timeline of corona formation around silica nanocarriers highlights the role of the protein interactome |
| Prot0293 | 103 | sphere | 159 | other | 500.0 | FBS | nan | 0.126944444 | 15000.0 | -38.7 | 1 | 20.0 | SiO2 | PBS | 50.0 | Neutral | 168.0 | buffer | 37 | 25 | 7.4 | Serum protein | The timeline of corona formation around silica nanocarriers highlights the role of the protein interactome |
| Prot0294 | 116.6 | sphere | 220.8 | other | 1000.0 | HS | nan | 0.288 | 15000.0 | -19.9 | 1 | 20.0 | SiO2 | plasma | 10.0 | Neutral | 24.0 | buffer | 37 | 25 | 7.4 | Serum protein | The species origin of the serum in the culture medium influences the in vitro toxicity of silica nanoparticles to HepG2 cells |
| Prot0295 | 116.6 | sphere | 193.3 | other | 1000.0 | FBS | nan | 0.187 | 15000.0 | -20.1 | 1 | 20.0 | SiO2 | plasma | 10.0 | Neutral | 24.0 | buffer | 37 | 25 | 7.4 | Serum protein | The species origin of the serum in the culture medium influences the in vitro toxicity of silica nanoparticles to HepG2 cells |
| Prot0296 | 116.6 | sphere | 143.5 | other | 1000.0 | FBS | nan | 0.111 | 15000.0 | -39.1 | 1 | 20.0 | SiO2 | buffer | 10.0 | Neutral | 24.0 | buffer | 37 | 25 | 7.4 | Serum protein | The species origin of the serum in the culture medium influences the in vitro toxicity of silica nanoparticles to HepG2 cells |
| Prot0297 | 116.6 | sphere | 143.5 | other | 1000.0 | HS | nan | 0.111 | 15000.0 | -39.1 | 1 | 20.0 | SiO2 | buffer | 10.0 | Neutral | 24.0 | buffer | 37 | 25 | 7.4 | Serum protein | The species origin of the serum in the culture medium influences the in vitro toxicity of silica nanoparticles to HepG2 cells |
| Prot0298 | 203 | sphere | 203 | other | 1000.0 | HP | nan | 0.19 | 14000.0 | -16.2 | 1 | 15.0 | SiO2 | plasma | 50.0 | Neutral | 1.0 | buffer | 37 | 25 | 7.4 | Plasma protein | Stealth Effect of Biomolecular Corona on Nanoparticle Uptake by Immune Cells |
| Prot0299 | 152 | sphere | 152 | other | 1000.0 | HP | nan | 0.18 | 14000.0 | -18.4 | 1 | 15.0 | SiO2 | buffer | 50.0 | Neutral | 1.0 | buffer | 37 | 25 | 7.4 | Plasma protein | Stealth Effect of Biomolecular Corona on Nanoparticle Uptake by Immune Cells |
| Prot0300 | 141 | sphere | 158 | other | 60.0 | HP | nan | 0.007 | 15300.0 | -6 | 1 | 20.0 | SiO2 | plasma | 90.0 | Neutral | 0.5 | buffer | 37 | 4 | 7.4 | Plasma protein | Rapid formation of plasma protein corona critically affects nanoparticle pathophysiology |
| Prot0301 | 141 | sphere | 158 | other | 60.0 | HP | nan | 0.007 | 15300.0 | -6 | 1 | 20.0 | SiO2 | plasma | 90.0 | Neutral | 2.0 | buffer | 37 | 4 | 7.4 | Plasma protein | Rapid formation of plasma protein corona critically affects nanoparticle pathophysiology |
| Prot0302 | 141 | sphere | 158 | other | 60.0 | HP | nan | 0.007 | 15300.0 | -6 | 1 | 20.0 | SiO2 | plasma | 90.0 | Neutral | 5.0 | buffer | 37 | 4 | 7.4 | Plasma protein | Rapid formation of plasma protein corona critically affects nanoparticle pathophysiology |
| Prot0303 | 141 | sphere | 158 | other | 60.0 | HP | nan | 0.007 | 15300.0 | -6 | 1 | 20.0 | SiO2 | plasma | 90.0 | Neutral | 15.0 | buffer | 37 | 4 | 7.4 | Plasma protein | Rapid formation of plasma protein corona critically affects nanoparticle pathophysiology |
| Prot0304 | 141 | sphere | 158 | other | 60.0 | HP | nan | 0.007 | 15300.0 | -6 | 1 | 20.0 | SiO2 | plasma | 90.0 | Neutral | 30.0 | buffer | 37 | 4 | 7.4 | Plasma protein | Rapid formation of plasma protein corona critically affects nanoparticle pathophysiology |
| Prot0305 | 141 | sphere | 158 | other | 60.0 | HP | nan | 0.007 | 15300.0 | -6 | 1 | 20.0 | SiO2 | plasma | 90.0 | Neutral | 60.0 | buffer | 37 | 4 | 7.4 | Plasma protein | Rapid formation of plasma protein corona critically affects nanoparticle pathophysiology |
| Prot0306 | 141 | sphere | 158 | other | 60.0 | HP | nan | 0.007 | 15300.0 | -6 | 1 | 20.0 | SiO2 | plasma | 90.0 | Neutral | 120.0 | buffer | 37 | 4 | 7.4 | Plasma protein | Rapid formation of plasma protein corona critically affects nanoparticle pathophysiology |
| Prot0307 | 144.8 | sphere | 172 | other | 60.0 | HP | NH2 | 0.009 | 15300.0 | -8 | 1 | 20.0 | SiO2 | plasma | 90.0 | Anionic | 0.5 | buffer | 37 | 4 | 7.4 | Plasma protein | Rapid formation of plasma protein corona critically affects nanoparticle pathophysiology |
| Prot0308 | 129 | sphere | 180 | other | 60.0 | HP | COOH | 0.007 | 15300.0 | -8 | 1 | 20.0 | SiO2 | plasma | 90.0 | Anionic | 0.5 | buffer | 37 | 4 | 7.4 | Plasma protein | Rapid formation of plasma protein corona critically affects nanoparticle pathophysiology |
| Prot0309 | 144.8 | sphere | 172 | other | 60.0 | HP | NH2 | 0.009 | 15300.0 | -8 | 1 | 20.0 | SiO2 | plasma | 90.0 | Anionic | 2.0 | buffer | 37 | 4 | 7.4 | Plasma protein | Rapid formation of plasma protein corona critically affects nanoparticle pathophysiology |
| Prot0310 | 129 | sphere | 180 | other | 60.0 | HP | COOH | 0.007 | 15300.0 | -8 | 1 | 20.0 | SiO2 | plasma | 90.0 | Anionic | 2.0 | buffer | 37 | 4 | 7.4 | Plasma protein | Rapid formation of plasma protein corona critically affects nanoparticle pathophysiology |
| Prot0311 | 144.8 | sphere | 172 | other | 60.0 | HP | NH2 | 0.009 | 15300.0 | -8 | 1 | 20.0 | SiO2 | plasma | 90.0 | Anionic | 5.0 | buffer | 37 | 4 | 7.4 | Plasma protein | Rapid formation of plasma protein corona critically affects nanoparticle pathophysiology |
| Prot0312 | 129 | sphere | 180 | other | 60.0 | HP | COOH | 0.007 | 15300.0 | -8 | 1 | 20.0 | SiO2 | plasma | 90.0 | Anionic | 5.0 | buffer | 37 | 4 | 7.4 | Plasma protein | Rapid formation of plasma protein corona critically affects nanoparticle pathophysiology |
| Prot0313 | 144.8 | sphere | 172 | other | 60.0 | HP | NH2 | 0.009 | 15300.0 | -8 | 1 | 20.0 | SiO2 | plasma | 90.0 | Anionic | 15.0 | buffer | 37 | 4 | 7.4 | Plasma protein | Rapid formation of plasma protein corona critically affects nanoparticle pathophysiology |
| Prot0314 | 129 | sphere | 180 | other | 60.0 | HP | COOH | 0.007 | 15300.0 | -8 | 1 | 20.0 | SiO2 | plasma | 90.0 | Anionic | 15.0 | buffer | 37 | 4 | 7.4 | Plasma protein | Rapid formation of plasma protein corona critically affects nanoparticle pathophysiology |
| Prot0315 | 144.8 | sphere | 172 | other | 60.0 | HP | NH2 | 0.009 | 15300.0 | -8 | 1 | 20.0 | SiO2 | plasma | 90.0 | Anionic | 30.0 | buffer | 37 | 4 | 7.4 | Plasma protein | Rapid formation of plasma protein corona critically affects nanoparticle pathophysiology |
| Prot0316 | 129 | sphere | 180 | other | 60.0 | HP | COOH | 0.007 | 15300.0 | -8 | 1 | 20.0 | SiO2 | plasma | 90.0 | Anionic | 30.0 | buffer | 37 | 4 | 7.4 | Plasma protein | Rapid formation of plasma protein corona critically affects nanoparticle pathophysiology |
| Prot0317 | 144.8 | sphere | 172 | other | 60.0 | HP | NH2 | 0.009 | 15300.0 | -8 | 1 | 20.0 | SiO2 | plasma | 90.0 | Anionic | 60.0 | buffer | 37 | 4 | 7.4 | Plasma protein | Rapid formation of plasma protein corona critically affects nanoparticle pathophysiology |
| Prot0318 | 129 | sphere | 180 | other | 60.0 | HP | COOH | 0.007 | 15300.0 | -8 | 1 | 20.0 | SiO2 | plasma | 90.0 | Anionic | 60.0 | buffer | 37 | 4 | 7.4 | Plasma protein | Rapid formation of plasma protein corona critically affects nanoparticle pathophysiology |
| Prot0319 | 144.8 | sphere | 172 | other | 60.0 | HP | NH2 | 0.009 | 15300.0 | -8 | 1 | 20.0 | SiO2 | plasma | 90.0 | Anionic | 120.0 | buffer | 37 | 4 | 7.4 | Plasma protein | Rapid formation of plasma protein corona critically affects nanoparticle pathophysiology |
| Prot0320 | 129 | sphere | 180 | other | 60.0 | HP | COOH | 0.007 | 15300.0 | -8 | 1 | 20.0 | SiO2 | plasma | 90.0 | Anionic | 120.0 | buffer | 37 | 4 | 7.4 | Plasma protein | Rapid formation of plasma protein corona critically affects nanoparticle pathophysiology |
| Prot0321 | 30.2 | sphere | 72 | other | 60.0 | HP | NH2 | 0.085 | 15300.0 | -9 | 1 | 20.0 | SiO2 | plasma | 90.0 | Anionic | 0.5 | buffer | 37 | 4 | 7.4 | Plasma protein | Rapid formation of plasma protein corona critically affects nanoparticle pathophysiology |
| Prot0322 | 31.6 | sphere | 75 | other | 60.0 | HP | nan | 0.051 | 15300.0 | -9 | 1 | 20.0 | SiO2 | plasma | 90.0 | Neutral | 0.5 | buffer | 37 | 4 | 7.4 | Plasma protein | Rapid formation of plasma protein corona critically affects nanoparticle pathophysiology |
| Prot0323 | 30.2 | sphere | 72 | other | 60.0 | HP | NH2 | 0.085 | 15300.0 | -9 | 1 | 20.0 | SiO2 | plasma | 90.0 | Anionic | 2.0 | buffer | 37 | 4 | 7.4 | Plasma protein | Rapid formation of plasma protein corona critically affects nanoparticle pathophysiology |
| Prot0324 | 31.6 | sphere | 75 | other | 60.0 | HP | nan | 0.051 | 15300.0 | -9 | 1 | 20.0 | SiO2 | plasma | 90.0 | Neutral | 2.0 | buffer | 37 | 4 | 7.4 | Plasma protein | Rapid formation of plasma protein corona critically affects nanoparticle pathophysiology |
| Prot0325 | 30.2 | sphere | 72 | other | 60.0 | HP | NH2 | 0.085 | 15300.0 | -9 | 1 | 20.0 | SiO2 | plasma | 90.0 | Anionic | 5.0 | buffer | 37 | 4 | 7.4 | Plasma protein | Rapid formation of plasma protein corona critically affects nanoparticle pathophysiology |
| Prot0326 | 31.6 | sphere | 75 | other | 60.0 | HP | nan | 0.051 | 15300.0 | -9 | 1 | 20.0 | SiO2 | plasma | 90.0 | Neutral | 5.0 | buffer | 37 | 4 | 7.4 | Plasma protein | Rapid formation of plasma protein corona critically affects nanoparticle pathophysiology |
| Prot0327 | 30.2 | sphere | 72 | other | 60.0 | HP | NH2 | 0.085 | 15300.0 | -9 | 1 | 20.0 | SiO2 | plasma | 90.0 | Anionic | 15.0 | buffer | 37 | 4 | 7.4 | Plasma protein | Rapid formation of plasma protein corona critically affects nanoparticle pathophysiology |
| Prot0328 | 31.6 | sphere | 75 | other | 60.0 | HP | nan | 0.051 | 15300.0 | -9 | 1 | 20.0 | SiO2 | plasma | 90.0 | Neutral | 15.0 | buffer | 37 | 4 | 7.4 | Plasma protein | Rapid formation of plasma protein corona critically affects nanoparticle pathophysiology |
| Prot0329 | 30.2 | sphere | 72 | other | 60.0 | HP | NH2 | 0.085 | 15300.0 | -9 | 1 | 20.0 | SiO2 | plasma | 90.0 | Anionic | 30.0 | buffer | 37 | 4 | 7.4 | Plasma protein | Rapid formation of plasma protein corona critically affects nanoparticle pathophysiology |
| Prot0330 | 31.6 | sphere | 75 | other | 60.0 | HP | nan | 0.051 | 15300.0 | -9 | 1 | 20.0 | SiO2 | plasma | 90.0 | Neutral | 30.0 | buffer | 37 | 4 | 7.4 | Plasma protein | Rapid formation of plasma protein corona critically affects nanoparticle pathophysiology |
| Prot0331 | 30.2 | sphere | 72 | other | 60.0 | HP | NH2 | 0.085 | 15300.0 | -9 | 1 | 20.0 | SiO2 | plasma | 90.0 | Anionic | 60.0 | buffer | 37 | 4 | 7.4 | Plasma protein | Rapid formation of plasma protein corona critically affects nanoparticle pathophysiology |
| Prot0332 | 31.6 | sphere | 75 | other | 60.0 | HP | nan | 0.051 | 15300.0 | -9 | 1 | 20.0 | SiO2 | plasma | 90.0 | Neutral | 60.0 | buffer | 37 | 4 | 7.4 | Plasma protein | Rapid formation of plasma protein corona critically affects nanoparticle pathophysiology |
| Prot0333 | 30.2 | sphere | 72 | other | 60.0 | HP | NH2 | 0.085 | 15300.0 | -9 | 1 | 20.0 | SiO2 | plasma | 90.0 | Anionic | 120.0 | buffer | 37 | 4 | 7.4 | Plasma protein | Rapid formation of plasma protein corona critically affects nanoparticle pathophysiology |
| Prot0334 | 31.6 | sphere | 75 | other | 60.0 | HP | nan | 0.051 | 15300.0 | -9 | 1 | 20.0 | SiO2 | plasma | 90.0 | Neutral | 120.0 | buffer | 37 | 4 | 7.4 | Plasma protein | Rapid formation of plasma protein corona critically affects nanoparticle pathophysiology |
| Prot0335 | 31.4 | sphere | 35.2 | other | 60.0 | HP | nan | 0.0001 | 15300.0 | -25 | 1 | 20.0 | SiO2 | buffer | 90.0 | Neutral | 0.5 | buffer | 37 | 4 | 7.4 | Plasma protein | Rapid formation of plasma protein corona critically affects nanoparticle pathophysiology |
| Prot0336 | 31.4 | sphere | 35.2 | other | 60.0 | HP | nan | 0.0001 | 15300.0 | -25 | 1 | 20.0 | SiO2 | buffer | 90.0 | Neutral | 2.0 | buffer | 37 | 4 | 7.4 | Plasma protein | Rapid formation of plasma protein corona critically affects nanoparticle pathophysiology |
| Prot0337 | 31.4 | sphere | 35.2 | other | 60.0 | HP | nan | 0.0001 | 15300.0 | -25 | 1 | 20.0 | SiO2 | buffer | 90.0 | Neutral | 5.0 | buffer | 37 | 4 | 7.4 | Plasma protein | Rapid formation of plasma protein corona critically affects nanoparticle pathophysiology |
| Prot0338 | 31.4 | sphere | 35.2 | other | 60.0 | HP | nan | 0.0001 | 15300.0 | -25 | 1 | 20.0 | SiO2 | buffer | 90.0 | Neutral | 15.0 | buffer | 37 | 4 | 7.4 | Plasma protein | Rapid formation of plasma protein corona critically affects nanoparticle pathophysiology |
| Prot0339 | 31.4 | sphere | 35.2 | other | 60.0 | HP | nan | 0.0001 | 15300.0 | -25 | 1 | 20.0 | SiO2 | buffer | 90.0 | Neutral | 30.0 | buffer | 37 | 4 | 7.4 | Plasma protein | Rapid formation of plasma protein corona critically affects nanoparticle pathophysiology |
| Prot0340 | 31.4 | sphere | 35.2 | other | 60.0 | HP | nan | 0.0001 | 15300.0 | -25 | 1 | 20.0 | SiO2 | buffer | 90.0 | Neutral | 60.0 | buffer | 37 | 4 | 7.4 | Plasma protein | Rapid formation of plasma protein corona critically affects nanoparticle pathophysiology |
| Prot0341 | 31.4 | sphere | 35.2 | other | 60.0 | HP | nan | 0.0001 | 15300.0 | -25 | 1 | 20.0 | SiO2 | buffer | 90.0 | Neutral | 120.0 | buffer | 37 | 4 | 7.4 | Plasma protein | Rapid formation of plasma protein corona critically affects nanoparticle pathophysiology |
| Prot0342 | 129 | sphere | 133 | other | 60.0 | HP | COOH | 0.006 | 15300.0 | -28 | 1 | 20.0 | SiO2 | buffer | 90.0 | Anionic | 0.5 | buffer | 37 | 4 | 7.4 | Plasma protein | Rapid formation of plasma protein corona critically affects nanoparticle pathophysiology |
| Prot0343 | 129 | sphere | 133 | other | 60.0 | HP | COOH | 0.006 | 15300.0 | -28 | 1 | 20.0 | SiO2 | buffer | 90.0 | Anionic | 2.0 | buffer | 37 | 4 | 7.4 | Plasma protein | Rapid formation of plasma protein corona critically affects nanoparticle pathophysiology |
| Prot0344 | 129 | sphere | 133 | other | 60.0 | HP | COOH | 0.006 | 15300.0 | -28 | 1 | 20.0 | SiO2 | buffer | 90.0 | Anionic | 5.0 | buffer | 37 | 4 | 7.4 | Plasma protein | Rapid formation of plasma protein corona critically affects nanoparticle pathophysiology |
| Prot0345 | 129 | sphere | 133 | other | 60.0 | HP | COOH | 0.006 | 15300.0 | -28 | 1 | 20.0 | SiO2 | buffer | 90.0 | Anionic | 15.0 | buffer | 37 | 4 | 7.4 | Plasma protein | Rapid formation of plasma protein corona critically affects nanoparticle pathophysiology |
| Prot0346 | 129 | sphere | 133 | other | 60.0 | HP | COOH | 0.006 | 15300.0 | -28 | 1 | 20.0 | SiO2 | buffer | 90.0 | Anionic | 30.0 | buffer | 37 | 4 | 7.4 | Plasma protein | Rapid formation of plasma protein corona critically affects nanoparticle pathophysiology |
| Prot0347 | 129 | sphere | 133 | other | 60.0 | HP | COOH | 0.006 | 15300.0 | -28 | 1 | 20.0 | SiO2 | buffer | 90.0 | Anionic | 60.0 | buffer | 37 | 4 | 7.4 | Plasma protein | Rapid formation of plasma protein corona critically affects nanoparticle pathophysiology |
| Prot0348 | 129 | sphere | 133 | other | 60.0 | HP | COOH | 0.006 | 15300.0 | -28 | 1 | 20.0 | SiO2 | buffer | 90.0 | Anionic | 120.0 | buffer | 37 | 4 | 7.4 | Plasma protein | Rapid formation of plasma protein corona critically affects nanoparticle pathophysiology |
| Prot0349 | 141 | sphere | 141 | other | 60.0 | HP | nan | 0.002 | 15300.0 | -21 | 1 | 20.0 | SiO2 | buffer | 90.0 | Neutral | 0.5 | buffer | 37 | 4 | 7.4 | Plasma protein | Rapid formation of plasma protein corona critically affects nanoparticle pathophysiology |
| Prot0350 | 141 | sphere | 141 | other | 60.0 | HP | nan | 0.002 | 15300.0 | -21 | 1 | 20.0 | SiO2 | buffer | 90.0 | Neutral | 2.0 | buffer | 37 | 4 | 7.4 | Plasma protein | Rapid formation of plasma protein corona critically affects nanoparticle pathophysiology |
| Prot0351 | 141 | sphere | 141 | other | 60.0 | HP | nan | 0.002 | 15300.0 | -21 | 1 | 20.0 | SiO2 | buffer | 90.0 | Neutral | 5.0 | buffer | 37 | 4 | 7.4 | Plasma protein | Rapid formation of plasma protein corona critically affects nanoparticle pathophysiology |
| Prot0352 | 141 | sphere | 141 | other | 60.0 | HP | nan | 0.002 | 15300.0 | -21 | 1 | 20.0 | SiO2 | buffer | 90.0 | Neutral | 15.0 | buffer | 37 | 4 | 7.4 | Plasma protein | Rapid formation of plasma protein corona critically affects nanoparticle pathophysiology |
| Prot0353 | 141 | sphere | 141 | other | 60.0 | HP | nan | 0.002 | 15300.0 | -21 | 1 | 20.0 | SiO2 | buffer | 90.0 | Neutral | 30.0 | buffer | 37 | 4 | 7.4 | Plasma protein | Rapid formation of plasma protein corona critically affects nanoparticle pathophysiology |
| Prot0354 | 141 | sphere | 141 | other | 60.0 | HP | nan | 0.002 | 15300.0 | -21 | 1 | 20.0 | SiO2 | buffer | 90.0 | Neutral | 60.0 | buffer | 37 | 4 | 7.4 | Plasma protein | Rapid formation of plasma protein corona critically affects nanoparticle pathophysiology |
| Prot0355 | 141 | sphere | 141 | other | 60.0 | HP | nan | 0.002 | 15300.0 | -21 | 1 | 20.0 | SiO2 | buffer | 90.0 | Neutral | 120.0 | buffer | 37 | 4 | 7.4 | Plasma protein | Rapid formation of plasma protein corona critically affects nanoparticle pathophysiology |
| Prot0356 | 27.2 | sphere | 28 | other | 60.0 | HP | COOH | 0.063 | 15300.0 | -18 | 1 | 20.0 | SiO2 | buffer | 90.0 | Anionic | 60.0 | buffer | 37 | 4 | 7.4 | Plasma protein | Rapid formation of plasma protein corona critically affects nanoparticle pathophysiology |
| Prot0357 | 144.8 | sphere | 148 | other | 60.0 | HP | NH2 | 0.004 | 15300.0 | -18 | 1 | 20.0 | SiO2 | buffer | 90.0 | Anionic | 60.0 | buffer | 37 | 4 | 7.4 | Plasma protein | Rapid formation of plasma protein corona critically affects nanoparticle pathophysiology |
| Prot0358 | 27.2 | sphere | 28 | other | 60.0 | HP | COOH | 0.063 | 15300.0 | -18 | 1 | 20.0 | SiO2 | buffer | 90.0 | Anionic | 120.0 | buffer | 37 | 4 | 7.4 | Plasma protein | Rapid formation of plasma protein corona critically affects nanoparticle pathophysiology |
| Prot0359 | 144.8 | sphere | 148 | other | 60.0 | HP | NH2 | 0.004 | 15300.0 | -18 | 1 | 20.0 | SiO2 | buffer | 90.0 | Anionic | 120.0 | buffer | 37 | 4 | 7.4 | Plasma protein | Rapid formation of plasma protein corona critically affects nanoparticle pathophysiology |
| Prot0360 | 144.8 | sphere | 148 | other | 60.0 | HP | NH2 | 0.004 | 15300.0 | -18 | 1 | 20.0 | SiO2 | buffer | 90.0 | Anionic | 30.0 | buffer | 37 | 4 | 7.4 | Plasma protein | Rapid formation of plasma protein corona critically affects nanoparticle pathophysiology |
| Prot0361 | 27.2 | sphere | 28 | other | 60.0 | HP | COOH | 0.063 | 15300.0 | -18 | 1 | 20.0 | SiO2 | buffer | 90.0 | Anionic | 30.0 | buffer | 37 | 4 | 7.4 | Plasma protein | Rapid formation of plasma protein corona critically affects nanoparticle pathophysiology |
| Prot0362 | 27.2 | sphere | 28 | other | 60.0 | HP | COOH | 0.063 | 15300.0 | -18 | 1 | 20.0 | SiO2 | buffer | 90.0 | Anionic | 15.0 | buffer | 37 | 4 | 7.4 | Plasma protein | Rapid formation of plasma protein corona critically affects nanoparticle pathophysiology |
| Prot0363 | 144.8 | sphere | 148 | other | 60.0 | HP | NH2 | 0.004 | 15300.0 | -18 | 1 | 20.0 | SiO2 | buffer | 90.0 | Anionic | 15.0 | buffer | 37 | 4 | 7.4 | Plasma protein | Rapid formation of plasma protein corona critically affects nanoparticle pathophysiology |
| Prot0364 | 27.2 | sphere | 28 | other | 60.0 | HP | COOH | 0.063 | 15300.0 | -18 | 1 | 20.0 | SiO2 | buffer | 90.0 | Anionic | 5.0 | buffer | 37 | 4 | 7.4 | Plasma protein | Rapid formation of plasma protein corona critically affects nanoparticle pathophysiology |
| Prot0365 | 144.8 | sphere | 148 | other | 60.0 | HP | NH2 | 0.004 | 15300.0 | -18 | 1 | 20.0 | SiO2 | buffer | 90.0 | Anionic | 5.0 | buffer | 37 | 4 | 7.4 | Plasma protein | Rapid formation of plasma protein corona critically affects nanoparticle pathophysiology |
| Prot0366 | 27.2 | sphere | 28 | other | 60.0 | HP | COOH | 0.063 | 15300.0 | -18 | 1 | 20.0 | SiO2 | buffer | 90.0 | Anionic | 2.0 | buffer | 37 | 4 | 7.4 | Plasma protein | Rapid formation of plasma protein corona critically affects nanoparticle pathophysiology |
| Prot0367 | 144.8 | sphere | 148 | other | 60.0 | HP | NH2 | 0.004 | 15300.0 | -18 | 1 | 20.0 | SiO2 | buffer | 90.0 | Anionic | 2.0 | buffer | 37 | 4 | 7.4 | Plasma protein | Rapid formation of plasma protein corona critically affects nanoparticle pathophysiology |
| Prot0368 | 30.2 | sphere | 31 | other | 60.0 | HP | NH2 | 0.104 | 15300.0 | -10 | 1 | 20.0 | SiO2 | buffer | 90.0 | Anionic | 0.5 | buffer | 37 | 4 | 7.4 | Plasma protein | Rapid formation of plasma protein corona critically affects nanoparticle pathophysiology |
| Prot0369 | 30.2 | sphere | 31 | other | 60.0 | HP | NH2 | 0.104 | 15300.0 | -10 | 1 | 20.0 | SiO2 | buffer | 90.0 | Anionic | 2.0 | buffer | 37 | 4 | 7.4 | Plasma protein | Rapid formation of plasma protein corona critically affects nanoparticle pathophysiology |
| Prot0370 | 30.2 | sphere | 31 | other | 60.0 | HP | NH2 | 0.104 | 15300.0 | -10 | 1 | 20.0 | SiO2 | buffer | 90.0 | Anionic | 5.0 | buffer | 37 | 4 | 7.4 | Plasma protein | Rapid formation of plasma protein corona critically affects nanoparticle pathophysiology |
| Prot0371 | 30.2 | sphere | 31 | other | 60.0 | HP | NH2 | 0.104 | 15300.0 | -10 | 1 | 20.0 | SiO2 | buffer | 90.0 | Anionic | 15.0 | buffer | 37 | 4 | 7.4 | Plasma protein | Rapid formation of plasma protein corona critically affects nanoparticle pathophysiology |
| Prot0372 | 30.2 | sphere | 31 | other | 60.0 | HP | NH2 | 0.104 | 15300.0 | -10 | 1 | 20.0 | SiO2 | buffer | 90.0 | Anionic | 30.0 | buffer | 37 | 4 | 7.4 | Plasma protein | Rapid formation of plasma protein corona critically affects nanoparticle pathophysiology |
| Prot0373 | 30.2 | sphere | 31 | other | 60.0 | HP | NH2 | 0.104 | 15300.0 | -10 | 1 | 20.0 | SiO2 | buffer | 90.0 | Anionic | 60.0 | buffer | 37 | 4 | 7.4 | Plasma protein | Rapid formation of plasma protein corona critically affects nanoparticle pathophysiology |
| Prot0374 | 30.2 | sphere | 31 | other | 60.0 | HP | NH2 | 0.104 | 15300.0 | -10 | 1 | 20.0 | SiO2 | buffer | 90.0 | Anionic | 120.0 | buffer | 37 | 4 | 7.4 | Plasma protein | Rapid formation of plasma protein corona critically affects nanoparticle pathophysiology |
| Prot0375 | 31.4 | sphere | 48 | other | 60.0 | HP | nan | 0.004 | 15300.0 | -14 | 1 | 20.0 | SiO2 | plasma | 90.0 | Neutral | 0.5 | buffer | 37 | 4 | 7.4 | Plasma protein | Rapid formation of plasma protein corona critically affects nanoparticle pathophysiology |
| Prot0376 | 27.2 | sphere | 69 | other | 60.0 | HP | COOH | 0.068 | 15300.0 | -14 | 1 | 20.0 | SiO2 | plasma | 90.0 | Anionic | 0.5 | buffer | 37 | 4 | 7.4 | Plasma protein | Rapid formation of plasma protein corona critically affects nanoparticle pathophysiology |
| Prot0377 | 31.4 | sphere | 48 | other | 60.0 | HP | nan | 0.004 | 15300.0 | -14 | 1 | 20.0 | SiO2 | plasma | 90.0 | Neutral | 2.0 | buffer | 37 | 4 | 7.4 | Plasma protein | Rapid formation of plasma protein corona critically affects nanoparticle pathophysiology |
| Prot0378 | 27.2 | sphere | 69 | other | 60.0 | HP | COOH | 0.068 | 15300.0 | -14 | 1 | 20.0 | SiO2 | plasma | 90.0 | Anionic | 2.0 | buffer | 37 | 4 | 7.4 | Plasma protein | Rapid formation of plasma protein corona critically affects nanoparticle pathophysiology |
| Prot0379 | 31.4 | sphere | 48 | other | 60.0 | HP | nan | 0.004 | 15300.0 | -14 | 1 | 20.0 | SiO2 | plasma | 90.0 | Neutral | 5.0 | buffer | 37 | 4 | 7.4 | Plasma protein | Rapid formation of plasma protein corona critically affects nanoparticle pathophysiology |
| Prot0380 | 27.2 | sphere | 69 | other | 60.0 | HP | COOH | 0.068 | 15300.0 | -14 | 1 | 20.0 | SiO2 | plasma | 90.0 | Anionic | 5.0 | buffer | 37 | 4 | 7.4 | Plasma protein | Rapid formation of plasma protein corona critically affects nanoparticle pathophysiology |
| Prot0381 | 31.4 | sphere | 48 | other | 60.0 | HP | nan | 0.004 | 15300.0 | -14 | 1 | 20.0 | SiO2 | plasma | 90.0 | Neutral | 15.0 | buffer | 37 | 4 | 7.4 | Plasma protein | Rapid formation of plasma protein corona critically affects nanoparticle pathophysiology |
| Prot0382 | 27.2 | sphere | 69 | other | 60.0 | HP | COOH | 0.068 | 15300.0 | -14 | 1 | 20.0 | SiO2 | plasma | 90.0 | Anionic | 15.0 | buffer | 37 | 4 | 7.4 | Plasma protein | Rapid formation of plasma protein corona critically affects nanoparticle pathophysiology |
| Prot0383 | 31.4 | sphere | 48 | other | 60.0 | HP | nan | 0.004 | 15300.0 | -14 | 1 | 20.0 | SiO2 | plasma | 90.0 | Neutral | 30.0 | buffer | 37 | 4 | 7.4 | Plasma protein | Rapid formation of plasma protein corona critically affects nanoparticle pathophysiology |
| Prot0384 | 27.2 | sphere | 69 | other | 60.0 | HP | COOH | 0.068 | 15300.0 | -14 | 1 | 20.0 | SiO2 | plasma | 90.0 | Anionic | 30.0 | buffer | 37 | 4 | 7.4 | Plasma protein | Rapid formation of plasma protein corona critically affects nanoparticle pathophysiology |
| Prot0385 | 31.4 | sphere | 48 | other | 60.0 | HP | nan | 0.004 | 15300.0 | -14 | 1 | 20.0 | SiO2 | plasma | 90.0 | Neutral | 60.0 | buffer | 37 | 4 | 7.4 | Plasma protein | Rapid formation of plasma protein corona critically affects nanoparticle pathophysiology |
| Prot0386 | 27.2 | sphere | 69 | other | 60.0 | HP | COOH | 0.068 | 15300.0 | -14 | 1 | 20.0 | SiO2 | plasma | 90.0 | Anionic | 60.0 | buffer | 37 | 4 | 7.4 | Plasma protein | Rapid formation of plasma protein corona critically affects nanoparticle pathophysiology |
| Prot0387 | 31.4 | sphere | 48 | other | 60.0 | HP | nan | 0.004 | 15300.0 | -14 | 1 | 20.0 | SiO2 | plasma | 90.0 | Neutral | 120.0 | buffer | 37 | 4 | 7.4 | Plasma protein | Rapid formation of plasma protein corona critically affects nanoparticle pathophysiology |
| Prot0388 | 27.2 | sphere | 69 | other | 60.0 | HP | COOH | 0.068 | 15300.0 | -14 | 20.0 | SiO2 | plasma | 90.0 | Anionic | 120.0 | buffer | 37 | 4 | 7.4 | Plasma protein | Rapid formation of plasma protein corona critically affects nanoparticle pathophysiology | |
| Prot0389 | 31.6 | sphere | 33 | other | 60.0 | HP | nan | 0.045 | 15300.0 | -15 | 1 | 20.0 | SiO2 | buffer | 90.0 | Neutral | 0.5 | buffer | 37 | 4 | 7.4 | Plasma protein | Rapid formation of plasma protein corona critically affects nanoparticle pathophysiology |
| Prot0390 | 31.6 | sphere | 33 | other | 60.0 | HP | nan | 0.045 | 15300.0 | -15 | 1 | 20.0 | SiO2 | buffer | 90.0 | Neutral | 2.0 | buffer | 37 | 4 | 7.4 | Plasma protein | Rapid formation of plasma protein corona critically affects nanoparticle pathophysiology |
| Prot0391 | 31.6 | sphere | 33 | other | 60.0 | HP | nan | 0.045 | 15300.0 | -15 | 1 | 20.0 | SiO2 | buffer | 90.0 | Neutral | 5.0 | buffer | 37 | 4 | 7.4 | Plasma protein | Rapid formation of plasma protein corona critically affects nanoparticle pathophysiology |
| Prot0392 | 31.6 | sphere | 33 | other | 60.0 | HP | nan | 0.045 | 15300.0 | -15 | 1 | 20.0 | SiO2 | buffer | 90.0 | Neutral | 15.0 | buffer | 37 | 4 | 7.4 | Plasma protein | Rapid formation of plasma protein corona critically affects nanoparticle pathophysiology |
| Prot0393 | 31.6 | sphere | 33 | other | 60.0 | HP | nan | 0.045 | 15300.0 | -15 | 1 | 20.0 | SiO2 | buffer | 90.0 | Neutral | 30.0 | buffer | 37 | 4 | 7.4 | Plasma protein | Rapid formation of plasma protein corona critically affects nanoparticle pathophysiology |
| Prot0394 | 31.6 | sphere | 33 | other | 60.0 | HP | nan | 0.045 | 15300.0 | -15 | 1 | 20.0 | SiO2 | buffer | 90.0 | Neutral | 60.0 | buffer | 37 | 4 | 7.4 | Plasma protein | Rapid formation of plasma protein corona critically affects nanoparticle pathophysiology |
| Prot0395 | 31.6 | sphere | 33 | other | 60.0 | HP | nan | 0.045 | 15300.0 | -15 | 1 | 20.0 | SiO2 | buffer | 90.0 | Neutral | 120.0 | buffer | 37 | 4 | 7.4 | Plasma protein | Rapid formation of plasma protein corona critically affects nanoparticle pathophysiology |
| Prot0396 | 27.2 | sphere | 28 | other | 60.0 | HP | COOH | 0.063 | 15300.0 | -18 | 1 | 20.0 | SiO2 | buffer | 90.0 | Anionic | 0.5 | buffer | 37 | 4 | 7.4 | Plasma protein | Rapid formation of plasma protein corona critically affects nanoparticle pathophysiology |
| Prot0397 | 144.8 | sphere | 148 | other | 60.0 | HP | NH2 | 0.004 | 15300.0 | -18 | 1 | 20.0 | SiO2 | buffer | 90.0 | Anionic | 0.5 | buffer | 37 | 4 | 7.4 | Plasma protein | Rapid formation of plasma protein corona critically affects nanoparticle pathophysiology |
| Prot0398 | 47.02 | sphere | 383 | other | 200.0 | FBS | BCN | 0.28 | 10000.0 | -16.6 | 1 | 30.0 | SiO2 | plasma | 9.0 | Neutral | 1.0 | buffer | 37 | 25 | 7.4 | nan | Protein corona significantly reduces active targeting yield |
| Prot0399 | 47.02 | sphere | 154 | other | 200.0 | FBS | BCN | 0.19 | 10000.0 | -18.9 | 1 | 30.0 | SiO2 | PBS | 9.0 | Neutral | 1.0 | buffer | 37 | 25 | 7.4 | nan | Protein corona significantly reduces active targeting yield |
| Prot0400 | 47.02 | sphere | 154 | other | 200.0 | FBS | BCN | 0.19 | 10000.0 | -18.9 | 1 | 30.0 | SiO2 | PBS | 90.0 | Neutral | 1.0 | buffer | 37 | 25 | 7.4 | nan | Protein corona significantly reduces active targeting yield |
| Prot0401 | 47.02 | sphere | 634 | other | 200.0 | FBS | BCN | 0.34 | 10000.0 | -7.9 | 1 | 30.0 | SiO2 | plasma | 90.0 | Neutral | 1.0 | buffer | 37 | 25 | 7.4 | nan | Protein corona significantly reduces active targeting yield |
| Prot0402 | 869 | sphere | 754 | other | 1000.0 | FBS | nan | 0.371 | 14800.0 | -11.6 | 1 | 5.0 | SiO2 | water | 10.0 | Neutral | 1.0 | DMEM | 25 | 25 | 7.0 | Serum protein | Protein Adsorption from Biofluids on Silica Nanoparticles: Corona Analysis as a Function of Particle Diameter and Porosity |
| Prot0403 | 73 | sphere | 119 | other | 1000.0 | FBS | nan | 0.251 | 14800.0 | -12.2 | 1 | 5.0 | SiO2 | water | 10.0 | Neutral | 1.0 | DMEM | 25 | 25 | 7.0 | Serum protein | Protein Adsorption from Biofluids on Silica Nanoparticles: Corona Analysis as a Function of Particle Diameter and Porosity |
| Prot0404 | 914 | sphere | 1496 | other | 1000.0 | FBS | nan | 0.401 | 14800.0 | -20.1 | 1 | 5.0 | SiO2 | water | 10.0 | Neutral | 1.0 | DMEM | 25 | 25 | 7.0 | Serum protein | Protein Adsorption from Biofluids on Silica Nanoparticles: Corona Analysis as a Function of Particle Diameter and Porosity |
| Prot0405 | 251 | sphere | 281 | other | 1000.0 | FBS | nan | 0.074 | 14800.0 | -22.6 | 1 | 5.0 | SiO2 | water | 10.0 | Neutral | 1.0 | DMEM | 25 | 25 | 7.0 | Serum protein | Protein Adsorption from Biofluids on Silica Nanoparticles: Corona Analysis as a Function of Particle Diameter and Porosity |
| Prot0406 | 482 | sphere | 525 | other | 1000.0 | FBS | nan | 0.265 | 14800.0 | -37.2 | 1 | 5.0 | SiO2 | water | 10.0 | Neutral | 1.0 | DMEM | 25 | 25 | 7.0 | Serum protein | Protein Adsorption from Biofluids on Silica Nanoparticles: Corona Analysis as a Function of Particle Diameter and Porosity |
| Prot0407 | 85 | sphere | 137 | other | 1000.0 | FBS | nan | 0.123 | 14800.0 | -37.7 | 1 | 5.0 | SiO2 | water | 10.0 | Neutral | 1.0 | DMEM | 25 | 25 | 7.0 | Serum protein | Protein Adsorption from Biofluids on Silica Nanoparticles: Corona Analysis as a Function of Particle Diameter and Porosity |
| Prot0408 | 245.8 | sphere | 245.8 | other | 1250.0 | HP | nan | 0.07 | 18000.0 | -11.1 | 1 | 3.0 | SiO2 | plasma | 10.0 | Neutral | 1.0 | buffer | 0 | 4 | 7.4 | Plasma protein | Physical-Chemical aspects of protein corona: Relevance to in vitro and in vivo biological impacts of nanoparticles |
| Prot0409 | 245.8 | sphere | 245.8 | other | 1250.0 | HP | nan | 0.07 | 18000.0 | -11.1 | 1 | 3.0 | SiO2 | plasma | 55.0 | Neutral | 1.0 | buffer | 0 | 4 | 7.4 | Plasma protein | Physical-Chemical aspects of protein corona: Relevance to in vitro and in vivo biological impacts of nanoparticles |
| Prot0410 | 205 | sphere | 205 | other | 1250.0 | HP | nan | 0.041 | 18000.0 | -25.2 | 1 | 3.0 | SiO2 | PBS | 10.0 | Neutral | 1.0 | buffer | 0 | 4 | 7.4 | Plasma protein | Physical-Chemical aspects of protein corona: Relevance to in vitro and in vivo biological impacts of nanoparticles |
| Prot0411 | 205 | sphere | 205 | other | 1250.0 | HP | nan | 0.041 | 18000.0 | -25.2 | 1 | 3.0 | SiO2 | PBS | 55.0 | Neutral | 1.0 | buffer | 0 | 4 | 7.4 | Plasma protein | Physical-Chemical aspects of protein corona: Relevance to in vitro and in vivo biological impacts of nanoparticles |
| Prot0412 | 9.6 | sphere | 12.5 | other | 1660.0 | HP | nan | 0.126944444 | 12000.0 | -11 | 1 | 10.0 | SiO2 | buffer | 50.0 | Neutral | 1.0 | buffer | 4 | 4 | 7.4 | Plasma protein | Nanoparticle size is a critical physicochemical determinant of the human blood plasma corona: A comprehensive quantitative proteomic analysis |
| Prot0413 | 15.7 | sphere | 17.6 | other | 1660.0 | HP | nan | 0.126944444 | 12000.0 | -25 | 1 | 10.0 | SiO2 | buffer | 50.0 | Neutral | 1.0 | buffer | 4 | 4 | 7.4 | Plasma protein | Nanoparticle size is a critical physicochemical determinant of the human blood plasma corona: A comprehensive quantitative proteomic analysis |
| Prot0414 | 54.9 | sphere | 71.3 | other | 1660.0 | HP | nan | 0.126944444 | 12000.0 | -32 | 1 | 10.0 | SiO2 | buffer | 50.0 | Neutral | 1.0 | buffer | 4 | 4 | 7.4 | Plasma protein | Nanoparticle size is a critical physicochemical determinant of the human blood plasma corona: A comprehensive quantitative proteomic analysis |
| Prot0415 | 79 | sphere | 112 | other | 1000.0 | FBS | nan | 0.02 | 20000.0 | -13.5 | 3 | 20.0 | SiO2 | PBS | 80.0 | Neutral | 1.0 | buffer | 37 | 25 | 7.4 | Transferrin | In situ characterization of nanoparticle biomolecular interactions in complex biological media by flow cytometry |
| Prot0416 | 95 | sphere | 118 | other | 1000.0 | FBS | nan | 0.02 | 16000.0 | -13.5 | 1 | 20.0 | SiO2 | PBS | 10.0 | Neutral | 1.0 | buffer | 37 | 25 | 7.4 | low-density lipoprotein、immunoglobulin G | Identification of Receptor Binding to the Biomolecular Corona of Nanoparticles |
| Prot0417 | 95 | sphere | 118 | other | 1000.0 | FBS | nan | 0.02 | 16000.0 | -13.5 | 1 | 20.0 | SiO2 | PBS | 30.0 | Neutral | 1.0 | buffer | 37 | 25 | 7.4 | low-density lipoprotein、immunoglobulin G | Identification of Receptor Binding to the Biomolecular Corona of Nanoparticles |
| Prot0418 | 95 | sphere | 118 | other | 1000.0 | FBS | nan | 0.02 | 16000.0 | -13.5 | 1 | 20.0 | SiO2 | PBS | 50.0 | Neutral | 1.0 | buffer | 37 | 25 | 7.4 | low-density lipoprotein、immunoglobulin G | Identification of Receptor Binding to the Biomolecular Corona of Nanoparticles |
| Prot0419 | nan | sphere | 79 | other | 1000.0 | FBS | nan | 0.03 ± 0.02 | 18000.0 | -45.4 | 1 | nan | SiO2 | PBS | 1.98 | nan | 0.08933 | water | 37 | 4 | 7.4 | Serum protein | Nanoparticle Biomolecular Corona-Based Enrichment of Plasma Glycoproteinsfor N‑GlycanProfiling and Applicationin Biomarker Discovery |
| Prot0420 | 50 | sphere | 66 | other | 100.0 | FBS | nan | 0.2 | 20000.0 | -20 | 1 | 30.0 | Si | PBS | 100.0 | Neutral | 1.0 | DMEM | 37 | 4 | 7.4 | Serum protein | Effects of the presence or absence of a protein corona on silica nanoparticle uptake and impact on cells |
| Prot0421 | 50 | sphere | 44 | other | 100.0 | FBS | nan | 0.19 | 20000.0 | -13.5 | 1 | 30.0 | Si | cell culture | 100.0 | Neutral | 1.0 | DMEM | 37 | 4 | 7.4 | Serum protein | Effects of the presence or absence of a protein corona on silica nanoparticle uptake and impact on cells |
| Prot0422 | 184 | sphere | 184 | other | 166.7 | RP | PEG | 0.126944444 | 15000.0 | 0 | 1 | 20.0 | Si | water | 50.0 | Neutral | 0.25 | buffer | 37 | 25 | 7.0 | liver and immune active proteins | Tailored Dual PEGylation of Inorganic Porous Nanocarriers for Extremely Long Blood Circulation in Vivo |
| Prot0423 | 184 | sphere | 184 | other | 166.7 | RP | PEG | 0.126944444 | 15000.0 | 0 | 1 | 20.0 | Si | water | 50.0 | Neutral | 1.5 | buffer | 37 | 25 | 7.0 | liver and immune active proteins | Tailored Dual PEGylation of Inorganic Porous Nanocarriers for Extremely Long Blood Circulation in Vivo |
| Prot0424 | 82 | sphere | 165 | other | 166.7 | RP | nan | 0.126944444 | 15000.0 | -37 | 1 | 20.0 | Si | water | 50.0 | Neutral | 0.25 | buffer | 37 | 25 | 7.0 | liver and immune active proteins | Tailored Dual PEGylation of Inorganic Porous Nanocarriers for Extremely Long Blood Circulation in Vivo |
| Prot0425 | 82 | sphere | 165 | other | 166.7 | RP | nan | 0.126944444 | 15000.0 | -37 | 1 | 20.0 | Si | water | 50.0 | Neutral | 1.5 | buffer | 37 | 25 | 7.0 | liver and immune active proteins | Tailored Dual PEGylation of Inorganic Porous Nanocarriers for Extremely Long Blood Circulation in Vivo |
| Prot0426 | 13 | sheet | 12 | other | 100.0 | HP | nan | 0.126944444 | 10000.0 | -35 | 5 | 20.0 | zeolite | water | 10.0 | Neutral | 1.0 | water | 25 | 25 | 7.5 | Albumin/Fibrin | Corona protein composition and cytotoxicity evaluation of ultra-small zeolites synthesized from template free precursor suspensions |
| Prot0427 | 13 | sheet | 12 | other | 100.0 | HP | nan | 0.126944444 | 10000.0 | -35 | 5 | 20.0 | zeolite | water | 10.0 | Neutral | 1.0 | water | 25 | 25 | 7.5 | Albumin/Fibrin | Corona protein composition and cytotoxicity evaluation of ultra-small zeolites synthesized from template free precursor suspensions |
| Prot0428 | 13 | sheet | 12 | other | 100.0 | HP | nan | 0.126944444 | 10000.0 | -35 | 5 | 20.0 | zeolite | water | 10.0 | Neutral | 1.0 | water | 25 | 25 | 7.5 | Albumin/Fibrin | Corona protein composition and cytotoxicity evaluation of ultra-small zeolites synthesized from template free precursor suspensions |
| Prot0429 | 13 | sphere | 13 | other | 100.0 | HP | nan | 0.126944444 | 10000.0 | -35 | 5 | 20.0 | zeolite | water | 10.0 | Neutral | 1.0 | water | 25 | 25 | 7.5 | Albumin/Fibrin | Corona protein composition and cytotoxicity evaluation of ultra-small zeolites synthesized from template free precursor suspensions |
| Prot0430 | 13 | sphere | 13 | other | 100.0 | HP | nan | 0.126944444 | 10000.0 | -35 | 5 | 20.0 | zeolite | water | 10.0 | Neutral | 1.0 | water | 25 | 25 | 7.5 | Albumin/Fibrin | Corona protein composition and cytotoxicity evaluation of ultra-small zeolites synthesized from template free precursor suspensions |
| Prot0431 | 13 | sphere | 13 | other | 100.0 | HP | nan | 0.126944444 | 10000.0 | -35 | 5 | 20.0 | zeolite | water | 10.0 | Neutral | 1.0 | water | 25 | 25 | 7.5 | Albumin/Fibrin | Corona protein composition and cytotoxicity evaluation of ultra-small zeolites synthesized from template free precursor suspensions |
| Prot0432 | 13 | sphere | 13 | other | 100.0 | HP | nan | 0.126944444 | 10000.0 | -35 | 5 | 20.0 | zeolite | water | 10.0 | Neutral | 1.0 | water | 25 | 25 | 7.5 | Albumin/Fibrin | Corona protein composition and cytotoxicity evaluation of ultra-small zeolites synthesized from template free precursor suspensions |
| Prot0433 | 13 | sheet | 12 | other | 100.0 | HP | nan | 0.126944444 | 10000.0 | -35 | 5 | 20.0 | zeolite | water | 100.0 | Neutral | 1.0 | water | 25 | 25 | 7.5 | Albumin/Fibrin | Corona protein composition and cytotoxicity evaluation of ultra-small zeolites synthesized from template free precursor suspensions |
| Prot0434 | 13 | sheet | 12 | other | 100.0 | HP | nan | 0.126944444 | 10000.0 | -35 | 5 | 20.0 | zeolite | water | 100.0 | Neutral | 1.0 | water | 25 | 25 | 7.5 | Albumin/Fibrin | Corona protein composition and cytotoxicity evaluation of ultra-small zeolites synthesized from template free precursor suspensions |
| Prot0435 | 13 | sheet | 12 | other | 100.0 | HP | nan | 0.126944444 | 10000.0 | -35 | 5 | 20.0 | zeolite | water | 100.0 | Neutral | 1.0 | water | 25 | 25 | 7.5 | Albumin/Fibrin | Corona protein composition and cytotoxicity evaluation of ultra-small zeolites synthesized from template free precursor suspensions |
| Prot0436 | 13 | sheet | 12 | other | 100.0 | HP | nan | 0.126944444 | 10000.0 | -35 | 5 | 20.0 | zeolite | water | 100.0 | Neutral | 1.0 | water | 25 | 25 | 7.5 | Albumin/Fibrin | Corona protein composition and cytotoxicity evaluation of ultra-small zeolites synthesized from template free precursor suspensions |
| Prot0437 | 13 | sphere | 13 | other | 100.0 | HP | nan | 0.126944444 | 10000.0 | -35 | 5 | 20.0 | zeolite | water | 100.0 | Neutral | 1.0 | water | 25 | 25 | 7.5 | Albumin/Fibrin | Corona protein composition and cytotoxicity evaluation of ultra-small zeolites synthesized from template free precursor suspensions |
| Prot0438 | 13 | sphere | 13 | other | 100.0 | HP | nan | 0.126944444 | 10000.0 | -35 | 5 | 20.0 | zeolite | water | 100.0 | Neutral | 1.0 | water | 25 | 25 | 7.5 | Albumin/Fibrin | Corona protein composition and cytotoxicity evaluation of ultra-small zeolites synthesized from template free precursor suspensions |
| Prot0439 | 13 | sphere | 13 | other | 100.0 | HP | nan | 0.126944444 | 10000.0 | -35 | 5 | 20.0 | zeolite | water | 100.0 | Neutral | 1.0 | water | 25 | 25 | 7.5 | Albumin/Fibrin | Corona protein composition and cytotoxicity evaluation of ultra-small zeolites synthesized from template free precursor suspensions |
| Prot0440 | 13 | sphere | 13 | other | 100.0 | HP | nan | 0.126944444 | 10000.0 | -35 | 5 | 20.0 | zeolite | water | 100.0 | Neutral | 1.0 | water | 25 | 25 | 7.5 | Albumin/Fibrin | Corona protein composition and cytotoxicity evaluation of ultra-small zeolites synthesized from template free precursor suspensions |
| Prot0441 | 10 | sphere | 10 | other | 40000.0 | HP | EMT | 0.126944444 | 24000.0 | -44 | 1 | 30.0 | zeolite | water | 10.0 | Neutral | 1.0 | buffer | 37 | 25 | 7.0 | Plasma protein/apolipoprotein C-III (APOC-III) /fibrinogen | Zeolite Nanoparticles for Selective Sorption of Plasma Proteins |
| Prot0442 | 10 | sphere | 10 | other | 40000.0 | HP | EMT | 0.126944444 | 24000.0 | -44 | 1 | 30.0 | zeolite | water | 10.0 | Neutral | 1.0 | buffer | 37 | 25 | 7.0 | Plasma protein/apolipoprotein C-III (APOC-III) /fibrinogen | Zeolite Nanoparticles for Selective Sorption of Plasma Proteins |
| Prot0443 | 10 | sphere | 10 | other | 80000.0 | HP | EMT | 0.126944444 | 24000.0 | -44 | 1 | 30.0 | zeolite | water | 10.0 | Neutral | 1.0 | buffer | 37 | 25 | 7.0 | Plasma protein/apolipoprotein C-III (APOC-III) /fibrinogen | Zeolite Nanoparticles for Selective Sorption of Plasma Proteins |
| Prot0444 | 10 | sphere | 10 | other | 80000.0 | HP | EMT | 0.126944444 | 24000.0 | -44 | 1 | 30.0 | zeolite | water | 10.0 | Neutral | 1.0 | buffer | 37 | 25 | 7.0 | Plasma protein/apolipoprotein C-III (APOC-III) /fibrinogen | Zeolite Nanoparticles for Selective Sorption of Plasma Proteins |
| Prot0445 | 10 | sphere | 10 | other | 120000.0 | HP | EMT | 0.126944444 | 24000.0 | -44 | 1 | 30.0 | zeolite | water | 10.0 | Neutral | 1.0 | buffer | 37 | 25 | 7.0 | Plasma protein/apolipoprotein C-III (APOC-III) /fibrinogen | Zeolite Nanoparticles for Selective Sorption of Plasma Proteins |
| Prot0446 | 10 | sphere | 10 | other | 120000.0 | HP | EMT | 0.126944444 | 24000.0 | -44 | 1 | 30.0 | zeolite | water | 10.0 | Neutral | 1.0 | buffer | 37 | 25 | 7.0 | Plasma protein/apolipoprotein C-III (APOC-III) /fibrinogen | Zeolite Nanoparticles for Selective Sorption of Plasma Proteins |
| Prot0447 | 10 | sphere | 10 | other | 40000.0 | HP | EMT | 0.126944444 | 24000.0 | -44 | 1 | 30.0 | zeolite | water | 100.0 | Neutral | 1.0 | buffer | 37 | 25 | 7.0 | Plasma protein/apolipoprotein C-III (APOC-III) /fibrinogen | Zeolite Nanoparticles for Selective Sorption of Plasma Proteins |
| Prot0448 | 10 | sphere | 10 | other | 40000.0 | HP | EMT | 0.126944444 | 24000.0 | -44 | 1 | 30.0 | zeolite | water | 100.0 | Neutral | 1.0 | buffer | 37 | 25 | 7.0 | Plasma protein/apolipoprotein C-III (APOC-III) /fibrinogen | Zeolite Nanoparticles for Selective Sorption of Plasma Proteins |
| Prot0449 | 10 | sphere | 10 | other | 80000.0 | HP | EMT | 0.126944444 | 24000.0 | -44 | 1 | 30.0 | zeolite | water | 100.0 | Neutral | 1.0 | buffer | 37 | 25 | 7.0 | Plasma protein/apolipoprotein C-III (APOC-III) /fibrinogen | Zeolite Nanoparticles for Selective Sorption of Plasma Proteins |
| Prot0450 | 10 | sphere | 10 | other | 80000.0 | HP | EMT | 0.126944444 | 24000.0 | -44 | 1 | 30.0 | zeolite | water | 100.0 | Neutral | 1.0 | buffer | 37 | 25 | 7.0 | Plasma protein/apolipoprotein C-III (APOC-III) /fibrinogen | Zeolite Nanoparticles for Selective Sorption of Plasma Proteins |
| Prot0451 | 10 | sphere | 10 | other | 120000.0 | HP | EMT | 0.126944444 | 24000.0 | -44 | 1 | 30.0 | zeolite | water | 100.0 | Neutral | 1.0 | buffer | 37 | 25 | 7.0 | Plasma protein/apolipoprotein C-III (APOC-III) /fibrinogen | Zeolite Nanoparticles for Selective Sorption of Plasma Proteins |
| Prot0452 | 10 | sphere | 10 | other | 120000.0 | HP | EMT | 0.126944444 | 24000.0 | -44 | 1 | 30.0 | zeolite | water | 100.0 | Neutral | 1.0 | buffer | 37 | 25 | 7.0 | Plasma protein/apolipoprotein C-III (APOC-III) /fibrinogen | Zeolite Nanoparticles for Selective Sorption of Plasma Proteins |
| Prot0453 | 10 | sphere | 10 | other | 40000.0 | HP | FAu(GNP) | 0.126944444 | 24000.0 | -50 | 1 | 30.0 | zeolite | water | 10.0 | Neutral | 1.0 | buffer | 37 | 25 | 7.0 | Plasma protein/apolipoprotein C-III (APOC-III) /fibrinogen | Zeolite Nanoparticles for Selective Sorption of Plasma Proteins |
| Prot0454 | 10 | sphere | 10 | other | 40000.0 | HP | FAu(GNP) | 0.126944444 | 24000.0 | -50 | 1 | 30.0 | zeolite | water | 10.0 | Neutral | 1.0 | buffer | 37 | 25 | 7.0 | Plasma protein/apolipoprotein C-III (APOC-III) /fibrinogen | Zeolite Nanoparticles for Selective Sorption of Plasma Proteins |
| Prot0455 | 10 | sphere | 10 | other | 80000.0 | HP | FAu(GNP) | 0.126944444 | 24000.0 | -50 | 1 | 30.0 | zeolite | water | 10.0 | Neutral | 1.0 | buffer | 37 | 25 | 7.0 | Plasma protein/apolipoprotein C-III (APOC-III) /fibrinogen | Zeolite Nanoparticles for Selective Sorption of Plasma Proteins |
| Prot0456 | 10 | sphere | 10 | other | 80000.0 | HP | FAu(GNP) | 0.126944444 | 24000.0 | -50 | 1 | 30.0 | zeolite | water | 10.0 | Neutral | 1.0 | buffer | 37 | 25 | 7.0 | Plasma protein/apolipoprotein C-III (APOC-III) /fibrinogen | Zeolite Nanoparticles for Selective Sorption of Plasma Proteins |
| Prot0457 | 10 | sphere | 10 | other | 120000.0 | HP | FAu(GNP) | 0.126944444 | 24000.0 | -50 | 1 | 30.0 | zeolite | water | 10.0 | Neutral | 1.0 | buffer | 37 | 25 | 7.0 | Plasma protein/apolipoprotein C-III (APOC-III) /fibrinogen | Zeolite Nanoparticles for Selective Sorption of Plasma Proteins |
| Prot0458 | 10 | sphere | 10 | other | 120000.0 | HP | FAu(GNP) | 0.126944444 | 24000.0 | -50 | 1 | 30.0 | zeolite | water | 10.0 | Neutral | 1.0 | buffer | 37 | 25 | 7.0 | Plasma protein/apolipoprotein C-III (APOC-III) /fibrinogen | Zeolite Nanoparticles for Selective Sorption of Plasma Proteins |
| Prot0459 | 10 | sphere | 10 | other | 40000.0 | HP | FAu(GNP) | 0.126944444 | 24000.0 | -50 | 1 | 30.0 | zeolite | water | 100.0 | Neutral | 1.0 | buffer | 37 | 25 | 7.0 | Plasma protein/apolipoprotein C-III (APOC-III) /fibrinogen | Zeolite Nanoparticles for Selective Sorption of Plasma Proteins |
| Prot0460 | 10 | sphere | 10 | other | 40000.0 | HP | FAu(GNP) | 0.126944444 | 24000.0 | -50 | 1 | 30.0 | zeolite | water | 100.0 | Neutral | 1.0 | buffer | 37 | 25 | 7.0 | Plasma protein/apolipoprotein C-III (APOC-III) /fibrinogen | Zeolite Nanoparticles for Selective Sorption of Plasma Proteins |
| Prot0461 | 10 | sphere | 10 | other | 80000.0 | HP | FAu(GNP) | 0.126944444 | 24000.0 | -50 | 1 | 30.0 | zeolite | water | 100.0 | Neutral | 1.0 | buffer | 37 | 25 | 7.0 | Plasma protein/apolipoprotein C-III (APOC-III) /fibrinogen | Zeolite Nanoparticles for Selective Sorption of Plasma Proteins |
| Prot0462 | 10 | sphere | 10 | other | 80000.0 | HP | FAu(GNP) | 0.126944444 | 24000.0 | -50 | 1 | 30.0 | zeolite | water | 100.0 | Neutral | 1.0 | buffer | 37 | 25 | 7.0 | Plasma protein/apolipoprotein C-III (APOC-III) /fibrinogen | Zeolite Nanoparticles for Selective Sorption of Plasma Proteins |
| Prot0463 | 10 | sphere | 10 | other | 120000.0 | HP | FAu(GNP) | 0.126944444 | 24000.0 | -50 | 1 | 30.0 | zeolite | water | 100.0 | Neutral | 1.0 | buffer | 37 | 25 | 7.0 | Plasma protein/apolipoprotein C-III (APOC-III) /fibrinogen | Zeolite Nanoparticles for Selective Sorption of Plasma Proteins |
| Prot0464 | 10 | sphere | 10 | other | 120000.0 | HP | FAu(GNP) | 0.126944444 | 24000.0 | -50 | 1 | 30.0 | zeolite | water | 100.0 | Neutral | 1.0 | buffer | 37 | 25 | 7.0 | Plasma protein/apolipoprotein C-III (APOC-III) /fibrinogen | Zeolite Nanoparticles for Selective Sorption of Plasma Proteins |
| Prot0465 | 200 | sphere | 200 | liposome | 500.0 | HP | nan | 0.126944444 | 15000.0 | 50 | 1 | 10.0 | DOTAP/DNA | water | 50.0 | Neutral | 1.0 | water | 37 | 25 | 7.0 | Plasma protein | Differential analysis of "protein corona" profile adsorbed onto different nonviral gene delivery systems |
| Prot0466 | 200 | sphere | 200 | liposome | 500.0 | HP | nan | 0.126944444 | 15000.0 | 50 | 1 | 10.0 | DOTAP/DNA | water | 50.0 | Neutral | 1.0 | water | 37 | 25 | 7.0 | Plasma protein | Differential analysis of "protein corona" profile adsorbed onto different nonviral gene delivery systems |
| Prot0467 | 200 | sphere | 200 | liposome | 500.0 | HP | nan | 0.126944444 | 15000.0 | 50 | 1 | 10.0 | DOTAP/DNA | water | 50.0 | Neutral | 1.0 | water | 37 | 25 | 7.0 | Plasma protein | Differential analysis of "protein corona" profile adsorbed onto different nonviral gene delivery systems |
| Prot0468 | 100 | sphere | 100 | liposome | 500.0 | HP | nan | 0.126944444 | 15000.0 | 47.5 | 1 | 10.0 | DOTAP | water | 50.0 | Neutral | 1.0 | water | 37 | 25 | 7.0 | Plasma protein | Differential analysis of "protein corona" profile adsorbed onto different nonviral gene delivery systems |
| Prot0469 | 100 | sphere | 100 | liposome | 500.0 | HP | nan | 0.126944444 | 15000.0 | 47.5 | 1 | 10.0 | DOTAP | water | 50.0 | Neutral | 1.0 | water | 37 | 25 | 7.0 | Plasma protein | Differential analysis of "protein corona" profile adsorbed onto different nonviral gene delivery systems |
| Prot0470 | 100 | sphere | 100 | liposome | 500.0 | HP | nan | 0.126944444 | 15000.0 | 47.5 | 1 | 10.0 | DOTAP | water | 50.0 | Neutral | 1.0 | water | 37 | 25 | 7.0 | Plasma protein | Differential analysis of "protein corona" profile adsorbed onto different nonviral gene delivery systems |
| Prot0471 | 102 | sphere | 102 | liposome | 500.0 | HP | nan | 0.243 | 15000.0 | 54.3 | 1 | 10.0 | DC-Chol-DOPE | buffer | 50.0 | Neutral | 1.0 | buffer | 37 | 25 | 7.0 | Plasma protein | Do plasma proteins distinguish between liposomes of varying charge density? |
| Prot0472 | 102 | sphere | 102 | liposome | 500.0 | HP | nan | 0.243 | 15000.0 | 54.3 | 1 | 10.0 | DC-Chol-DOPE | buffer | 50.0 | Neutral | 1.0 | buffer | 37 | 25 | 7.0 | Plasma protein | Do plasma proteins distinguish between liposomes of varying charge density? |
| Prot0473 | 102 | sphere | 102 | liposome | 500.0 | HP | nan | 0.243 | 15000.0 | 54.3 | 1 | 10.0 | DC-Chol-DOPE | buffer | 50.0 | Neutral | 1.0 | buffer | 37 | 25 | 7.0 | Plasma protein | Do plasma proteins distinguish between liposomes of varying charge density? |
| Prot0474 | 109 | sphere | 109 | liposome | 500.0 | HP | nan | 0.212 | 15000.0 | 56.3 | 1 | 10.0 | DC-Chol-DOPE | buffer | 50.0 | Neutral | 1.0 | buffer | 37 | 25 | 7.0 | Plasma protein | Do plasma proteins distinguish between liposomes of varying charge density? |
| Prot0475 | 109 | sphere | 109 | liposome | 500.0 | HP | nan | 0.212 | 15000.0 | 56.3 | 1 | 10.0 | DC-Chol-DOPE | buffer | 50.0 | Neutral | 1.0 | buffer | 37 | 25 | 7.0 | Plasma protein | Do plasma proteins distinguish between liposomes of varying charge density? |
| Prot0476 | 109 | sphere | 109 | liposome | 500.0 | HP | nan | 0.212 | 15000.0 | 56.3 | 1 | 10.0 | DC-Chol-DOPE | buffer | 50.0 | Neutral | 1.0 | buffer | 37 | 25 | 7.0 | Plasma protein | Do plasma proteins distinguish between liposomes of varying charge density? |
| Prot0477 | 105 | sphere | 105 | liposome | 500.0 | HP | nan | 0.239 | 15000.0 | 60.5 | 1 | 10.0 | DC-Chol-DOPE | buffer | 50.0 | Neutral | 1.0 | buffer | 37 | 25 | 7.0 | Plasma protein | Do plasma proteins distinguish between liposomes of varying charge density? |
| Prot0478 | 105 | sphere | 105 | liposome | 500.0 | HP | nan | 0.239 | 15000.0 | 60.5 | 1 | 10.0 | DC-Chol-DOPE | buffer | 50.0 | Neutral | 1.0 | buffer | 37 | 25 | 7.0 | Plasma protein | Do plasma proteins distinguish between liposomes of varying charge density? |
| Prot0479 | 105 | sphere | 105 | liposome | 500.0 | HP | nan | 0.239 | 15000.0 | 60.5 | 1 | 10.0 | DC-Chol-DOPE | buffer | 50.0 | Neutral | 1.0 | buffer | 37 | 25 | 7.0 | Plasma protein | Do plasma proteins distinguish between liposomes of varying charge density? |
| Prot0480 | 83.5 | sphere | 83.5 | liposome | 500.0 | HP | nan | 0.293 | 15000.0 | 50.5 | 1 | 10.0 | DOTAP-Chol | buffer | 50.0 | Neutral | 1.0 | buffer | 37 | 25 | 7.4 | Fibrin/carrier protein | Effect of DOPE and cholesterol on the protein adsorption onto lipid nanoparticles |
| Prot0481 | 90.8 | sphere | 90.8 | liposome | 500.0 | HP | nan | 0.225 | 15000.0 | 51.2 | 1 | 10.0 | DOTAP-DOPE | buffer | 50.0 | Neutral | 1.0 | buffer | 37 | 25 | 7.4 | Fibrin/carrier protein | Effect of DOPE and cholesterol on the protein adsorption onto lipid nanoparticles |
| Prot0482 | 78.8 | sphere | 78.8 | liposome | 500.0 | HP | nan | 0.205 | 15000.0 | 55.7 | 1 | 10.0 | DOTAP | buffer | 50.0 | Neutral | 1.0 | buffer | 37 | 25 | 7.4 | Fibrin/carrier protein | Effect of DOPE and cholesterol on the protein adsorption onto lipid nanoparticles |
| Prot0483 | 103.2 | sphere | 103.2 | liposome | 500.0 | HP | PEG | 0.126944444 | 14000.0 | 11.3 | 1 | 15.0 | DOTAP-DOPC-DC-Chol-DOPE/DOPE-PEG | water | 50.0 | Neutral | 1.0 | buffer | 37 | 25 | 7.0 | Apolipoproteins | Effect of polyethyleneglycol (PEG) chain length on the bio-nano- interactions between PEGylated lipid nanoparticles and biological fluids: From nanostructure to uptake in cancer cells |
| Prot0484 | 118.7 | sphere | 118.7 | liposome | 500.0 | HP | PEG | 0.126944444 | 14000.0 | 15.5 | 1 | 15.0 | DOTAP-DOPC-DC-Chol-DOPE/DOPE-PEG | water | 50.0 | Neutral | 1.0 | buffer | 37 | 25 | 7.0 | Apolipoproteins | Effect of polyethyleneglycol (PEG) chain length on the bio-nano- interactions between PEGylated lipid nanoparticles and biological fluids: From nanostructure to uptake in cancer cells |
| Prot0485 | 116.9 | sphere | 116.9 | liposome | 500.0 | HP | PEG | 0.126944444 | 14000.0 | 18.3 | 1 | 15.0 | DOTAP-DOPC-DC-Chol-DOPE/DOPE-PEG | water | 50.0 | Neutral | 1.0 | buffer | 37 | 25 | 7.0 | Apolipoproteins | Effect of polyethyleneglycol (PEG) chain length on the bio-nano- interactions between PEGylated lipid nanoparticles and biological fluids: From nanostructure to uptake in cancer cells |
| Prot0486 | 86 | sphere | 86 | liposome | 500.0 | HP | nan | 0.126944444 | 14000.0 | 27.4 | 1 | 15.0 | DOTAP-DOPC-DC-Chol-DOPE | water | 50.0 | Neutral | 1.0 | buffer | 37 | 25 | 7.0 | Apolipoproteins | Effect of polyethyleneglycol (PEG) chain length on the bio-nano- interactions between PEGylated lipid nanoparticles and biological fluids: From nanostructure to uptake in cancer cells |
| Prot0487 | 127.27 | sphere | 104.76 | liposome | 90.0 | RP | nan | 0.17 | 9000.0 | -27.87 | 1 | 20.0 | HSPC-Chol | plasma | 82.0 | Neutral | 0.166666667 | water | 37 | 25 | 7.4 | Plasma protein | In Vivo Biomolecule Corona around Blood-Circulating, Clinically Used and Antibody-Targeted Lipid Bilayer Nanoscale Vesicles |
| Prot0488 | 127.27 | sphere | 104.76 | liposome | 5.0 | RP | nan | 0.17 | 9000.0 | -27.87 | 8 | 20.0 | HSPC-Chol | plasma | 100.0 | Neutral | 0.166666667 | water | 37 | 25 | 7.4 | Plasma protein | In Vivo Biomolecule Corona around Blood-Circulating, Clinically Used and Antibody-Targeted Lipid Bilayer Nanoscale Vesicles |
| Prot0489 | 121.82 | sphere | 100.98 | liposome | 90.0 | RP | PEG | 0.15 | 9000.0 | -30.37 | 1 | 20.0 | HSPC-Chol-DSPE-PEG20000 | plasma | 82.0 | Neutral | 0.166666667 | water | 37 | 25 | 7.4 | Plasma protein | In Vivo Biomolecule Corona around Blood-Circulating, Clinically Used and Antibody-Targeted Lipid Bilayer Nanoscale Vesicles |
| Prot0490 | 121.82 | sphere | 100.98 | liposome | 5.0 | RP | PEG | 0.15 | 9000.0 | -30.37 | 9 | 20.0 | HSPC-Chol-DSPE-PEG20000 | plasma | 100.0 | Neutral | 0.166666667 | water | 37 | 25 | 7.4 | Plasma protein | In Vivo Biomolecule Corona around Blood-Circulating, Clinically Used and Antibody-Targeted Lipid Bilayer Nanoscale Vesicles |
| Prot0491 | 110.91 | sphere | 103.86 | liposome | 90.0 | RP | nan | 0.2 | 9000.0 | -32.1 | 1 | 20.0 | HSPC-Chol | plasma | 82.0 | Neutral | 0.166666667 | water | 37 | 25 | 7.4 | Plasma protein | In Vivo Biomolecule Corona around Blood-Circulating, Clinically Used and Antibody-Targeted Lipid Bilayer Nanoscale Vesicles |
| Prot0492 | 110.91 | sphere | 103.86 | liposome | 5.0 | RP | nan | 0.2 | 9000.0 | -32.1 | 10 | 20.0 | HSPC-Chol | plasma | 100.0 | Neutral | 0.166666667 | water | 37 | 25 | 7.4 | Plasma protein | In Vivo Biomolecule Corona around Blood-Circulating, Clinically Used and Antibody-Targeted Lipid Bilayer Nanoscale Vesicles |
| Prot0493 | 110.91 | sphere | 120.83 | liposome | 90.0 | RP | nan | 0.2 | 9000.0 | -36.23 | 1 | 20.0 | HSPC-Chol | plasma | 82.0 | Neutral | 0.166666667 | water | 37 | 25 | 7.4 | Plasma protein | In Vivo Biomolecule Corona around Blood-Circulating, Clinically Used and Antibody-Targeted Lipid Bilayer Nanoscale Vesicles |
| Prot0494 | 110.91 | sphere | 120.83 | liposome | 5.0 | RP | nan | 0.2 | 9000.0 | -36.23 | 7 | 20.0 | HSPC-Chol | plasma | 100.0 | Neutral | 0.166666667 | water | 37 | 25 | 7.4 | Plasma protein | In Vivo Biomolecule Corona around Blood-Circulating, Clinically Used and Antibody-Targeted Lipid Bilayer Nanoscale Vesicles |
| Prot0495 | 127.27 | sphere | 119.2 | liposome | 90.0 | RP | nan | 0.17 | 9000.0 | -36.54 | 1 | 20.0 | HSPC-Chol | plasma | 82.0 | Neutral | 0.166666667 | water | 37 | 25 | 7.4 | Plasma protein | In Vivo Biomolecule Corona around Blood-Circulating, Clinically Used and Antibody-Targeted Lipid Bilayer Nanoscale Vesicles |
| Prot0496 | 127.27 | sphere | 119.2 | liposome | 5.0 | RP | nan | 0.17 | 9000.0 | -36.54 | 5 | 20.0 | HSPC-Chol | plasma | 100.0 | Neutral | 0.166666667 | water | 37 | 25 | 7.4 | Plasma protein | In Vivo Biomolecule Corona around Blood-Circulating, Clinically Used and Antibody-Targeted Lipid Bilayer Nanoscale Vesicles |
| Prot0497 | 121.82 | sphere | 113.97 | liposome | 90.0 | RP | PEG | 0.18 | 9000.0 | -37.51 | 1 | 20.0 | HSPC-Chol-DSPE-PEG20000 | plasma | 82.0 | Neutral | 0.166666667 | water | 37 | 25 | 7.4 | Plasma protein | In Vivo Biomolecule Corona around Blood-Circulating, Clinically Used and Antibody-Targeted Lipid Bilayer Nanoscale Vesicles |
| Prot0498 | 121.82 | sphere | 113.97 | liposome | 5.0 | RP | PEG | 0.18 | 9000.0 | -37.51 | 6 | 20.0 | HSPC-Chol-DSPE-PEG20000 | plasma | 100.0 | Neutral | 0.166666667 | water | 37 | 25 | 7.4 | Plasma protein | In Vivo Biomolecule Corona around Blood-Circulating, Clinically Used and Antibody-Targeted Lipid Bilayer Nanoscale Vesicles |
| Prot0499 | 185 | sphere | 266 | liposome | 500.0 | RP | nan | 0.373 | 1800.0 | -20.5 | 1 | 10.0 | HSPC-DSPG-Chol | plasma | 95.23 | Neutral | 0.166666667 | water | 37 | 4 | 7.4 | Plasma protein | In vivo protein corona patterns of lipid nanoparticles |
| Prot0500 | 185 | sphere | 266 | liposome | 500.0 | RP | nan | 0.373 | 1800.0 | -20.5 | 1 | 10.0 | HSPC-DSPG-Chol | plasma | 100.0 | Neutral | 0.166666667 | water | 37 | 4 | 7.4 | Plasma protein | In vivo protein corona patterns of lipid nanoparticles |
| Prot0501 | 185 | sphere | 334 | liposome | 500.0 | RP | nan | 0.312 | 1800.0 | -26.1 | 1 | 10.0 | HSPC-DSPG-Chol | plasma | 95.23 | Neutral | 0.166666667 | water | 37 | 4 | 7.4 | Plasma protein | In vivo protein corona patterns of lipid nanoparticles |
| Prot0502 | 185 | sphere | 334 | liposome | 500.0 | RP | nan | 0.312 | 1800.0 | -26.1 | 1 | 10.0 | HSPC-DSPG-Chol | plasma | 100.0 | Neutral | 0.166666667 | water | 37 | 4 | 7.4 | Plasma protein | In vivo protein corona patterns of lipid nanoparticles |
| Prot0503 | 139 | sphere | 205 | liposome | 500.0 | FBS | nan | 0.126944444 | 14000.0 | -24 | 1 | 10.0 | DOTAP:DOPC:DC-Chol:DOPE | plasma | 50.0 | Neutral | 0.083333333 | buffer | 25 | 25 | 7.4 | Serum protein | Influence of dynamic flow environment on nanoparticle-protein corona: From protein patterns to uptake in cancer cells |
| Prot0504 | 139 | sphere | 230 | liposome | 500.0 | FBS | nan | 0.126944444 | 14000.0 | -24 | 1 | 10.0 | DOTAP:DOPC:DC-Chol:DOPE | plasma | 50.0 | Neutral | 0.083333333 | buffer | 25 | 25 | 7.4 | Serum protein | Influence of dynamic flow environment on nanoparticle-protein corona: From protein patterns to uptake in cancer cells |
| Prot0505 | 131 | sphere | 150 | liposome | 500.0 | FBS | PEG | 0.126944444 | 14000.0 | -25 | 1 | 10.0 | DOTAP:DOPC:DC-Chol:DOPE-PEG | plasma | 50.0 | Neutral | 0.083333333 | buffer | 25 | 25 | 7.4 | Serum protein | Influence of dynamic flow environment on nanoparticle-protein corona: From protein patterns to uptake in cancer cells |
| Prot0506 | 131 | sphere | 163 | liposome | 500.0 | FBS | PEG | 0.126944444 | 14000.0 | -25 | 1 | 10.0 | DOTAP:DOPC:DC-Chol:DOPE-PEG | plasma | 50.0 | Neutral | 0.083333333 | buffer | 25 | 25 | 7.4 | Serum protein | Influence of dynamic flow environment on nanoparticle-protein corona: From protein patterns to uptake in cancer cells |
| Prot0507 | 139 | sphere | 205 | liposome | 500.0 | FBS | nan | 0.126944444 | 14000.0 | -26 | 1 | 10.0 | DOTAP:DOPC:DC-Chol:DOPE | plasma | 50.0 | Neutral | 1.5 | buffer | 25 | 25 | 7.4 | Serum protein | Influence of dynamic flow environment on nanoparticle-protein corona: From protein patterns to uptake in cancer cells |
| Prot0508 | 139 | sphere | 230 | liposome | 500.0 | FBS | nan | 0.126944444 | 14000.0 | -26 | 1 | 10.0 | DOTAP:DOPC:DC-Chol:DOPE | plasma | 50.0 | Neutral | 1.5 | buffer | 25 | 25 | 7.4 | Serum protein | Influence of dynamic flow environment on nanoparticle-protein corona: From protein patterns to uptake in cancer cells |
| Prot0509 | 131 | sphere | 150 | liposome | 500.0 | FBS | PEG | 0.126944444 | 14000.0 | -28 | 1 | 10.0 | DOTAP:DOPC:DC-Chol:DOPE-PEG | plasma | 50.0 | Neutral | 1.5 | buffer | 25 | 25 | 7.4 | Serum protein | Influence of dynamic flow environment on nanoparticle-protein corona: From protein patterns to uptake in cancer cells |
| Prot0510 | 131 | sphere | 163 | liposome | 500.0 | FBS | PEG | 0.126944444 | 14000.0 | -28 | 1 | 10.0 | DOTAP:DOPC:DC-Chol:DOPE-PEG | plasma | 50.0 | Neutral | 1.5 | buffer | 25 | 25 | 7.4 | Serum protein | Influence of dynamic flow environment on nanoparticle-protein corona: From protein patterns to uptake in cancer cells |
| Prot0511 | 83.5 | sphere | 83.5 | liposome | 500.0 | HP | nan | 0.126944444 | 14000.0 | 50.5 | 1 | 15.0 | DOTAP-Chol | buffer | 50.0 | Neutral | 1.0 | buffer | 37 | 25 | 7.4 | Plasma protein | Lipid composition: a "key factor" for the rational manipulation of the liposome-protein corona by liposome design |
| Prot0512 | 90.8 | sphere | 90.8 | liposome | 500.0 | HP | nan | 0.126944444 | 14000.0 | 51.2 | 1 | 15.0 | DOTAP-DOPE | buffer | 50.0 | Neutral | 1.0 | buffer | 37 | 25 | 7.4 | Plasma protein | Lipid composition: a "key factor" for the rational manipulation of the liposome-protein corona by liposome design |
| Prot0513 | 85.6 | sphere | 85.6 | liposome | 500.0 | HP | nan | 0.126944444 | 14000.0 | 55.6 | 1 | 15.0 | Chol-DC | buffer | 50.0 | Neutral | 1.0 | buffer | 37 | 25 | 7.4 | Plasma protein | Lipid composition: a "key factor" for the rational manipulation of the liposome-protein corona by liposome design |
| Prot0514 | 78.8 | sphere | 78.8 | liposome | 500.0 | HP | nan | 0.126944444 | 14000.0 | 55.7 | 1 | 15.0 | DOTAP | buffer | 50.0 | Neutral | 1.0 | buffer | 37 | 25 | 7.4 | Plasma protein | Lipid composition: a "key factor" for the rational manipulation of the liposome-protein corona by liposome design |
| Prot0515 | 119.2 | sphere | 119.2 | liposome | 500.0 | HP | nan | 0.126944444 | 14000.0 | 56.3 | 1 | 15.0 | DC-Chol-DOPE | buffer | 50.0 | Neutral | 1.0 | buffer | 37 | 25 | 7.4 | Plasma protein | Lipid composition: a "key factor" for the rational manipulation of the liposome-protein corona by liposome design |
| Prot0516 | 99.6 | sphere | 99.6 | liposome | 500.0 | HP | nan | 0.126944444 | 14000.0 | 59.2 | 1 | 15.0 | Chol-DC | buffer | 50.0 | Neutral | 1.0 | buffer | 37 | 25 | 7.4 | Plasma protein | Lipid composition: a "key factor" for the rational manipulation of the liposome-protein corona by liposome design |
| Prot0517 | 156.5 | sphere | 156.5 | liposome | 500.0 | HP | nan | 0.126944444 | 14000.0 | -1.5 | 1 | 15.0 | DOTAP | plasma | 50.0 | Neutral | 1.0 | buffer | 37 | 25 | 7.4 | Plasma protein | Lipid composition: a "key factor" for the rational manipulation of the liposome-protein corona by liposome design |
| Prot0518 | 220 | sphere | 220 | liposome | 500.0 | HP | nan | 0.126944444 | 14000.0 | -10.6 | 1 | 15.0 | Chol-DC | plasma | 50.0 | Neutral | 1.0 | buffer | 37 | 25 | 7.4 | Plasma protein | Lipid composition: a "key factor" for the rational manipulation of the liposome-protein corona by liposome design |
| Prot0519 | 210 | sphere | 210 | liposome | 500.0 | HP | nan | 0.126944444 | 14000.0 | -11.2 | 1 | 15.0 | Chol-DC | plasma | 50.0 | Neutral | 1.0 | buffer | 37 | 25 | 7.4 | Plasma protein | Lipid composition: a "key factor" for the rational manipulation of the liposome-protein corona by liposome design |
| Prot0520 | 250 | sphere | 250 | liposome | 500.0 | HP | nan | 0.126944444 | 14000.0 | -11.4 | 1 | 15.0 | DC-Chol-DOPE | plasma | 50.0 | Neutral | 1.0 | buffer | 37 | 25 | 7.4 | Plasma protein | Lipid composition: a "key factor" for the rational manipulation of the liposome-protein corona by liposome design |
| Prot0521 | 178.1 | sphere | 178.1 | liposome | 500.0 | HP | nan | 0.126944444 | 14000.0 | -2.1 | 1 | 15.0 | DOTAP-DOPE | plasma | 50.0 | Neutral | 1.0 | buffer | 37 | 25 | 7.4 | Plasma protein | Lipid composition: a "key factor" for the rational manipulation of the liposome-protein corona by liposome design |
| Prot0522 | 187.4 | sphere | 187.4 | liposome | 500.0 | HP | nan | 0.126944444 | 14000.0 | -2.4 | 1 | 15.0 | DOTAP-Chol | plasma | 50.0 | Neutral | 1.0 | buffer | 37 | 25 | 7.4 | Plasma protein | Lipid composition: a "key factor" for the rational manipulation of the liposome-protein corona by liposome design |
| Prot0523 | 152.85 | sphere | 152.85 | liposome | 500.0 | HP | PEG | 0.126944444 | 14000.0 | -13.74 | 1 | 15.0 | DOTAP | plasma | 50.0 | Neutral | 1.0 | buffer | 37 | 25 | 7.4 | Plasma protein(HP MP) | The liposome-protein corona in mice and humans and its implications for in vivo delivery |
| Prot0524 | 208 | sphere | 208 | liposome | 500.0 | HP | nan | 0.126944444 | 14000.0 | -15.7 | 1 | 15.0 | DOTAP-DSPC-Chol | plasma | 50.0 | Neutral | 1.0 | buffer | 37 | 25 | 7.4 | Plasma protein(HP MP) | The liposome-protein corona in mice and humans and its implications for in vivo delivery |
| Prot0525 | 258.54 | sphere | 258.54 | liposome | 500.0 | RP | PEG | 0.126944444 | 14000.0 | -19.64 | 1 | 15.0 | DOTAP | plasma | 50.0 | Neutral | 1.0 | buffer | 37 | 25 | 7.4 | Plasma protein(HP MP) | The liposome-protein corona in mice and humans and its implications for in vivo delivery |
| Prot0526 | 164.8 | sphere | 164.8 | liposome | 500.0 | RP | nan | 0.126944444 | 14000.0 | -42.03 | 1 | 15.0 | DOTAP-DSPC-Chol | plasma | 50.0 | Neutral | 1.0 | buffer | 37 | 25 | 7.4 | Plasma protein(HP MP) | The liposome-protein corona in mice and humans and its implications for in vivo delivery |
| Prot0527 | 103.2 | sphere | 103.2 | liposome | 500.0 | HP | PEG | 0.09 | 14000.0 | 9.9 | 1 | 15.0 | DOTAP-DC-Chol | buffer | 50.0 | Neutral | 1.0 | water | 37 | 4 | 7.4 | Serum protein | Nanoparticles-cell association predicted by protein corona fingerprints |
| Prot0528 | 123 | sphere | 123 | liposome | 500.0 | HP | PEG | 0.12 | 14000.0 | 17.9 | 1 | 15.0 | DOTAP-DC-Chol | buffer | 50.0 | Neutral | 1.0 | water | 37 | 4 | 7.4 | Serum protein | Nanoparticles-cell association predicted by protein corona fingerprints |
| Prot0529 | 114 | sphere | 114 | liposome | 500.0 | HP | PEG | 0.08 | 14000.0 | 18.1 | 1 | 15.0 | DOTAP-DC-Chol | buffer | 50.0 | Neutral | 1.0 | water | 37 | 4 | 7.4 | Serum protein | Nanoparticles-cell association predicted by protein corona fingerprints |
| Prot0530 | 131 | sphere | 131 | liposome | 500.0 | HP | nan | 0.1 | 14000.0 | 26.1 | 1 | 15.0 | DOTAP-DC-Chol | buffer | 50.0 | Neutral | 1.0 | water | 37 | 4 | 7.4 | Serum protein | Nanoparticles-cell association predicted by protein corona fingerprints |
| Prot0531 | 135 | sphere | 135 | liposome | 500.0 | HP | nan | 0.14 | 14000.0 | 30.1 | 1 | 15.0 | DOTAP-DC-Chol | buffer | 50.0 | Neutral | 1.0 | water | 37 | 4 | 7.4 | Serum protein | Nanoparticles-cell association predicted by protein corona fingerprints |
| Prot0532 | 144 | sphere | 144 | liposome | 500.0 | HP | nan | 0.09 | 14000.0 | 30.2 | 1 | 15.0 | DOTAP-DC-Chol | buffer | 50.0 | Neutral | 1.0 | water | 37 | 4 | 7.4 | Serum protein | Nanoparticles-cell association predicted by protein corona fingerprints |
| Prot0533 | 254.6 | sphere | 254.6 | liposome | 500.0 | HP | nan | 0.12 | 14000.0 | 33.1 | 1 | 15.0 | DOTAP-DC-Chol | buffer | 50.0 | Neutral | 1.0 | water | 37 | 4 | 7.4 | Serum protein | Nanoparticles-cell association predicted by protein corona fingerprints |
| Prot0534 | 108 | sphere | 108 | liposome | 500.0 | HP | nan | 0.14 | 14000.0 | 34.5 | 1 | 15.0 | DOTAP-DC-Chol | buffer | 50.0 | Neutral | 1.0 | water | 37 | 4 | 7.4 | Serum protein | Nanoparticles-cell association predicted by protein corona fingerprints |
| Prot0535 | 193.4 | sphere | 193.4 | liposome | 500.0 | HP | nan | 0.13 | 14000.0 | 42.1 | 1 | 15.0 | DOTAP-DC-Chol | buffer | 50.0 | Neutral | 1.0 | water | 37 | 4 | 7.4 | Serum protein | Nanoparticles-cell association predicted by protein corona fingerprints |
| Prot0536 | 125 | sphere | 125 | liposome | 500.0 | HP | nan | 0.18 | 14000.0 | 46.2 | 1 | 15.0 | DOTAP-DC-Chol | buffer | 50.0 | Neutral | 1.0 | water | 37 | 4 | 7.4 | Serum protein | Nanoparticles-cell association predicted by protein corona fingerprints |
| Prot0537 | 128 | sphere | 128 | liposome | 500.0 | HP | nan | 0.11 | 14000.0 | 47.4 | 1 | 15.0 | DOTAP-DC-Chol | buffer | 50.0 | Neutral | 1.0 | water | 37 | 4 | 7.4 | Serum protein | Nanoparticles-cell association predicted by protein corona fingerprints |
| Prot0538 | 157 | sphere | 157 | liposome | 500.0 | HP | nan | 0.17 | 14000.0 | 58.2 | 1 | 15.0 | DOTAP-DC-Chol | buffer | 50.0 | Neutral | 1.0 | water | 37 | 4 | 7.4 | Serum protein | Nanoparticles-cell association predicted by protein corona fingerprints |
| Prot0539 | 115 | sphere | 115 | liposome | 500.0 | HP | PEG | 0.13 | 14000.0 | -13.2 | 1 | 15.0 | DOTAP-DC-Chol | plasma | 50.0 | Neutral | 1.0 | water | 37 | 4 | 7.4 | Serum protein | Nanoparticles-cell association predicted by protein corona fingerprints |
| Prot0540 | 137 | sphere | 137 | liposome | 500.0 | HP | PEG | 0.16 | 14000.0 | -13.9 | 1 | 15.0 | DOTAP-DC-Chol | plasma | 50.0 | Neutral | 1.0 | water | 37 | 4 | 7.4 | Serum protein | Nanoparticles-cell association predicted by protein corona fingerprints |
| Prot0541 | 126 | sphere | 126 | liposome | 500.0 | HP | nan | 0.11 | 14000.0 | -14.2 | 1 | 15.0 | DOPG-DOPA | buffer | 50.0 | Neutral | 1.0 | water | 37 | 4 | 7.4 | Serum protein | Nanoparticles-cell association predicted by protein corona fingerprints |
| Prot0542 | 329 | sphere | 329 | liposome | 500.0 | HP | nan | 0.15 | 14000.0 | -15.4 | 1 | 15.0 | DOTAP-DC-Chol | plasma | 50.0 | Neutral | 1.0 | water | 37 | 4 | 7.4 | Serum protein | Nanoparticles-cell association predicted by protein corona fingerprints |
| Prot0543 | 216 | sphere | 216 | liposome | 500.0 | HP | nan | 0.22 | 14000.0 | -17.9 | 1 | 15.0 | DOTAP-DC-Chol | plasma | 50.0 | Neutral | 1.0 | water | 37 | 4 | 7.4 | Serum protein | Nanoparticles-cell association predicted by protein corona fingerprints |
| Prot0544 | 152 | sphere | 152 | liposome | 500.0 | HP | nan | 0.15 | 14000.0 | -18.2 | 1 | 15.0 | DOPG-DOPA | plasma | 50.0 | Neutral | 1.0 | water | 37 | 4 | 7.4 | Serum protein | Nanoparticles-cell association predicted by protein corona fingerprints |
| Prot0545 | 259 | sphere | 259 | liposome | 500.0 | HP | nan | 0.12 | 14000.0 | -19.3 | 1 | 15.0 | DOTAP-DC-Chol | plasma | 50.0 | Neutral | 1.0 | water | 37 | 4 | 7.4 | Serum protein | Nanoparticles-cell association predicted by protein corona fingerprints |
| Prot0546 | 236 | sphere | 236 | liposome | 500.0 | HP | nan | 0.19 | 14000.0 | -19.3 | 1 | 15.0 | DOTAP-DC-Chol | plasma | 50.0 | Neutral | 1.0 | water | 37 | 4 | 7.4 | Serum protein | Nanoparticles-cell association predicted by protein corona fingerprints |
| Prot0547 | 207 | sphere | 207 | liposome | 500.0 | HP | nan | 0.21 | 14000.0 | -20.4 | 1 | 15.0 | DOTAP-DC-Chol | plasma | 50.0 | Neutral | 1.0 | water | 37 | 4 | 7.4 | Serum protein | Nanoparticles-cell association predicted by protein corona fingerprints |
| Prot0548 | 301 | sphere | 301 | liposome | 500.0 | HP | nan | 0.15 | 14000.0 | -22.1 | 1 | 15.0 | DOPC-DOPE-PEG-DSPC-DPPC | plasma | 50.0 | Neutral | 1.0 | water | 37 | 4 | 7.4 | Serum protein | Nanoparticles-cell association predicted by protein corona fingerprints |
| Prot0549 | 150 | sphere | 150 | liposome | 500.0 | HP | nan | 0.15 | 14000.0 | -23 | 1 | 15.0 | DOTAP-DC-Chol | plasma | 50.0 | Neutral | 1.0 | water | 37 | 4 | 7.4 | Serum protein | Nanoparticles-cell association predicted by protein corona fingerprints |
| Prot0550 | 169 | sphere | 169 | liposome | 500.0 | HP | PEG | 0.17 | 14000.0 | -24.5 | 1 | 15.0 | DOTAP-DC-Chol | plasma | 50.0 | Neutral | 1.0 | water | 37 | 4 | 7.4 | Serum protein | Nanoparticles-cell association predicted by protein corona fingerprints |
| Prot0551 | 182 | sphere | 182 | liposome | 500.0 | HP | nan | 0.16 | 14000.0 | -25.5 | 1 | 15.0 | DOTAP-DC-Chol | plasma | 50.0 | Neutral | 1.0 | water | 37 | 4 | 7.4 | Serum protein | Nanoparticles-cell association predicted by protein corona fingerprints |
| Prot0552 | 136 | sphere | 136 | liposome | 500.0 | HP | nan | 0.1 | 14000.0 | -26.6 | 1 | 15.0 | DOPG-DOPA | buffer | 50.0 | Neutral | 1.0 | water | 37 | 4 | 7.4 | Serum protein | Nanoparticles-cell association predicted by protein corona fingerprints |
| Prot0553 | 211 | sphere | 211 | liposome | 500.0 | HP | nan | 0.23 | 14000.0 | -28.5 | 1 | 15.0 | DOTAP-DC-Chol | plasma | 50.0 | Neutral | 1.0 | water | 37 | 4 | 7.4 | Serum protein | Nanoparticles-cell association predicted by protein corona fingerprints |
| Prot0554 | 171 | sphere | 171 | liposome | 500.0 | HP | nan | 0.13 | 14000.0 | -28.6 | 1 | 15.0 | DOPG-DOPA | plasma | 50.0 | Neutral | 1.0 | water | 37 | 4 | 7.4 | Serum protein | Nanoparticles-cell association predicted by protein corona fingerprints |
| Prot0555 | 178 | sphere | 178 | liposome | 500.0 | HP | nan | 0.14 | 14000.0 | -29.3 | 1 | 15.0 | DOTAP-DC-Chol | plasma | 50.0 | Neutral | 1.0 | water | 37 | 4 | 7.4 | Serum protein | Nanoparticles-cell association predicted by protein corona fingerprints |
| Prot0556 | 191 | sphere | 191 | liposome | 500.0 | HP | nan | 0.11 | 14000.0 | -8.4 | 1 | 15.0 | DOPC-DOPE-PEG-DSPC-DPPC | buffer | 50.0 | Neutral | 1.0 | water | 37 | 4 | 7.4 | Serum protein | Nanoparticles-cell association predicted by protein corona fingerprints |
| Prot0557 | 60 | sphere | 60 | liposome | 500.0 | HP | PEG | 0.126944444 | 84000.0 | 58.4 | 1 | 30.0 | DOTAP/DOPC/DC-Chol/DOPE/DOPE-PEG2k | buffer | 50.0 | Neutral | 1.0 | water | 37 | 4 | 7.4 | Plasma protein | A proteomics-based methodology to investigate the protein corona effect for targeted drug delivery |
| Prot0558 | 223.5 | sphere | 223.5 | liposome | 1000.0 | HP | nan | 0.126944444 | 15000.0 | 49.5 | 1 | 10.0 | DOTAP/DNA | buffer | 10.0 | Neutral | 1.0 | buffer | 37 | 25 | 7.4 | Serum protein | Selective targeting capability acquired with a protein corona adsorbed on the surface of 1,2-dioleoyl-3-trimethylammonium propane/dna nanoparticles |
| Prot0559 | 223.5 | sphere | 223.5 | liposome | 1000.0 | HP | nan | 0.126944444 | 15000.0 | 49.5 | 1 | 10.0 | DOTAP/DNA | buffer | 50.0 | Neutral | 1.0 | buffer | 37 | 25 | 7.4 | Serum protein | Selective targeting capability acquired with a protein corona adsorbed on the surface of 1,2-dioleoyl-3-trimethylammonium propane/dna nanoparticles |
| Prot0560 | 287.7 | sphere | 287.7 | liposome | 1000.0 | HP | nan | 0.126944444 | 15000.0 | -7.6 | 1 | 10.0 | DOTAP/DNA | plasma | 10.0 | Neutral | 1.0 | buffer | 37 | 25 | 7.4 | Serum protein | Selective targeting capability acquired with a protein corona adsorbed on the surface of 1,2-dioleoyl-3-trimethylammonium propane/dna nanoparticles |
| Prot0561 | 287.7 | sphere | 287.7 | liposome | 1000.0 | HP | nan | 0.126944444 | 15000.0 | -7.6 | 1 | 10.0 | DOTAP/DNA | plasma | 50.0 | Neutral | 1.0 | buffer | 37 | 25 | 7.4 | Serum protein | Selective targeting capability acquired with a protein corona adsorbed on the surface of 1,2-dioleoyl-3-trimethylammonium propane/dna nanoparticles |
| Prot0562 | 246.3 | sphere | 246.3 | liposome | 500.0 | RP | nan | 0.126944444 | 18000.0 | 34 | 1 | 15.0 | DOTAP-Chol-DPPC | buffer | 50.0 | Neutral | 1.0 | buffer | 37 | 25 | 7.4 | Plasma protein | Surface chemistry and serum type both determine the nanoparticle-protein corona |
| Prot0563 | 246.3 | sphere | 246.3 | liposome | 500.0 | HP | nan | 0.126944444 | 18000.0 | 34 | 1 | 15.0 | DOTAP-Chol-DPPC | buffer | 50.0 | Neutral | 1.0 | buffer | 37 | 25 | 7.4 | Plasma protein | Surface chemistry and serum type both determine the nanoparticle-protein corona |
| Prot0564 | 421.8 | sphere | 421.8 | liposome | 500.0 | RP | nan | 0.126944444 | 18000.0 | 37.1 | 1 | 15.0 | DOTAP-Chol-DSPC | buffer | 50.0 | Neutral | 1.0 | buffer | 37 | 25 | 7.4 | Plasma protein | Surface chemistry and serum type both determine the nanoparticle-protein corona |
| Prot0565 | 421.8 | sphere | 421.8 | liposome | 500.0 | HP | nan | 0.126944444 | 18000.0 | 37.1 | 1 | 15.0 | DOTAP-Chol-DSPC | buffer | 50.0 | Neutral | 1.0 | buffer | 37 | 25 | 7.4 | Plasma protein | Surface chemistry and serum type both determine the nanoparticle-protein corona |
| Prot0566 | 203 | sphere | 203 | liposome | 500.0 | RP | nan | 0.126944444 | 18000.0 | 40.8 | 1 | 15.0 | Shingosine-Chol-DSPC | buffer | 50.0 | Cationic | 1.0 | buffer | 37 | 25 | 7.4 | Plasma protein | Surface chemistry and serum type both determine the nanoparticle-protein corona |
| Prot0567 | 203 | sphere | 203 | liposome | 500.0 | HP | nan | 0.126944444 | 18000.0 | 40.8 | 1 | 15.0 | Shingosine-Chol-DSPC | buffer | 50.0 | Cationic | 1.0 | buffer | 37 | 25 | 7.4 | Plasma protein | Surface chemistry and serum type both determine the nanoparticle-protein corona |
| Prot0568 | 244.3 | sphere | 244.3 | liposome | 500.0 | RP | nan | 0.126944444 | 18000.0 | 45.7 | 1 | 15.0 | DOTAP-Chol-PC | buffer | 50.0 | Neutral | 1.0 | buffer | 37 | 25 | 7.4 | Plasma protein | Surface chemistry and serum type both determine the nanoparticle-protein corona |
| Prot0569 | 244.3 | sphere | 244.3 | liposome | 500.0 | HP | nan | 0.126944444 | 18000.0 | 45.7 | 1 | 15.0 | DOTAP-Chol-PC | buffer | 50.0 | Neutral | 1.0 | buffer | 37 | 25 | 7.4 | Plasma protein | Surface chemistry and serum type both determine the nanoparticle-protein corona |
| Prot0570 | 248.8 | sphere | 248.8 | liposome | 500.0 | RP | nan | 0.126944444 | 18000.0 | -10.9 | 1 | 15.0 | Chol-PC | buffer | 50.0 | Anionic | 1.0 | buffer | 37 | 25 | 7.4 | Plasma protein | Surface chemistry and serum type both determine the nanoparticle-protein corona |
| Prot0571 | 248.8 | sphere | 248.8 | liposome | 500.0 | HP | nan | 0.126944444 | 18000.0 | -10.9 | 1 | 15.0 | Chol-PC | buffer | 50.0 | Anionic | 1.0 | buffer | 37 | 25 | 7.4 | Plasma protein | Surface chemistry and serum type both determine the nanoparticle-protein corona |
| Prot0572 | 130 | sphere | 130 | liposome | 500.0 | HP | nan | 0.2 | 14000.0 | 55 | 1 | 15.0 | DC-Chol-DOPE | water | 50.0 | Neutral | 0.016666667 | buffer | 37 | 25 | 7.0 | apolipoproteins (Apo A-I, Apo C-II, Apo D, and Apo E are the most enriched) | Time evolution of nanoparticle-protein corona in human plasma: Relevance for targeted drug delivery |
| Prot0573 | 130 | sphere | 130 | liposome | 500.0 | HP | nan | 0.2 | 14000.0 | 55 | 1 | 15.0 | DC-Chol-DOPE | water | 50.0 | Neutral | 0.5 | buffer | 37 | 25 | 7.0 | apolipoproteins (Apo A-I, Apo C-II, Apo D, and Apo E are the most enriched) | Time evolution of nanoparticle-protein corona in human plasma: Relevance for targeted drug delivery |
| Prot0574 | 130 | sphere | 130 | liposome | 500.0 | HP | nan | 0.2 | 14000.0 | 55 | 1 | 15.0 | DC-Chol-DOPE | water | 50.0 | Neutral | 1.0 | buffer | 37 | 25 | 7.0 | apolipoproteins (Apo A-I, Apo C-II, Apo D, and Apo E are the most enriched) | Time evolution of nanoparticle-protein corona in human plasma: Relevance for targeted drug delivery |
| Prot0575 | 87 | sphere | 114 | liposome | 500.0 | RP | PEG | 0.056 | 1300.0 | -36.2 | 1 | 12.0 | HSPC-Chol-DSPE | plasma | 100.0 | Neutral | 0.166666667 | water | 37 | 4 | 7.4 | apolipoproteins (Apo A-I, Apo C-II, Apo D, and Apo E are the most enriched) | Time-evolution of in vivo protein corona onto blood-circulating PEGylated liposomal doxorubicin (DOXIL) nanoparticles |
| Prot0576 | 115.46 | sphere | 114 | liposome | 500.0 | RP | PEG | 0.056 | 1300.0 | -36.2 | 1 | 12.0 | HSPC-Chol-DSPE | plasma | 100.0 | Neutral | 1.0 | water | 37 | 4 | 7.4 | apolipoproteins (Apo A-I, Apo C-II, Apo D, and Apo E are the most enriched) | Time-evolution of in vivo protein corona onto blood-circulating PEGylated liposomal doxorubicin (DOXIL) nanoparticles |
| Prot0577 | 80.33 | sphere | 114 | liposome | 500.0 | RP | PEG | 0.056 | 1300.0 | -36.2 | 1 | 12.0 | HSPC-Chol-DSPE | plasma | 100.0 | Neutral | 3.0 | water | 37 | 4 | 7.4 | apolipoproteins (Apo A-I, Apo C-II, Apo D, and Apo E are the most enriched) | Time-evolution of in vivo protein corona onto blood-circulating PEGylated liposomal doxorubicin (DOXIL) nanoparticles |
| Prot0578 | 58.27 | sphere | 50 | metal | 1000.0 | FBS | nan | 0.126944444 | 16000.0 | -13.5 | 1 | 10.0 | CaCO3 | PBS | 5.0 | Neutral | 12.0 | DMEM | 22 | 25 | 7.4 | nan | A story told by a single nanoparticle in the body fluid: demonstration of dissolution-reprecipitation of nanocrystals in a biological system |
| Prot0579 | 65.13 | sphere | 50 | metal | 1000.0 | FBS | nan | 0.126944444 | 16000.0 | -13.5 | 1 | 10.0 | CaCO3 | PBS | 5.0 | Neutral | 12.0 | DMEM | 22 | 25 | 7.4 | nan | A story told by a single nanoparticle in the body fluid: demonstration of dissolution-reprecipitation of nanocrystals in a biological system |
| Prot0580 | 45.58 | sphere | 100 | metal | 1000.0 | FBS | nan | 0.126944444 | 16000.0 | -13.5 | 1 | 10.0 | Ca3(PO4)2 | PBS | 5.0 | Anionic | 12.0 | DMEM | 22 | 25 | 7.4 | nan | A story told by a single nanoparticle in the body fluid: demonstration of dissolution-reprecipitation of nanocrystals in a biological system |
| Prot0581 | 8.95 | sphere | 131 | metal | 1107.3 | HP | OAOA | 0.126944444 | 20000.0 | -10.7 | 1 | 30.0 | Fe3O4 | plasma | 10.0 | Anionic | 1.0 | buffer | 25 | 4 | 7.4 | Plasma protein | Surface coatings shape the protein corona of SPIONs with relevance to their application in vivo |
| Prot0582 | 9.95 | sphere | 99.6 | metal | 1107.3 | HP | CA | 0.126944444 | 20000.0 | -29.8 | 1 | 30.0 | Fe3O4 | PBS | 10.0 | Anionic | 1.0 | buffer | 25 | 4 | 7.4 | Plasma protein | Surface coatings shape the protein corona of SPIONs with relevance to their application in vivo |
| Prot0583 | 9.95 | sphere | 134.6 | metal | 1107.3 | HP | CA | 0.126944444 | 20000.0 | -29.8 | 1 | 30.0 | Fe3O4 | plasma | 10.0 | Anionic | 1.0 | buffer | 25 | 4 | 7.4 | Plasma protein | Surface coatings shape the protein corona of SPIONs with relevance to their application in vivo |
| Prot0584 | 9.95 | sphere | 95.4 | metal | 3555.6 | HP | CA | 0.126944444 | 20000.0 | -35.3 | 1 | 30.0 | Fe3O4 | PBS | 55.0 | Anionic | 1.0 | buffer | 25 | 4 | 7.4 | Plasma protein | Surface coatings shape the protein corona of SPIONs with relevance to their application in vivo |
| Prot0585 | 8.95 | sphere | 313 | metal | 3555.6 | HP | OAOA | 0.126944444 | 20000.0 | -51.4 | 1 | 30.0 | Fe3O4 | PBS | 55.0 | Anionic | 1.0 | buffer | 25 | 4 | 7.4 | Plasma protein | Surface coatings shape the protein corona of SPIONs with relevance to their application in vivo |
| Prot0586 | 8.95 | sphere | 127 | metal | 1107.3 | HP | OAOA | 0.126944444 | 20000.0 | -55.9 | 1 | 30.0 | Fe3O4 | PBS | 10.0 | Anionic | 1.0 | buffer | 25 | 4 | 7.4 | Plasma protein | Surface coatings shape the protein corona of SPIONs with relevance to their application in vivo |
| Prot0587 | 8.95 | sphere | 1303.3 | metal | 3555.6 | HP | OAOA | 0.126944444 | 20000.0 | -7.6 | 1 | 30.0 | Fe3O4 | plasma | 55.0 | Anionic | 1.0 | buffer | 25 | 4 | 7.4 | Plasma protein | Surface coatings shape the protein corona of SPIONs with relevance to their application in vivo |
| Prot0588 | 9.95 | sphere | 169 | metal | 3555.6 | HP | CA | 0.126944444 | 20000.0 | -8.9 | 1 | 30.0 | Fe3O4 | plasma | 55.0 | Anionic | 1.0 | buffer | 25 | 4 | 7.4 | Plasma protein | Surface coatings shape the protein corona of SPIONs with relevance to their application in vivo |
| Prot0589 | 15.1 | sphere | 32.7 | metal | 100.0 | FBS | NH2 | 0.126944444 | 15000.0 | -13.9 | 1 | 20.0 | Fe3O4 | PBS | 90.0 | Anionic | 1.0 | water | 39 | 25 | 7.4 | albumin, apolipoproteins, keratins, and other serum proteins | Slight temperature changes affect protein affinity and cellular uptake/toxicity of nanoparticles |
| Prot0590 | 15.1 | sphere | 32.7 | metal | 100.0 | FBS | NH2 | 0.126944444 | 15000.0 | -13.9 | 1 | 20.0 | Fe3O4 | PBS | 90.0 | Anionic | 1.0 | water | 39 | 25 | 7.4 | albumin, apolipoproteins, keratins, and other serum proteins | Slight temperature changes affect protein affinity and cellular uptake/toxicity of nanoparticles |
| Prot0591 | 15.1 | sphere | 32.7 | metal | 100.0 | FBS | NH2 | 0.126944444 | 15000.0 | -13.9 | 1 | 20.0 | Fe3O4 | PBS | 90.0 | Anionic | 1.0 | water | 39 | 25 | 7.4 | albumin, apolipoproteins, keratins, and other serum proteins | Slight temperature changes affect protein affinity and cellular uptake/toxicity of nanoparticles |
| Prot0592 | 15.1 | sphere | 32.7 | metal | 100.0 | FBS | NH2 | 0.126944444 | 15000.0 | -13.9 | 1 | 20.0 | Fe3O4 | PBS | 90.0 | Anionic | 1.0 | water | 39 | 25 | 7.4 | albumin, apolipoproteins, keratins, and other serum proteins | Slight temperature changes affect protein affinity and cellular uptake/toxicity of nanoparticles |
| Prot0593 | 15.1 | sphere | 43.8 | metal | 100.0 | FBS | NH2 | 0.126944444 | 15000.0 | -20.8 | 1 | 20.0 | Fe3O4 | water | 90.0 | Anionic | 1.0 | water | 39 | 25 | 7.0 | albumin, apolipoproteins, keratins, and other serum proteins | Slight temperature changes affect protein affinity and cellular uptake/toxicity of nanoparticles |
| Prot0594 | 15.1 | sphere | 43.8 | metal | 100.0 | FBS | NH2 | 0.126944444 | 15000.0 | -20.8 | 1 | 20.0 | Fe3O4 | water | 90.0 | Anionic | 1.0 | water | 39 | 25 | 7.0 | albumin, apolipoproteins, keratins, and other serum proteins | Slight temperature changes affect protein affinity and cellular uptake/toxicity of nanoparticles |
| Prot0595 | 15.1 | sphere | 43.8 | metal | 100.0 | FBS | NH2 | 0.126944444 | 15000.0 | -20.8 | 1 | 20.0 | Fe3O4 | water | 90.0 | Anionic | 1.0 | water | 39 | 25 | 7.0 | albumin, apolipoproteins, keratins, and other serum proteins | Slight temperature changes affect protein affinity and cellular uptake/toxicity of nanoparticles |
| Prot0596 | 15.1 | sphere | 43.8 | metal | 100.0 | FBS | NH2 | 0.126944444 | 15000.0 | -20.8 | 1 | 20.0 | Fe3O4 | water | 90.0 | Anionic | 1.0 | water | 39 | 25 | 7.0 | albumin, apolipoproteins, keratins, and other serum proteins | Slight temperature changes affect protein affinity and cellular uptake/toxicity of nanoparticles |
| Prot0597 | 7.7 | sphere | 112.7 | metal | 23540.0 | FBS | PVA | 0.126944444 | 20000.0 | 5.6 | 1 | 10.0 | Fe3O4 | water | 77.8 | Anionic | 1.0 | buffer | 37 | 25 | 7.0 | Serum protein | Significance of surface charge and shell material of superparamagnetic iron oxide nanoparticle (SPION) based core/shell nanoparticles on the composition of the protein corona |
| Prot0598 | 7.7 | sphere | 46.8 | metal | 23540.0 | FBS | PVA | 0.126944444 | 20000.0 | 13.6 | 1 | 10.0 | Fe3O4 | water | 77.8 | Anionic | 1.0 | buffer | 37 | 25 | 7.0 | Serum protein | Significance of surface charge and shell material of superparamagnetic iron oxide nanoparticle (SPION) based core/shell nanoparticles on the composition of the protein corona |
| Prot0599 | 7.7 | sphere | 28 | metal | 23540.0 | FBS | nan | 0.126944444 | 20000.0 | 27.5 | 1 | 10.0 | Fe3O4 | water | 77.8 | Cationic | 1.0 | buffer | 37 | 25 | 7.0 | Serum protein | Significance of surface charge and shell material of superparamagnetic iron oxide nanoparticle (SPION) based core/shell nanoparticles on the composition of the protein corona |
| Prot0600 | 7.7 | sphere | 71.8 | metal | 23540.0 | FBS | PVA | 0.126944444 | 20000.0 | 34.6 | 1 | 10.0 | Fe3O4 | water | 77.8 | Anionic | 1.0 | buffer | 37 | 25 | 7.0 | Serum protein | Significance of surface charge and shell material of superparamagnetic iron oxide nanoparticle (SPION) based core/shell nanoparticles on the composition of the protein corona |
| Prot0601 | 100.7 | sphere | 100.7 | metal | 35653.0 | FBS | SiO2 | 0.126944444 | 20000.0 | 36.8 | 1 | 10.0 | Fe3O4 | water | 77.8 | Neutral | 1.0 | buffer | 37 | 25 | 7.0 | Serum protein | Significance of surface charge and shell material of superparamagnetic iron oxide nanoparticle (SPION) based core/shell nanoparticles on the composition of the protein corona |
| Prot0602 | 7.7 | sphere | 78.5 | metal | 23540.0 | FBS | PVA | 0.126944444 | 20000.0 | -15.5 | 1 | 10.0 | Fe3O4 | water | 77.8 | Anionic | 1.0 | buffer | 37 | 25 | 7.0 | Serum protein | Significance of surface charge and shell material of superparamagnetic iron oxide nanoparticle (SPION) based core/shell nanoparticles on the composition of the protein corona |
| Prot0603 | 102.1 | sphere | 102.1 | metal | 64825.0 | FBS | TiO2 | 0.126944444 | 20000.0 | -24.9 | 1 | 10.0 | Fe3O4 | water | 77.8 | Cationic | 1.0 | buffer | 37 | 25 | 7.0 | Serum protein | Significance of surface charge and shell material of superparamagnetic iron oxide nanoparticle (SPION) based core/shell nanoparticles on the composition of the protein corona |
| Prot0604 | 102.1 | sphere | 102.1 | metal | 35653.0 | FBS | SiO2 | 0.126944444 | 20000.0 | -36.6 | 1 | 10.0 | Fe3O4 | water | 77.8 | Neutral | 1.0 | buffer | 37 | 25 | 7.0 | Serum protein | Significance of surface charge and shell material of superparamagnetic iron oxide nanoparticle (SPION) based core/shell nanoparticles on the composition of the protein corona |
| Prot0605 | 143.9 | sphere | 143.9 | metal | 23540.0 | FBS | nan | 0.126944444 | 20000.0 | -48.2 | 1 | 10.0 | Fe3O4 | water | 77.8 | Cationic | 1.0 | buffer | 37 | 25 | 7.0 | Serum protein | Significance of surface charge and shell material of superparamagnetic iron oxide nanoparticle (SPION) based core/shell nanoparticles on the composition of the protein corona |
| Prot0606 | 44 | sphere | 391.7 | metal | 1000.0 | HP | SiO2 | 0.126944444 | 3500.0 | -11.24 | 1 | 15.0 | Fe3O4 | cell culture | 100.0 | Neutral | 1.0 | water | 37 | 4 | 7.4 | Plasma protein | Proteomics analysis reveals distinct corona composition on magnetic nanoparticles with different surface coatings: Implications for interactions with primary human macrophages |
| Prot0607 | 30 | sphere | 250 | metal | 10000.0 | HP | nan | 0.126944444 | 1400.0 | -19.5 | 1 | 60.0 | Fe3O4 | PBS | 50.0 | Cationic | 1.0 | buffer | 37 | 37 | 7.4 | Plasma protein | The on-bead digestion of protein corona on nanoparticles by trypsin immobilized on the magnetic nanoparticle |
| Prot0608 | 7 | sphere | 74.9 | metal | 20.0 | RS | PC | 0.14 | 16000.0 | -11.5 | 1 | 120.0 | Fe3O4 | PBS | 80.0 | Anionic | 0.25 | buffer | 37 | 10 | 7.4 | Apolipoproteins | Phosphatidylcholine-Coated Iron Oxide Nanomicelles for in Vivo Prolonged Circulation Time with an Antibiofouling Protein Corona |
| Prot0609 | 7 | sphere | 74.9 | metal | 20.0 | RS | PC | 0.14 | 16000.0 | -11.5 | 1 | 120.0 | Fe3O4 | PBS | 80.0 | Anionic | 1.5 | buffer | 37 | 10 | 7.4 | Apolipoproteins | Phosphatidylcholine-Coated Iron Oxide Nanomicelles for in Vivo Prolonged Circulation Time with an Antibiofouling Protein Corona |
| Prot0610 | 7 | sphere | 74.9 | metal | 20.0 | RS | PC | 0.14 | 16000.0 | -11.5 | 1 | 120.0 | Fe3O4 | PBS | 80.0 | Anionic | 3.0 | buffer | 37 | 10 | 7.4 | Apolipoproteins | Phosphatidylcholine-Coated Iron Oxide Nanomicelles for in Vivo Prolonged Circulation Time with an Antibiofouling Protein Corona |
| Prot0611 | 11 | sphere | 25 | metal | 20.0 | RS | nan | 0.19 | 16000.0 | -4 | 1 | 120.0 | Fe3O4 | PBS | 80.0 | Cationic | 0.25 | buffer | 37 | 10 | 7.4 | Apolipoproteins | Phosphatidylcholine-Coated Iron Oxide Nanomicelles for in Vivo Prolonged Circulation Time with an Antibiofouling Protein Corona |
| Prot0612 | 11 | sphere | 25 | metal | 20.0 | RS | nan | 0.19 | 16000.0 | -4 | 1 | 120.0 | Fe3O4 | PBS | 80.0 | Cationic | 1.5 | buffer | 37 | 10 | 7.4 | Apolipoproteins | Phosphatidylcholine-Coated Iron Oxide Nanomicelles for in Vivo Prolonged Circulation Time with an Antibiofouling Protein Corona |
| Prot0613 | 11 | sphere | 25 | metal | 20.0 | RS | nan | 0.19 | 16000.0 | -4 | 1 | 120.0 | Fe3O4 | PBS | 80.0 | Cationic | 3.0 | buffer | 37 | 10 | 7.4 | Apolipoproteins | Phosphatidylcholine-Coated Iron Oxide Nanomicelles for in Vivo Prolonged Circulation Time with an Antibiofouling Protein Corona |
| Prot0614 | 225 | sphere | 643.1 | metal | 1660.0 | HP | nan | 0.38 | 1000.0 | -23.4 | 1 | 20.0 | Fe3O4 | PBS | 50.0 | Cationic | 1.0 | buffer | 37 | 25 | 7.4 | Plasma protein | Nanoparticle size matters in the formation of plasma protein coronas on Fe3O4 nanoparticles |
| Prot0615 | 225 | sphere | 643.1 | metal | 1660.0 | HP | nan | 0.38 | 1000.0 | -23.4 | 1 | 20.0 | Fe3O4 | PBS | 50.0 | Cationic | 1.0 | buffer | 37 | 25 | 7.4 | Plasma protein | Nanoparticle size matters in the formation of plasma protein coronas on Fe3O4 nanoparticles |
| Prot0616 | 225 | sphere | 643.1 | metal | 1660.0 | HP | nan | 0.38 | 1000.0 | -23.4 | 1 | 20.0 | Fe3O4 | PBS | 50.0 | Cationic | 1.0 | buffer | 37 | 25 | 7.4 | Plasma protein | Nanoparticle size matters in the formation of plasma protein coronas on Fe3O4 nanoparticles |
| Prot0617 | 375 | sphere | 571.1 | metal | 1660.0 | HP | nan | 0.44 | 1000.0 | -24.3 | 1 | 20.0 | Fe3O4 | PBS | 50.0 | Cationic | 1.0 | buffer | 37 | 25 | 7.4 | Plasma protein | Nanoparticle size matters in the formation of plasma protein coronas on Fe3O4 nanoparticles |
| Prot0618 | 375 | sphere | 571.1 | metal | 1660.0 | HP | nan | 0.44 | 1000.0 | -24.3 | 1 | 20.0 | Fe3O4 | PBS | 50.0 | Cationic | 1.0 | buffer | 37 | 25 | 7.4 | Plasma protein | Nanoparticle size matters in the formation of plasma protein coronas on Fe3O4 nanoparticles |
| Prot0619 | 375 | sphere | 571.1 | metal | 1660.0 | HP | nan | 0.44 | 1000.0 | -24.3 | 1 | 20.0 | Fe3O4 | PBS | 50.0 | Cationic | 1.0 | buffer | 37 | 25 | 7.4 | Plasma protein | Nanoparticle size matters in the formation of plasma protein coronas on Fe3O4 nanoparticles |
| Prot0620 | 30 | sphere | 833.4 | metal | 1660.0 | HP | nan | 0.41 | 1000.0 | -28.9 | 1 | 20.0 | Fe3O4 | PBS | 50.0 | Cationic | 1.0 | buffer | 37 | 25 | 7.4 | Plasma protein | Nanoparticle size matters in the formation of plasma protein coronas on Fe3O4 nanoparticles |
| Prot0621 | 30 | sphere | 833.4 | metal | 1660.0 | HP | nan | 0.41 | 1000.0 | -28.9 | 1 | 20.0 | Fe3O4 | PBS | 50.0 | Cationic | 1.0 | buffer | 37 | 25 | 7.4 | Plasma protein | Nanoparticle size matters in the formation of plasma protein coronas on Fe3O4 nanoparticles |
| Prot0622 | 30 | sphere | 833.4 | metal | 1660.0 | HP | nan | 0.41 | 1000.0 | -28.9 | 1 | 20.0 | Fe3O4 | PBS | 50.0 | Cationic | 1.0 | buffer | 37 | 25 | 7.4 | Plasma protein | Nanoparticle size matters in the formation of plasma protein coronas on Fe3O4 nanoparticles |
| Prot0623 | 51 | sphere | 209 | metal | 250.0 | FBS | SiO2 | 0.196 | 20000.0 | -13.5 | 1 | 20.0 | Fe3O4 | water | 10.0 | Neutral | 24.0 | DMEM | 37 | 4 | 7.0 | Serum protein | Magnetic nanoparticles to recover cellular organelles and study the time resolved nanoparticle-cell interactome throughout uptake |
| Prot0624 | 175.3 | sphere | 175.3 | metal | 60.0 | FBS | nan | 0.126944444 | 15000.0 | -19 | 1 | 20.0 | Fe3O4 | cell culture | 10.0 | Cationic | 12.0 | DMEM | 37 | 25 | 7.4 | apolipoproteins,/complement system proteins/acute phase proteins | A magnetic-dependent protein corona of tailor-made superparamagnetic iron oxides alters their biological behaviors |
| Prot0625 | 178.2 | sphere | 178.2 | metal | 60.0 | FBS | nan | 0.126944444 | 15000.0 | -22.7 | 1 | 20.0 | Fe3O4 | cell culture | 10.0 | Cationic | 12.0 | DMEM | 37 | 25 | 7.4 | apolipoproteins,/complement system proteins/acute phase proteins | A magnetic-dependent protein corona of tailor-made superparamagnetic iron oxides alters their biological behaviors |
| Prot0626 | 44 | sphere | 124.8 | metal | 1000.0 | HP | SiO2 | 0.126944444 | 3500.0 | -19.92 | 1 | 15.0 | Fe3O4 | cell culture | 100.0 | Neutral | 1.0 | water | 37 | 4 | 7.4 | Plasma protein | Proteomics analysis reveals distinct corona composition on magnetic nanoparticles with different surface coatings: Implications for interactions with primary human macrophages |
| Prot0627 | 1.45 | tube | 1.45 | carbon | 1000.0 | RS | nan | 0.126944444 | 14000.0 | -13.5 | 1 | 10.0 | SWCNT | PBS | 10.0 | Neutral | 8.0 | water | 4 | 25 | 7.4 | Serum protein | Variations in biocorona formation related to defects in the structure of single walled carbon nanotubes and the hyperlipidemic disease state |
| Prot0628 | 1.45 | tube | 1.45 | carbon | 1000.0 | RS | nan | 0.126944444 | 14000.0 | -13.5 | 1 | 10.0 | SWCNT | PBS | 10.0 | Neutral | 8.0 | water | 4 | 25 | 7.4 | Serum protein | Variations in biocorona formation related to defects in the structure of single walled carbon nanotubes and the hyperlipidemic disease state |
| Prot0629 | 1.45 | tube | 1.45 | carbon | 1000.0 | RS | nan | 0.126944444 | 14000.0 | -13.5 | 1 | 10.0 | SWCNT | PBS | 10.0 | Neutral | 8.0 | water | 4 | 25 | 7.4 | Serum protein | Variations in biocorona formation related to defects in the structure of single walled carbon nanotubes and the hyperlipidemic disease state |
| Prot0630 | 1.45 | tube | 1.45 | carbon | 1000.0 | RS | nan | 0.126944444 | 14000.0 | -13.5 | 1 | 10.0 | SWCNT | PBS | 10.0 | Neutral | 8.0 | water | 4 | 25 | 7.4 | Serum protein | Variations in biocorona formation related to defects in the structure of single walled carbon nanotubes and the hyperlipidemic disease state |
| Prot0631 | 1.45 | tube | 1.45 | carbon | 1000.0 | RS | nan | 0.126944444 | 14000.0 | -13.5 | 1 | 10.0 | SWCNT | PBS | 10.0 | Neutral | 8.0 | water | 4 | 25 | 7.4 | Serum protein | Variations in biocorona formation related to defects in the structure of single walled carbon nanotubes and the hyperlipidemic disease state |
| Prot0632 | 1.45 | tube | 1.45 | carbon | 1000.0 | RS | nan | 0.126944444 | 14000.0 | -13.5 | 1 | 10.0 | SWCNT | PBS | 10.0 | Neutral | 8.0 | water | 4 | 25 | 7.4 | Serum protein | Variations in biocorona formation related to defects in the structure of single walled carbon nanotubes and the hyperlipidemic disease state |
| Prot0633 | 1.45 | tube | 1.45 | carbon | 1000.0 | RS | nan | 0.126944444 | 14000.0 | -13.5 | 1 | 10.0 | SWCNT | PBS | 10.0 | Neutral | 8.0 | water | 4 | 25 | 7.4 | Serum protein | Variations in biocorona formation related to defects in the structure of single walled carbon nanotubes and the hyperlipidemic disease state |
| Prot0634 | 1.45 | tube | 1.45 | carbon | 1000.0 | RS | nan | 0.126944444 | 14000.0 | -13.5 | 1 | 10.0 | SWCNT | PBS | 10.0 | Neutral | 8.0 | water | 4 | 25 | 7.4 | Serum protein | Variations in biocorona formation related to defects in the structure of single walled carbon nanotubes and the hyperlipidemic disease state |
| Prot0635 | 1.45 | tube | 1.45 | carbon | 1000.0 | RS | nan | 0.126944444 | 14000.0 | -13.5 | 1 | 10.0 | SWCNT | PBS | 10.0 | Neutral | 8.0 | water | 4 | 25 | 7.4 | Serum protein | Variations in biocorona formation related to defects in the structure of single walled carbon nanotubes and the hyperlipidemic disease state |
| Prot0636 | 1.45 | tube | 1.45 | carbon | 1000.0 | RS | nan | 0.126944444 | 14000.0 | -13.5 | 1 | 10.0 | SWCNT | PBS | 10.0 | Neutral | 8.0 | water | 4 | 25 | 7.4 | Serum protein | Variations in biocorona formation related to defects in the structure of single walled carbon nanotubes and the hyperlipidemic disease state |
| Prot0637 | 10 | powder | 880.7 | metal | 100.0 | FBS | nan | 0.396 | 2700.0 | -5.87 | 1 | 5.0 | TiO2 | cell culture | 10.0 | Cationic | 1.0 | buffer | 37 | 4 | 7.4 | nan | Surface proteomics on nanoparticles: a step to simplify the rapid prototyping of nanoparticles |
| Prot0638 | 10 | powder | 880.7 | metal | 100.0 | FBS | nan | 0.396 | 2700.0 | -5.87 | 1 | 5.0 | TiO2 | cell culture | 10.0 | Cationic | 1.0 | buffer | 37 | 4 | 7.4 | nan | Surface proteomics on nanoparticles: a step to simplify the rapid prototyping of nanoparticles |
| Prot0639 | 10 | powder | 880.7 | metal | 100.0 | FBS | nan | 0.396 | 2700.0 | -5.87 | 1 | 5.0 | TiO2 | cell culture | 10.0 | Cationic | 1.0 | buffer | 37 | 4 | 7.4 | nan | Surface proteomics on nanoparticles: a step to simplify the rapid prototyping of nanoparticles |
| Prot0640 | 10 | powder | 880.7 | metal | 100.0 | FBS | nan | 0.396 | 2700.0 | -5.87 | 1 | 5.0 | TiO2 | cell culture | 10.0 | Cationic | 1.0 | buffer | 37 | 4 | 7.4 | nan | Surface proteomics on nanoparticles: a step to simplify the rapid prototyping of nanoparticles |
| Prot0641 | 10 | powder | 880.7 | metal | 100.0 | FBS | nan | 0.396 | 2700.0 | -5.87 | 1 | 5.0 | TiO2 | cell culture | 10.0 | Cationic | 1.0 | buffer | 37 | 4 | 7.4 | nan | Surface proteomics on nanoparticles: a step to simplify the rapid prototyping of nanoparticles |
| Prot0642 | 10 | powder | 880.7 | metal | 100.0 | FBS | nan | 0.396 | 2700.0 | -5.87 | 1 | 5.0 | TiO2 | cell culture | 10.0 | Cationic | 1.0 | buffer | 37 | 4 | 7.4 | nan | Surface proteomics on nanoparticles: a step to simplify the rapid prototyping of nanoparticles |
| Prot0643 | 10 | powder | 858.5 | metal | 100.0 | FBS | nan | 0.241 | 2700.0 | -9.62 | 1 | 5.0 | TiO2 | water | 10.0 | Cationic | 1.0 | buffer | 37 | 4 | 7.0 | nan | Surface proteomics on nanoparticles: a step to simplify the rapid prototyping of nanoparticles |
| Prot0644 | 10 | powder | 858.5 | metal | 100.0 | FBS | nan | 0.241 | 2700.0 | -9.62 | 1 | 5.0 | TiO2 | water | 10.0 | Cationic | 1.0 | buffer | 37 | 4 | 7.0 | nan | Surface proteomics on nanoparticles: a step to simplify the rapid prototyping of nanoparticles |
| Prot0645 | 10 | powder | 858.5 | metal | 100.0 | FBS | nan | 0.241 | 2700.0 | -9.62 | 1 | 5.0 | TiO2 | water | 10.0 | Cationic | 1.0 | buffer | 37 | 4 | 7.0 | nan | Surface proteomics on nanoparticles: a step to simplify the rapid prototyping of nanoparticles |
| Prot0646 | 10 | powder | 858.5 | metal | 100.0 | FBS | nan | 0.241 | 2700.0 | -9.62 | 1 | 5.0 | TiO2 | water | 10.0 | Cationic | 1.0 | buffer | 37 | 4 | 7.0 | nan | Surface proteomics on nanoparticles: a step to simplify the rapid prototyping of nanoparticles |
| Prot0647 | 10 | powder | 858.5 | metal | 100.0 | FBS | nan | 0.241 | 2700.0 | -9.62 | 1 | 5.0 | TiO2 | water | 10.0 | Cationic | 1.0 | buffer | 37 | 4 | 7.0 | nan | Surface proteomics on nanoparticles: a step to simplify the rapid prototyping of nanoparticles |
| Prot0648 | 10 | powder | 858.5 | metal | 100.0 | FBS | nan | 0.241 | 2700.0 | -9.62 | 1 | 5.0 | TiO2 | water | 10.0 | Cationic | 1.0 | buffer | 37 | 4 | 7.0 | nan | Surface proteomics on nanoparticles: a step to simplify the rapid prototyping of nanoparticles |
| Prot0649 | 200 | sphere | 200 | liposome | 500.0 | HP | nan | 0.126944444 | 15000.0 | 45 | 1 | 10.0 | LPD | water | 50.0 | Neutral | 1.0 | water | 37 | 25 | 7.0 | Plasma protein | Differential analysis of "protein corona" profile adsorbed onto different nonviral gene delivery systems |
| Prot0650 | 200 | sphere | 200 | liposome | 500.0 | HP | nan | 0.126944444 | 15000.0 | 45 | 1 | 10.0 | LPD | water | 50.0 | Neutral | 1.0 | water | 37 | 25 | 7.0 | Plasma protein | Differential analysis of "protein corona" profile adsorbed onto different nonviral gene delivery systems |
| Prot0651 | 200 | sphere | 200 | liposome | 500.0 | HP | nan | 0.126944444 | 15000.0 | 45 | 1 | 10.0 | LPD | water | 50.0 | Neutral | 1.0 | water | 37 | 25 | 7.0 | Plasma protein | Differential analysis of "protein corona" profile adsorbed onto different nonviral gene delivery systems |
| Prot0652 | 114 | sphere | 114 | liposome | 500.0 | HS | nan | 0.21 | 14000.0 | 29.8 | 1 | 15.0 | ADM70 | plasma | 50.0 | Anionic | 1.0 | water | 37 | 3 | 7.4 | Plasma protein | Biophysics and protein corona analysis of Janus cyclodextrin-DNA nanocomplexes. Efficient cellular transfection on cancer cells |
| Prot0653 | 149 | sphere | 149 | liposome | 500.0 | HS | nan | 0.41 | 14000.0 | 31.7 | 1 | 15.0 | ADM105 | plasma | 50.0 | Anionic | 1.0 | water | 37 | 3 | 7.4 | Plasma protein | Biophysics and protein corona analysis of Janus cyclodextrin-DNA nanocomplexes. Efficient cellular transfection on cancer cells |
| Prot0654 | 191 | sphere | 191 | liposome | 500.0 | HS | pDNA | 0.64 | 14000.0 | -16.3 | 1 | 15.0 | ADM105 | plasma | 50.0 | Anionic | 1.0 | water | 37 | 3 | 7.4 | Plasma protein | Biophysics and protein corona analysis of Janus cyclodextrin-DNA nanocomplexes. Efficient cellular transfection on cancer cells |
| Prot0655 | 153 | sphere | 153 | liposome | 500.0 | HS | pDNA | 0.34 | 14000.0 | -17.4 | 1 | 15.0 | ADM70 | plasma | 50.0 | Anionic | 1.0 | water | 37 | 3 | 7.4 | Plasma protein | Biophysics and protein corona analysis of Janus cyclodextrin-DNA nanocomplexes. Efficient cellular transfection on cancer cells |
| Prot0656 | 80 | tube | 80 | carbon | 91.0 | HP | COOH | 0.126944444 | 10000.0 | -57 | 1 | 20.0 | MWCNT | PBS | 91.0 | Anionic | 1.0 | buffer | 25 | 25 | 7.4 | albumin (HSA)/fibrinogen (FBG)/ γ-globulins (IgG) /histone H1 (H1) | The effect of protein corona composition on the interaction of carbon nanotubes with human blood platelets |
| Prot0657 | nan | sphere | 164.5 ± 2.3 | metal | 20.0 | FBS | nan | 0.094 ± 0.01 | 10000.0 | −28.9 ± 4.3 | 1 | 20.0 | BSV | PBS | 10.0 | nan | 1.0 | water | 37 | 25 | 7.2 | Serum protein | ProteinNanoparticleChargeandHydrophobicityGovernProtein CoronaandMacrophageUptake |
| Prot0658 | nan | sphere | 205.8 ± 3.8 | metal | 6.2 | FBS | nan | 0.110 ± 0.01 | 18000.0 | −28.7 ± 3.2 | 1 | 30.0 | OVA | PBS | 10.0 | nan | 1.0 | water | 37 | 4 | 7.2 | Serum protein | ProteinNanoparticleChargeandHydrophobicityGovernProtein CoronaandMacrophageUptake |
| Prot0659 | nan | sphere | 186.3 ± 2.3 | metal | 25.0 | FBS | nan | 0.070 ± 0.01 | 10000.0 | +28.5 ± 2.7 | 1 | 20.0 | cBSA | PBS | 10.0 | nan | nan | water | 37 | 4 | 7.2 | Serum protein | ProteinNanoparticleChargeandHydrophobicityGovernProtein CoronaandMacrophageUptake |
| Prot0660 | nan | sphere | 140 | Polymer | 100.0 | PBS | nan | 0.018 | nan | nan | 1 | nan | PEG-PLGA | PBS | 50.0 | nan | 1.0 | buffer | 37 | 25 | 7.4 | Plasma protein | Mechanistic understanding of in vivo protein corona formation on polymeric nanoparticles and impact on pharmacokinetics |
| Prot0661 | 244.5 | sphere | 244.5 | liposome | 1250.0 | HP | nan | 0.051 | 18000.0 | -43.4 | 1 | 3.0 | PSOSO3 | PBS | 10.0 | Anionic | 1.0 | buffer | 0 | 4 | 7.4 | Plasma protein | Physical-Chemical aspects of protein corona: Relevance to in vitro and in vivo biological impacts of nanoparticles |
| Prot0662 | 244.5 | sphere | 244.5 | liposome | 1250.0 | HP | nan | 0.051 | 18000.0 | -43.4 | 1 | 3.0 | PSOSO3 | PBS | 55.0 | Anionic | 1.0 | buffer | 0 | 4 | 7.4 | Plasma protein | Physical-Chemical aspects of protein corona: Relevance to in vitro and in vivo biological impacts of nanoparticles |